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Health research with developing countries has been part of the European Commission's research agenda 
under its regular research budget for almost 15 years. 
It  is currently part of the specific RTD Programme in the field of Cooperation with Third Countries and 
International Organizations (INCO):  activity II of the Framework Programme IV (1994-1998)  (see 
annex). 
The selection of research areas is based on existing and newly identified health needs in developing 
countries and on the capacity to cope with these needs through research. 
This document presents the "health systems research" component of the health sector under the !NCO-
developing countries  (INCO-DC)  programme and its  predecessor STD-3  (1991-1994).  It combines 
summaries of completed contracts for STD3 and a catalogue of ongoing and new contracts of STD3 and 
INCO-DC,  1st and 2nd call.  Other health research areas on the tools for prevention and control of 
diseases (e.g. vaccines, drugs and diagnostic products) are presented in other volumes. 
Science has offered the technical ability to have a major input to a wider variety of health needs in 
developing countries. This, however, has not been sufficiently translated into health benefits for the 
population at large. Historically there has been a lack of emphasis on properly questioning the health 
system particularly in the way scientific questions and results are effectively delivered in a cultural and 
socio-economic framework. Hence, the aim of this section in the INCO-DC programme is to strengthen 
the scientific basis of the delivery of healthcare in order to optimise the impact of the application of 
available resources. 
Particular emphasis is given to the process of partnership-building in science. Capacity and capability 
development for all teams involved (in developing countries as  well as  in the EU) is the key to this 
process. 
Scientific cooperation being an integral part of the EU research policy is therefore also an essential 
instrument in support of the development policy of the EU. 
The specific objectives and the operational modalities are dealt with in annex 1 and in the information 
packages which are produced to accompany each 'call for proposals'. 
Address: 
European Commission 
Health research with Developing Countries 
DG XIIIB-4 
Rue de Ia Loi, 200 
1049 Brussels 
Belgium 
Tel: +32.2.295.91.72 
Fax: +32.2.296.62.52 
E-mail: marc.de-bruycker@dg12.cec.be 
R. Gerold 
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The INCO-DC Workprogramme : 
Field of Health Systems Research (HSR) : part of health related research 
Research on health systems in the context of health sector reform 
Developing Countries (DCs) are currently engaged in reforms of their health 
sector,  involving  aspects  such  as  cost  recovery,  decentralisation  and 
privatisation, which will  have  profound  implications on  the effectiveness, 
efficiency and the  equity of health  care  delivery.  Others  have to build or 
rebuild health care systems after long periods of neglect often due to political 
and economic disorder. The beneficial development of this process requires 
research based on a systems approach which may use a variety of tools and 
approaches, such  as  epidemiological methods, social  science  approaches, 
operational  and  action  research.  Consequently,  research  should  use  the 
various  techniques  to  study  the  process  of change  occurring  in  health 
systems.  In  order to be  relevant, such  research  has to take account of the 
historical and demographically background and of the social and economic 
processes taking place. and should describe how these changes occur, while 
guarding against the trend to seek only simple technological solutions for 
complex  social  and  economic  problems.  Attention  will  be  paid  to  the 
following fields: evaluation of health policy and of the operational strategies 
of  health  care,  management  and  financing  of  the  health  services, 
development and  validation of decentralised  health  care  delivery models, 
optimisation of the development of human resources, the prerequisites and 
conditions for the transfer and the introduction of  technologies, coverage and 
utilization of health services, ways to promote equity and cost effectiveness, 
quality of care, gender issues, better case  management and follow up, and 
ways to increase the participation and autonomy of the population served. 
Research on nutrition will be eligible if proposed in the context of the above 
mentioned  guidelines,  or  when  it  relates  to  the  study  of  methods  and 
relevance of health interventions. 
Complementary areas bridging science and application 
The  programme  will  contribute  to  improved  coordination  and  to  better 
research  methodology in  fields of growing  interest and  for which  only a 
limited number of international  links are  currently established,  linking  EU 
scientists to their colleagues in DC's. Opportunities to combine research with 
existing initiatives or future development initiatives of the EU and of Member 
States in these fields will be exploited. These topics are: 
Relevance and methodology of health interventions 
A  large  number  of  problems  and  of  important  bottlenecks  have  been 
identified  for  the  evaluation  of  specific  tools  and  of  methods  for  the 
interventions in health in the field. Apart from technical aspects such as  unequivocal contribution of morbidity 
and mortality of the health problem under study, there are issues of strategy, 
of ethics and relevance to be covered. Studies and tests of interventions have 
to he  integrated  into the existing  health  systems  and  the process  of this 
integration can consequently form part of the research. 
The  research  workers  responsibility  for  the  results  of their  intervention 
research and for the continuation of the health services depending on these 
studies should be adequately addressed. In  order to be eligible for support 
under this heading, the health problem for which an  intervention is planned 
should be relevant in epidemiological terms as well as in terms of the needs 
expressed by the community in which it is studied. Innovative methods on the 
interventions on health problems will be supported for evaluation in the field. 
The planning of interventions should take account of ongoing activities in 
appropriate geographical areas and concentrate preferably on those fields 
where significant investments have already been made, or are planned, so 
that optimum use is made of existing capacities. 
Reproductive health 
The accent will be put on the identification and the coordination of research 
aiming to promote safe,  effective,  affordable and  acceptable  methods for 
people to realise their choices and decisions regarding fertility and sexuality 
in order to achieve a transition from a pattern of uncontrolled reproduction, 
high  mortality and  morbidity towards  a  pattern  of desired  reproduction, 
combined with low mortality and morbidity. The aim is also to arrive at the 
integration  of  the  various  aspects  of  mother  and  child  health  in  a 
comprehensive way. 
Environmental health 
The accent will be put on the identification and the coordination of research 
on  the  changes  of the  epidemiological  patterns  induced  by  man-made 
ecological  modifications  (e.g..  waterworks  of  hydrology,  land  use  and 
demographic  transitions).  This  research  should  have  direct  operational 
implications for the design of local and/or regional development plans and 
contain realistic possibilities of maintaining or of improving the health status 
of the population. 
Health and human settlements 
The changing and the increasing health problems arising from the growth of 
population and the rapid and uncontrolled urbanisation in DC's can be dealt 
with under this heading. Such  research  activities should be  identified and 
coordinated  in  order to develop new specific  methods and  strategies for 
interventions  leading  to  the  improvement  of the  health  status  of urban 
populations. 
9 The European Commission and support for Health 
System Research 
* Geographical distribution 
*Context STD-3 (1991-1994) 
Under  the  3rd  Framework  Programme,  the  predecessor  of  the  INCO-DC 
programme,  the  STD-3  programme  (Life  Sciences  and  Technologies  for 
Developing Countries:  1991-1994, area  Health), resulted  in the participation of 
223 scientific teams, spread over 168 institutions in 78 different countries. Of the 
140  health  related  STD-3  contracts,  26  were  on  Health  System  Research 
(including Nutrition). Over 115 scientific teams involving 37 countries (Figure 1) 
received  European  Commission support for this specific subtopic totaling 7.4 
Million ECU.  This represented  about 19%  of the total  health  research  related 
budget of this EC RTD programme (Figure 2). 
INCO-DC (1994-1998) 
Under the 4th Framework Programme, the I  NCO-DC programme (sector health) 
has,  as  a  result of the first and  second call  in  1995  and  in  1996,  selected  29 
projects related to Health System Research  involving 59  countries (Figure  1  ). 
Therefore, a budget of 11 Million ECU (so far 28% of  the contribution to the health 
sector  of  INCO-DC)  has  been  in  support  of  192  teams  dealing  with  this 
component of health research (Figure 2). 
The evaluation process related to the 3rd Call for Proposals of 1997 will select 
another group of projects to be operational in 1998. 
Positive trend 
Since  the  beginning  of the  European  Commission's  RTD  programmes  with 
Developing Countries a positive trend towards a wider interest in Health System 
Research could be noted. From STD-3 to INCO-DC, more high quality proposals 
have  been  selected  with  a  broader geographical  distribution.  New equitable 
partnerships have been initiated and ongoing collaboration has been reinforced. 
12 Figure 1 
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! l. Clinical intervention.studies for specific health problems Areas of interest: 
1. Clinical studies for specific health problems 
IC18*CT960033 
IC18*CT960045 
TS3*CT940311 
TS3*CT920137 
TS3*CT940282 
TS3*CT940331 
TS3*CT930231 
TS3*CT910026 
TS3*CT930218 
TS3*CT940320 
TS3*CT940332 
IC18*CT960053 
IC18*CT960086 
Magnesium sulphate administration for prevention of 
eclampsia: reducing the human and health service burden 
associated with hypertensive disorders of pregnancy 
Effect of zinc and vitamin A supplementation on diarrhoea 
and physical growth in children 
Persistent diarrhoea in early childhood - a prospective 
community study 
Clinical benefit of selenium supplementation after the 
correction of iodine deficiency: community based 
strategies for prevention of both trace element deficiencies 
Effet de !'ingestion des produits laitiers fermentes sur Ia 
capacite immune des sujets bien nourris et malnourris 
The effectiveness of different strategies of case detection 
and management of sexually transmitted diseases in 
Mwanza, Tanzania 
Appropriateness of diagnostic ultrasound at district 
hospital level 
Comparative advantages of contrasting biological 
responses to energy deprivation of third world rural 
populations 
Health systems research for the improvement of 
tuberculosis control in Aceh province, Indonesia 
Intervention trial to reduce mortality and improve outcome 
of hospitalization of the most common serious childhood 
infections in Maputo, Mozambique 
Comprehensive prevention and control of STI/HIV in high-
risk groups. Community intervention study on CSWS in 
Surabaya, Indonesia 
Ensuring clinical effectiveness by closing the gap between 
science and practice: a European/Southern African 
collaboration 
Tropical medicine on trial : producing reliable reviews, 
designing better intervention studies, and using 
systematic reviews to inform practice 
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21 Contract number IC18*CT960033 
CONCERTED ACTION : MAGNESIUM SULPHATE ADMINISTRATION FOR PREVENTION 
OF  ECLAMPSIA:  REDUCING  THE  HUMAN  AND  HEALTH  SERVICE  BURDEN 
ASSOCIATED WITH HYPERTENSIVE DISORDERS OF PREGNANCY 
Period: 
Co-ordinator: 
Objectives 
October 1, 1996- September 30, 1999 
CENTRE FOR STATISTICS IN MEDICINE, 
INST. OF HEALTH SCIENCES, UNIVERSITY OF OXFORD, 
Oxford, United Kingdom (L. DULEY) 
•  To  estimate the overall  effectiveness  and  safety (for women and  their babies)  of 
magnesium  sulphate  when  administered,  within  the  existing  health  services,  to 
women with pre-eclampsia. 
•  To  contribute to  The  Cochrane  Library by preparing  and  maintaining  systematic 
reviews of the care of women with severe pre-eclampsia, and by ensuring that the 
implications for  practice  within  developing  countries  are  discussed  in  Cochrane 
reviews relevant to the care of women with hypertension during pregnancy. 
•  To  enhance  and  strengthen  existing  collaborative  networks  within  developing 
countries, and to increase the capacity to conduct high quality primary and secondary 
research and to implement appropriate evidence into practice. 
Activities 
*  Develop  a  common  core  protocol  for  a  trial  to  evaluate  the  administration  of 
magnesium sulphate to women with pre-eclampsia. 
*  Conduct a collaborative randomised trial evaluating magnesium sulphate. Women 
with  pre-eclampsia  will  be  randomised  to  receive  either magnesium  sulphate  or 
placebo. 
*  Trial co-ordination and management. The international co-ordinating centre will be in 
the UK; regional co-ordinating centres will be in Argentina, South Africa and Thailand. 
An international steering group will supervise overall management of the trial. 
*  Training. Workshops will be conducted by each of  the co-ordinating centres, and there 
will be regular meetings of collaborators. 
22 
I 
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'• Contract number IC18*CT960033 
*  Recruitment. The estimated sample size is 14,000 women, and recruitment will take 
place over two years in Africa, South America, Asia, Europe and Australasia. 
*  Data  collection.  Primary  outcomes  will  be  eclampsia  and  perinatal  mortality. 
Secondary  outcomes  will  include  measures  of  serious  maternal  and  perinatal 
morbidity, and the use  of health service  resources.  Data  will also  be  collected  on 
compliance with the allocated treatment. 
*  Long-term follow-up of the children. Although not part of  this proposal, follow-up will 
be facilitated by generating randomised cohorts of children exposed and not exposed 
to magnesium sulphate in utero, and where possible collecting contact details for the 
children. 
*  Systematic reviews. Prepare and maintain reviews of the care of women with severe 
pre-eclampsia for the publication in The Cochrane Library. 
*  Implementation.  Develop  and  pilot  strategies  for  local  dissemination  and 
implementation of research evidence. 
Expected outcomes 
=>This trial will provide reliable evidence, of direct clinical and policy relevance, about 
the effectiveness and safety of magnesium sulphate for women with pre-eclampsia 
and their children. 
=> If magnesium  sulphate  is  effective, this study will  allow economic evaluation  to 
determine cost-effectiveness in a variety of settings. 
=> The results of this trial are likely to suggest hypotheses for the pathophysiology of 
eclampsia, and the mode of action of magnesium sulphate. 
=>This project will contribute to the mission of the Cochrane Collaboration by making 
available Cochrane reviews relevant to the care of women with hypertension during 
pregnancy. 
=> This project will strengthen the capacity within developing countries to design and 
conduct high-quality multicentre randomised trials. 
23 Contract number IC18*CT960033 
Partners 
Centre for Statistics in Medicine 
Institute of Health Sciences 
Old Road, Headington 
Oxford OX3 7LF 
United Kingdom 
Aarhus University Hospital 
Dept. of Obstetrics and Gynaecology 
37-39 Norrebrogade 
8000 Aarhus C 
Denmark 
Coombe Women's Hospital 
Dept. of Obstetrics and Gynaecology 
Dolphins Barn 
Dublin 8 
Ireland 
King Edward VIII Hospital 
Faculty of Medicine 
MRC Pregnancy Hypertension Research Unit 
Dept. of Obstetrics and Gynaecology 
PO Box 17039 
719 Umbilo Road, Congella H013 
South Africa 
University of Witwatersrand 
7 York Road, Parktown 
Johannesburg 2193 
South Africa 
University of Pretoria 
Dept. of Obstetrics and Gynaecology 
Private Bag X396 
Pretoria 0001 
South Africa 
University of Zimbabwe 
Medical School 
Dept. of Obstetrics 
Box A 178 
Avondale 
Harare 
Zimbabwe 
24 
L. Duley 
Tel: +44/1865/22.66.43 
Fax: +44/1865/22.71.73 
E-mail: lduley@cochrane.ac.uk 
N. Secher 
Tel: +45/86/12.55.55 
Fax: +45/86/19.74.13 
P.  Crowley 
Tel: +353/1/453.75.61 
Fax: +353/1/453.60.33 
J. Moodley 
Tel: +27/031/260.42.41 
Fax: +27  /031/260.44.28 
J. Hofmeyr 
Tel: +27/11/470.90.00 
Fax: +27  /11/470.90.90 
R.C. Pattinson 
Tel: +27  /12/373.80.41 
Fax: +27/12/373.90.31 
K. Mahomed 
Tel: +263/4/66.34.76 
Fax: +263/4n9.41.08 Contract number IC18*CT960033 
Partners 
Christian Medical College Hospital 
Dept. of OBGYN Unit 1 
Vellore 632004 
Tamil Nadu 
South India 
Escola Paulista de Medicina 
Centro de Estudos de Epidemiologia 
Grupo lnterdisciplinar de Epidemiologia 
Clinica - GRIDEC 
Rua Pedro de Toledo, 598 
Sao Paulo 
Brazil 
Centro Rosarino de Estudios Perinatales 
San Luis 2493 
Rosario 2000 
Argentina 
Hospital Universitario del Valle 
Dept. de Obstetricia y Ginecologia 
AA 020333 
Avenida Simon Bolivar 
Carrera 98# 18-49 
Colombia 
Concepcion Palacios' Maternity Hospital 
Dept. of Reproductive Endocrinology 
20714 San Martin, Av San Martin 
Caracas 
Venezuela 
K. George 
Tel: +91/416/22.102 
Fax: +91/416/32.1 03 
A.N. Atallah 
Tel: +56/11/570.04.69 
Fax: +55/11/549.21.27 
G. Carroli 
Tel: +54/41/48.38.87 
Fax: +54/41/48.38.87 
E.Cobo 
Tel: +57/2/331.7474 
Fax: +57/2/331.7499 
F.  Febres 
Tel: +58/2/451.2732 
Fax: +58/2/451.6442 
25 Contract number IC18*CT960045 
EFFECT OF ZINC AND VITAMIN A SUPPLEMENTATION ON DIARRHOEA AND PHYSICAL 
GROWTH IN CHILDREN 
Period: 
Co-ordinator: 
Objectives 
December 1, 1996- May 31, 2000 
UNIVERSITY OF BERGEN, CENTRE FOR INTERNATIONAL 
HEALTH, Bergen, Norway (H. SOMMERFELT) 
To measure the impact of supplementation with zinc alone and a combination of zinc and 
vitamin A on: 
•  the outcome of acute diarrhoea, particularly the risk of persistence. 
•  moderately malnourished children of 6-23 months of age. 
Activities 
The  efficacy  of  micronutrient  supplementation  will  be  assessed  in  a  two-centre 
placebo-controlled community-based trial where project staff will administer a single 
large dose of vitamin A  upon enrolment and  zinc  5 days per week until  12  weeks 
following recovery. 
The study will enrol a total of 1,600 children who will be followed up twice weekly to 
measure the impact on: 
*  enrolment diarrhoeal episode (duration of diarrhoea, number of diarrhoeal  stools 
during the episode, proportion of episodes that become persistent, and change in 
weight during the episode) 
*  subsequent diarrhoeal morbidity over 12  weeks (incidence of acute diarrhoea and 
persistent diarrhoea, and daily diarrhoea prevalence) 
*  growth over 12 weeks after recovery (change in weight and length/height and risk of 
developing severe malnutrition) 
Furthermore, the effect of zinc supplementation on serum and hair zinc levels and on the 
severity of the enrolment episode will be  measured after a programmatically relevant 
delivery approach, namely administration of zinc by mothers. 
Comparison of baseline features including hair- and serum-zinc levels will be tnade to 
confirm comparability across intervention groups. Outcome measures will be compared 
across the intervention groups initially on an 
11intent-to-treat-basis". Further analyses 
using  generalised  linear  models will  be  performed  to  adjust for any  imbalance  at 
baseline and to take into account intervention compliance. 
26 Contract number IC18*CT960045 
Expected outcome 
The study will assess whether daily supplementation with zinc alone or zinc combined 
with vitamin A substantially reduces the severity and duration of  acute diarrhoea and the 
nutritional insult of, particularly prolonged, diarrhoeal illness. If so, it is desirable and 
feasible  to  implement  this  reasonable  intervention  in  national  programmes,  an 
intervention which will be  particularly relevant to the 20% of children who experience 
recurrent diarrhoea and impaired physical growth. 
Demonstrating  the  postulated  benefits  of micronutrient supplementation  has  other 
important programmatic implications, for example in influencing which foods should be 
promoted  during  nutritional  counselling,  the  choice  of  diets  to  be  offered  in 
supplementation  schemes  and  strategies for micronutrient food  fortification, e.g.  of 
domestic salt, wheat flour and animal milk. 
Partners 
University of Bergen 
Centre for International Health 
Armauer Hansens Building 
5021  Bergen 
Norway 
All India Institute of Medical Sciences 
Indian Council of Medical Research 
Advanced Centre for Diarrhoeal Disease 
Research 
Paediatrics Department 
Ansari Nagar 
110029 New Delhi 
India 
Tribhuvan University 
Institute of Medicine 
Dept. of Paediatrics and Dept. of 
Community of Medicine 
Maharajgunj 
Kathmandu 
Nepal 
Statens Serum lnstitut 
Dept. of Epidemiology Research 
Artillerivej 5 
2300 Copenhagen S 
Denmark 
H. Sommerfelt 
Tel: +47/55.97.49.80 
Fax: +47/55.97.49.79 
M.K.Bhan 
Tel: +91/11/696.38.22 
Fax: +91/11/686.26.63 
R.K. Adhikari 
Tel: +977/1/52.44.88 
Fax: +977 /1/41.37.95 
K. Melbak 
Tel: +45/32.68.31.57 
Fax: +45/32.68.31.65 
27 Contract number TS3*CT940311 
PERSISTENT DIARRHOEA IN EARLY CHILDHOOD- A PROSPECTIVE COMMUNITY STUDY 
Period: 
Co-ordinator: 
Objectives 
January 1, 1995- December 31, 1997 
STATENS SERUM INSTITUT, EPIDEMIOLOGY RESEARCH  UNIT, 
Copenhagen, Denmark (K. M0LBAK) 
The aim of the study is to improve community - and health-center based management 
of acute and persistent diarrhoea in early childhood. Furthermore, we wish to suggest 
vaccine-based or other targeted interventions against acute and persistent diarrhoea, 
and explore the long term impact of infections with specific enteropathogens on child 
survival and growth faltering. 
Finally, the study will provide a substantial technology transfer to the National Public Health 
Laboratory in Bissau, and exchange and training of scientists, health workers and technicians. 
Activities 
The  core  of the study is  an  ongoing  prospective community based  surveillance for 
diarrhoeal disease, which is carried out in a semi-urban area of Bissau, the capital of 
Guinea-Bissau. All children below three years of age, residing in 600 randomly selected 
houses,  are  followed  by  weekly  visits.  At  these  household  interviews,  we  obtain 
information on diarrhoeal diseases, other morbidity, and feeding patterns. All children 
have their height and weight measured at three-monthly intervals. In  addition, more 
detailed anthropometric follow-up and microbiological examination of weekly collected 
stool samples are carried out in cases of persistent diarrhoea and in the intensive cohort 
(see below). 
Within this frame, the study contains three work packages: 
*  A  community-based,  randomized  controlled  trial  (RCT),  comparing  standard  oral 
rehydration salt (ORS) with reduced osmolarity ORS. 
*  The  development and  controlled  evaluation  of an  algorithm  for the  appropriate 
management of persistent diarrhoea. 
*  An intensive cohort study with weekly collection of stool specimens from birth to the 
age of two years. 
The  aim with this third package  is to determine the microbial etiology of acute and 
persistent diarrhoea and to characterize  in  detail  persistent, sequential  and  repeated 
infections by, as  well as  disease-to-infection ratios, for major enteropathogens. These 
data will be used for the investigation of the long term impact of infection with specific 
enteropathogens. 
Results 
Data collection for the RCT of reduced osmolarity ORS will be completed by the end of 
1996, with a total of 600 episodes of acute diarrhoeal episodes included. If low-osmolarity 
ORS  proves to be more efficacious and/or acceptable than standard ORS, a strong case 
has been made for changing the official recommendations for the composition of ORS. 
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For the management of persistent diarrhoea (PD),  an  algorithm was adapted  during 
1995.  The algorithm is  primarily based  on  dietary therapy with a frequently offered 
modified traditional diet, a millet gruel with an  energy density of 96 kcal/100 g, and a 
protein content of 2.3%.  In addition, children with PD  are examined at a health center, 
and  treated  with  antibiotics  or  antimalarials  upon  scientific  indications.  Follow-up 
includes  detailed  anthropometry,  including  knee-heel  measurements,  in  order  to 
evaluate catch-up  growth. Children  with  PD  from  a carefully selected  control  group 
receive  the  same  clinical  examination,  treatment  of  severe  infections,  and 
anthropometric follow-up as the algorithm group. 
The intensive cohort, with approximately 150 children, will be assembled during 1996. The 
sampling scheme, with weekly collection of stool specimens was implemented from early 
1996,  during  the  assembly  of the  cohort.  In  1995- 1996,  the  diagnostic  setup  was 
established  at  the  National  Public  Health  Laboratory  in  Bissau.  The  diagnosis  of 
enteropathogens  is  undertaken  by  a  combination  of  conventional  and  probe-based 
microbiological techniques. For the detection of pathogenic E.  coli, bacterial lysates are 
screened  by a  panel  of DNA  probes.  For  this  purpose,  a  number of different probes 
identifying the virulence factors of the most important diarrhoeagenic types of E.  coli as 
well as Shigella spp. have been modified and cloned into the same vector plasmid, PBS, 
thereby enabling an effective labelling with the non-radioactive marker digoxigenin by the 
polymerase chain  reaction  using  the  same  set  of primers for all  the different probes. 
Because of  the substantial sample load, a system of pooling the individual probes has been 
developed as well as systems for the handling and transportation of the large number of 
probe-positive strains. 
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University of Bergen 
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All India Institute of Medical Sciences 
Indian Council of Medical Research 
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Paediatrics Department 
Ansari Nagar 
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CLINICAL BENEFIT OF  SELENIUM SUPPLEMENTATION AFTER THE  CORRECTION  OF 
IODINE DEFICIENCY:  COMMUNITY BASED STRATEGIES  FOR  PREVENTION OF  BOTH 
TRACE ELEMENT DEFICIENCIES 
Period: 
Co-ordinator: 
Objectives 
December 1, 1992- November 30, 1994 
UNIVERSITE LIBRE DE BRUXELLES, FAC.  DE MEDECINE, 
CAMPUS ERASMUS, Mons, Belgium (J. VANDERPAS) 
A previous contract (TS20286.B TT)  has  documented combined severe  iodine (I) and 
Selenium  (Se)  deficiency  in  Northern  Zaire.  Also  a  detrimental  effect  of the  Se 
supplementation  in  1- and  Sa-deficient  subjects  on  thyroid  hormone  metabolism 
(aggravation of hypothyroidism), in schoolchildren and in cretins has been reported. 
The aim of this contract was to assess the safety and the efficiency of correcting first I 
deficiency, and thereafter the Se deficiency. 
Activities 
9 -18-year old schoolchildren (n = 100) were supplemented first with I (0.1 ml oral iodised 
oil  given  once  Lipiodol®).  After  2  weeks  (I  Day  +15/SeDay  0),  Se  (200  f..Lg/day  as 
Selenomethionine) (n = 78)  or placebo (n = 22)  was administered for 120 days. Blood 
samples and urine were collected at Day 0 (n =  100); at (I Day +15/SeDay 0) (n =  90); and 
at  I  Day+ 135/Se  Day  +  120  (n  =  81)  to determine the  Se  status  (plasma  glutathione 
peroxidase activity (GPX) and Se concentration) and the thyroid function (serum TSH, 
T4, T3,  urinary iodine); blood samples were also collected sequentially at intermediate 
intervals in subsamples of 10 to 13 subjects. 
Results 
=>Hypothyroidism (TSH>10mU/I) was frequent at entry in the study (58/100 cases, with 
41  cases of TSH>50 mU/ssa. It was corrected within two weeks after I supplement (I 
Day+15:  3/93  TSH>10  mU/1; 0/93  TSH>50  mU/1).  Hypothyroiodism was  no  longer 
observed up to I Day + 46. Nevertheless, at I Day +  75 and at I Day +  135, respectively, 
2/10  cases  and  9/77  cases  were  again  hyperthyroid.  1 absorption  was sufficient: 
urinary I was  very low at  entry in  the study (geom.  mean  ±1sd:  25(9.6-65)  f..Lg/1) 
(Normal: >50); it increased to elevated values within one month in all cases (I Day+  15: 
148(57-382) f..Lg/1;  I Day + 30:  221  (70-698)  f..Lg/1).  Ten  weeks after I supplementation (I 
Day +75), it was again in a deficiency range (39(26-59)  ~tg/1). 
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Conclusion I 
The  low  dose  of  oraliodised  oil  administered  is  not  adequate  for  some  young 
schoolchildren of Ubangi, Northern Zaire. 
Of the  81  schoolchildren  seen  at  I Day  +75  or at  I Day  +135,  12  cases  of recurrent 
hypothyroidism (TSH  >10  mU/1)  occurred  in  subjects initially hyperthyroid (TSH  > 10 
mU/A at  Day  0), suggesting  a decreased  functional  capacity  of the thyroid  in  an  I 
deficiency stress. 
Conclusion II 
By analogy to the marked involution of thyroid in cretins, short lasting response t.o  I 
supplementation in some schoolchildren could represent a less severe form of  the same 
defect. 
Serum thyroglobulin is  a marker of thyroid functional state.  In  various clinical states 
where thyroid volume is increased (goitre; adenoma; neoplasia) and/or the thyroid is 
stimulated (toxic adenoma; Graves-Basedow disease), serum thyroglobulin is markedly 
increased, and  reflects the thyroid functional capacity.  This biochemical  marker was 
used  to  assess  the  thyroid  functional  capacity  in  schoolchildren,  in  relation  to the 
responsiveness to iodine supplementation. In the schoolchildren poorly responsive to 
iodine supplement, initial serum thyroglobulin (Day 0) was less elevated than in those 
who adequately responded. By comparison, serum thyroglobulin was still significantly 
lower in  young  myxedematous cretins, with  paradoxically low serum  thyroglobulin 
levels in presence of  elevated serum TSH values. These data show that, besides endemic 
myxedematous cretins, a significant proportion of schoolchildren (12  out of 81  in our 
series, 15%) present a degree of decreased functional capacity of the thyroid gland. In 
other words, a low serum thyroglobulin concentration in a subject with elevated serum 
TSH  concentration (>10 mU/1) is predictive of a low response to iodine supplement. It 
remains to be  established whether,  in  some cases,  this decreased functional thyroid 
capacity is  already present in  neonates.  A  biochemical  spectrum covers the various 
degrees of decreased functional thyroid capacity in cretins and in phenotypically normal 
schoolchildren.  By taking the  ratio of serum thyroglobulin/serum thyrotropin, it was 
possible to discriminate with a 100 per cent sensitivity and  a 100 per cent specificity 
myxedematous  cretins  with  non-palpable  goitre  and  hyperthyroid  schoolchildren 
adequately responsive to iodine supplement. 
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Conclusion Ill 
This  is  the  definitive  confirmation  that  cretins  and  hyperthyroid  schoolchildren 
adequately  responsive  to  iodine  supplementation  belong  to  two  different  clinical 
entities,  with  a  blurred  and  less  well-defined  border  (hyperthyroid  schoolchildren 
inadequately responsive to iodine). 
Euthyroid  Hyperthyroid  Hyperthyroid 
(Euthyroid on  (Hyperthyroid on 
completion)  completion) 
TSH <10mU/I  TSH Day 0 >OmU/1  TSH Day 0 >10mU/I 
TSH 4 months >10mU/I  TSH 4 months >10mU/I 
n :33  n :36  n =  12 
DayO 
Serum Thyrotropin  2.9(2.1-3.9)  93(65-141)  104(52-213) 
Serum Thyroglobulin  346±46  1109±130  457±105 
1 Day +15/Se Day 0 
Serum Thyrotropin  1.3(1.0-1.7)  3.5(2.8-4.1)  8.6(5.6-13.2) 
Serum Thyroglobulin  151±52  262±44  204±61 
1 Day+ 135/Se Day +120 
Serum Thyrotropin  1.5( 1.2-1.9)  3.1 (2.5-3.8)  32(16-63) 
Serum Thyroglobulin  124±18  175±24  252±50 
Selenium  status  (plasma  GPX)  was  very  low  at  entry  in  the  study;  it  increased 
progressively in a log-linear pattern with time (normal: >630 U/1): 
Day+O 
189±93 
Day+7 
277±62 
Day+14 
431±141 
Day+21 
507±111 
Day+31 
631±133 
Day+60 
763±77 
Day+120 
902±188 
At the end of the study, serum T4 was lower (5.7±1.6 J.Lg/dl  vs 7.0±2.2 Jlg/dl) and serum 
TSH and T3 were similar in +I+Se group vs +1-Se group (TSH: geom. mean ±1sd: 2.9(0.9-
8.7) mU/1 vs 3.8(1.2-12.6) mU/1; T3: arithm mean ±1sd 134±26 ng/dl vs 136±38ng/dl). 
Conclusion IV 
When  I deficiency is first corrected, the correction of Se  deficiency involves a small 
decrease  of  serum  T4,  remaining  within  a  normal  range,  without  aggravating 
hypothyroidism.  Nevertheless, the short duration of effectiveness of small  doses of 
iodised oil in some schoolchildren requires  new strategies for covering an  adequate 
iodine supply in all subjects over the long term (intramuscular iodised oil; iodised salt). 
32 
j. 
I 
I 
! 
I 
I. 
i 
I Contract number TS3*CT920137 
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EFFET  DE  L'INGESTION  DES  PRODUITS  LAITIERS  FERMENTES  SUR  LA  CAPACITE 
IMMUNE DES SUJETS BIEN NOURRIS ET MALNOURRIS 
P~riod: 
Co-ordinator: 
Objectives 
January 1, 1994- December 31, 1996 
UNIVERSIDAD AUTONOMA DE MADRID, 
INSTITUTO DE NUTRICION Y BROMATOLOGIA, 
Madrid, Spain (A. MARCOS) 
•  Comparative effects of yoghurt (enriched with non-pathogenic lactic bacterial) and 
milk consumption on immunocompetence in a healthy population. 
•  Comparative effects of yoghurt (enriched with non-pathogenic lactic bacteria)  and 
milk  consumption  on  immunocompetence  and  on  nutritional  recovery  on  two 
malnourished groups: 
1.  Young  patients (12-18 years of age)  suffering from anorexia nervosa 
(eating disorder increasingly seen in developing countries). 
2.  Malnourished African children (4-24 months of age). 
•  According to STD programme, within general objectives, we will try to establish the 
role  played  by  fermented  dairy  products  on  immune  capacity  and  thereby  on 
nutritional status and recovery. 
Summary 
One of the causes of the increased susceptibility to infectious disease of malnourished 
individuals is an impaired immune function. In addition, immunocompetence has been 
shown to be depleted by infection and to be a sensitive and functional measure of the 
nutritional status. This work is aimed at assessing the effect of yoghurt (enriched with 
non-pathogenic  lactic  bacteria)  consumption  on  immune  capacity  and  thereby  on 
nutritional status and recovery in three groups: 
~Control,  consisting of 50 healthy subjects (12-18 years of age). 
~  20 patients (12-18 years of age) suffering from anorexia nervosa (eating disorder seen 
increasingly in developing countries). 
~  20 malnourished African children (4-24 months of age). 
Each  group will be  divided into two subgroups: a)  300  ml/day yoghurt consumption 
during 2 months and b) 300 ml/day milk consumption during 2 months. Dietary intake 
and anthropometric parameters (weight, height, body mass index, ideal body weight 
percentage,  skin  folds)  will  be  measured.  The  following  immunological  parameters: 
lymphocyte proliferation 8 lymphocytes (CD19), T lymphocyte subsets (C02, CD3, CD4, 
CDS),  NK lymphocytes (CD57),  serum C3  and  C4  complement factors and -interferon 
production will be evaluated. 
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Partners 
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THE  EFFECTIVENESS  OF  DIFFERENT  STRATEGIES  OF  CASE  DETECTION  AND 
MANAGEMENT OF SEXUALLY TRANSMITTED DISEASES IN MWANZA, TANZANIA 
Period: 
Co-ordinator: 
Objectives 
January 1, 1995- December 31, 1997 
INSTITUTE OF TROPICAL MEDICINE, 
Antwerpen, Belgium (A. BUVE) 
General and long term objectives 
•  To  assess  the  effectiveness  of  public  health  services  in  case  detection  and 
management of sexually transmitted diseases (STDs) occurring in the general rural 
population. Effectiveness is defined as the proportion of cases of STD occurring in the 
population, that C!Jre cured by the public health services. 
Specific objectives to be achieved by this project 
•  To  assess the losses of patients occurring at each  of the following steps between 
infection and cure: perception of STD-related symptoms by infected persons; care-
seeking behaviour; performance of the diagnostic procedure; reception by the patient 
of an efficacious treatment; patient compliance. Assessment of  these losses will allow 
estimation  of the cure  rate,  i.e.  the  proportion  of cases  of STD  occurring  in  the 
population that are cured by health services. 
•  To  assess  the  effectiveness  and  the  feasibility  of  improved  case  detection  and 
management of STDs through contact tracing. 
Activities 
The effectiveness of case detection and management will be assessed by quantifying the 
losses of patients through each  of the steps described under the specific objectives. 
Assessment of the losses is done by: 
*  Analysis of data already collected, including: the proportion of patients with STDs 
occurring  in  the  population  who  contact  the  public  health  services;  the  factual 
knowledge  about  STD  diagnosis  and  management  of  health  care  workers; 
prescription patterns for STDs. 
*  A series of focus group discussions on health care behaviour for STDs in the general 
community;  among  patients  attending  the  outpatient  department  of  a  district 
hospital; and among health care workers. 
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*  Interview  and  examination  of  a  random  sample  of  1,000  men  in  the  general 
population, in order to assess the prevalence of asymptomatic urethritis in men and 
the extent to which symptoms of urethritis are perceived as worrisome. 
*  Interview and  examination of 500  men and  500  women presenting at the general 
outpatient department of a rural district hospital. Patients found with an STD will be 
followed up to assess compliance and will be requested to bring their partners. This 
study will enable assessment of the following losses: losses through non-recognition 
of symptoms  by  health  care  workers,  losses  through  lack  of sensitivity  of the 
diagnostic procedure, losses through ineffective treatment and non-compliance. By 
assessing the prevalence of true infections among partners of patients diagnosed as 
suffering from an  STD,  the effectiveness of contact tracing, in terms of additional 
cases of STD detected, will be assured. 
*  An observational study on the performance of health centre staff in case detection and 
management of STDs. 
Expected outcome 
The study will provide crucial information to guide the planning and implementation of 
improved case detection and management of STDs at the primary health care level in 
Tanzania. 
Results (so far) 
Analysis of existing data on prescription patterns 
In  1993 a survey was conducted on the number of patients with STD syndromes seen, 
and treatments prescribed, in 6 health centres and 12 dispensaries in Mwanza Region. 
There were 26  different prescriptions recorded for genital discharge and  15  different 
prescriptions for genital  ulceration. All  prescriptions had,  as  their main component, 
procaine,  penicillin  or tetracyclic.  A  panel  of STD  specialists  estimate  that  of the 
gonorrhoea cases that presented themselves to the health centres 15 - 25%  received a 
prescription that would cure their infection; for chlamydia infections this percentage was 
20 - 30%. Of the patients with GUO  an estimated 80%  received a prescription that was 
efficacious in interruption transmission of T.  pallidum but not necessarily in preventing 
tertiary syphilis. None of the prescriptions given had any efficacy against chancroid. In 
contrast, the new treatment regimens that were introduced as part of an intervention to 
improve  STD  case  management  have  an  estimated  efficacy  of  over  90%  against 
gonorrhoea, chlamydia infection, syphilis and chancroid. 
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Key findings of the qualitative research into health care seeking behaviour 
~  The most critical characteristic about having an STD is that it is shameful. Having an 
STD is associated with promiscuity and low moral status. The Swahili term for STD 
can be translated as ''diseases of sinfulness/promiscuity". 
~  Shame  and  the  lack  of  privacy/confidentiality  at  government  health  centres 
constitutes the most important reason  why people do not seek early, sufficient or 
consistent treatment for STDs. Long waiting time is also significant in putting people 
off accessing government health centres. 
~As  a result, the majority of people prefer other avenues for seeking treatments (that 
offer  greater  privacy  and  less  waiting  time,  including  self-medication),  and  will 
usually only go to a health centre as a last resort. 
~  People  perceive  that  symptoms  =  disease;  therefore  the  lack  or  reduction  of 
symptoms =  lack of disease.  Pain  is  the primary marker for the seriousness of a 
disease; pain that is not particularly bothersome will often not be  acted upon. For 
these reasons delayed treatment and incomplete treatment are common. 
A population-based study on the prevalence of asymptomatic urethritis in men 
This cross-sectional study was carried out in  a rural community living near a health 
centre. One thousand men (78%) aged 15 to 54 years out of 1286 eligible study subjects 
agreed to participate. All men were first interviewed on symptoms suggestive of STD, 
then examined for urethritis including the taking of laboratory specimens. 30 men (3.1o/o) 
were infected with N gonorrhoea, 15 (1.5%) had a chlamydia infection, 105 men (10.9%) 
had Trichomonas and 61  men (6.3%) were found with non-specific urethritis. A  large 
proportion of the men with gonococcal  and/or chlamydia  infection were  unlikely to 
receive effective treatment. 
First of all, 50 to 60% were asymptomatic, or were not aware of symptoms. Of the ones 
who were symptomatic less than  40% sought care from services that could provide 
effective treatment, i.e.  a health centre, hospital or private dispenser. Most men with 
symptoms had bought drugs or taken herbal treatments or had consulted a traditional 
healer. 
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APPROPRIATENESS OF DIAGNOSTIC ULTRASOUND AT DISTRICT HOSPITAL LEVEL 
Period: 
Co-ordinator: 
Objectives 
January 1, 1994- December 31, 1995 
UNIVERSITY CHILDREN HOSPITAL HEIDELBERG, 
Heidelberg, Germany (H. BUSSMANN) 
To  assess  the  appropriateness  of  a  comprehensive  ultrasound  service  for  district 
hospitals. The diagnostic value, the economic impact and the acceptance by patients and 
staff were studied. 
Activities 
In  a representative district hospital diagnostic ultrasound was introduced for indicated 
medical  problems.  An  observational  study was  performed  using  questionnaires  on 
diagnosis and  patient management before and after ultrasound examination and for 
follow-up.  A  detailed  costing  study  was  performed  simultaneously.  The  effect  of 
ultrasound  on  diagnosis,  accuracy  of  diagnosis  and  patient  management  were 
measured.  The  opportunity costs  and  marginal  costs  were  estimated.  In  a  control 
hospital the conventional diagnostic work-up and the management of similar medical 
problems were recorded. 
The  understanding  and  reactions  of patients  and  staff to the  new technology and 
obtained information were studied. Information was collected through semi-structured 
interviews not later than 2 weeks after the ultrasound examination. 
Results 
The use of ultrasound as an additional diagnostic tool improved the diagnosis in 30.1% 
of indicated cases. In 47.4% of these cases an ultrasound diagnosis was made that was 
different from the clinical diagnosis. In  the cases of improved diagnosis an  uncertain 
clinical diagnosis could be confirmed by ultrasound with a high degree of certainty. 
Of particular value was the use of ultrasound in pregnancy-related problems for which 
the  study found  an  overall  improvement of diagnosis  in  44.3%  of examined cases. 
Especially in cases of bleeding and amenorrhoea the ultrasound-assisted diagnosis was 
often different from the clinical diagnosis and required a change in management. Other 
useful obstetric indications included the confirmation of intrauterine death, of multiple 
pregnancy and the determination of gestational age in doubtful cases. 
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Notably  in  non-pregnant  cases  the  sensitivity  and  prediction  of diagnosing  pelvic 
masses  in  female  patients  was  enhanced  with  important  consequences  for  their 
management.  Other  useful  indications  included  the  screening  in  blunt  abdominal 
trauma and the confirmation of pleural or pericardia! effusions. The use of ultrasound in 
palpated masses (abdomen, liver, thyroid, scrotum) revealed a variety of pathological 
findings leading to a more focused management while the diagnostic yield in conditions 
like haematuria, jaundice or abdominal pain was scarce. These findings emphasise that 
for a rational use of ultrasound it is mandatory that the indication is based on a careful 
examination of the patient by the requesting health care worker prior to the ultrasound 
examination. 
The  new technology was well accepted  by patients and  health care workers, though 
unrealistic expectations were  generally encountered.  To  prevent over-use  and  avert 
mystification of ultrasound it will be  important to convey the indications and limits of 
ultrasound to the medical staff and clients alike. The service appears to be economically 
affordable for the Botswana Health Care System. The initial capital investment based on 
1994  prices  (1  Pula  =  0.295  ECU)  were  Pula  92,271  and  the  recurrent  cost  of the 
ultrasound service Pula 60,468. They could have been funded by the unspent balance of 
the study hospital  budget in  1994/95 financial  year.  The  marginal cost of ultrasound 
investigation (Pula 0.50) was less than a quarter of that of carrying out at radiological 
examination.  The  average  and  marginal  cost  obtaining  an  improved  diagnosis  by 
ultrasound also appeared affordable; Pula  156.30 and Pula  1.76 respectively. Similarly 
the average and marginal cost of obtaining an opportunity to change therapy in order to 
improve health outcome appeared affordable; Pula  720.41  and Pula  8.10 respectively. 
Resource savings could be demonstrated for one group of patients which was clinically 
diagnosed as threatened abortion when the true diagnosis obtained by ultrasound was 
an incomplete abortion. The option to train a nurse to provide an ultrasound service for 
indicated common medical problems seems to be realistic and cost-saving. 
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COMPARATIVE  ADVANTAGES  OF  CONTRASTING  BIOLOGICAL  RESPONSES  TO 
ENERGY DEPRIVATION OF THIRD WORLD RURAL POPULATIONS 
Period: 
Co-ordinator: 
Objectives 
June 1, 1992- Dec 31, 1995 
ISTITUTO NAZIONALE DELLA NUTRIZIONE, 
UNIT OF HUMAN NUTRITION, Roma, Italy 
(A. FERRO-LUZZI) 
The specific objectives of  the study were to define the biological and functional response 
of chronic energy deprivation  in  Third World  populations,  and  more particularly to 
establish whether the preservation of residual body energy reserves overrides the need 
to maintain normal physical activity and work capacity. Interest in this issue stems from 
the need to define the limits of costless adaptation and to assess, when these limits are 
exceeded, the extent to which the damage is reversible. 
Activities 
Two diverse naturally occurring models of energy shortage were studied and compared: 
exposure to life-long energy deficiency in South Indian peasants, and exposure to an 
appreciable  seasonal  cycling  in  food  security  and  energy  balance  in  a  nutritionally 
borderline rural community in Benin. In  both localities the entire village population was 
. recruited in the study and longitudinally monitored for the anthropometric indicators of 
food  sufficiency  over  a  whole  agricultural  year.  These  data  served  to  provide  the 
background picture. In each community, a subgroup of individuals was recruited for the 
in-depth  investigation  of their biological  and  functional  status  at  contrasting  energy 
balance stages. Subjects were selected on the basis of their energy status as defined by 
their body mass index (BMI,  kg/m2).  Only adults, both  men and women, entered the 
study. 
In  Benin,  the  study  was  conducted  on  subsistence  farmers  living  in  two  areas 
characterised by unimodal climatic seasonality located in the south and the centre of  the 
country. An overall sample of 214 women and 198 men was selected on the basis of age 
(between 18 and 45 years), and having at least one child. The group was followed over 
almost  three  years,  their  weight  being  measured  at  close  and  regular  intervals 
throughout. A data set covering the whole period of measurement was obtained on 139 
men and 114 women. A subgroup of women was recruited for the in-depth study of  their 
work capacity and energy turnover at different times of the year. Food consumption and 
time allocation was measured on a subset of 34 women. 
In India the study was conducted in the south of the country, in an subsistence farming 
area where previous studies had demonstrated only a very moderate climatic and food 
availability seasonality. The growth of  the children and the body weight of  the population 
of the village, consisting of 212 households for a total of over 1.000 individuals of all ages. 
A sub-sample of 150 adult women and men was recruited on the basis of their BMI for the 
in-depth study, other 180 were recruited from the poor neighbourhood of the nearby city 
of Bangalore. The two groups were perfectly comparable from the biological, functional, 
health and nutrition point of view and the data have been pooled, totdling 330 subjects. 
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These have been divided into three groups, the well nourished one (BMI<18.5), the first 
grade chronic energy deficiency (CEO)  (BMI 17.0- 18.5), and the moderate and severe 
CEO  (BMI <17.0).  Food consumption, work capacity, energy turnover (basal  metabolic 
rate, BMR), time allocation and body composition were measured. 
Results 
In Benin, the population was on the whole relatively well nourished, with only 2 to 5% of 
the study population classifiable as 2nd grade CEO (BMI 16-17), and no more than 6 to 
10% of the entire study group having a BMI below 18.5. This contrasts profoundly with 
the Indian study population where up to 34% subjects had a BMI below 18.5 and more 
than 15% were below 17, denoting a very severe and widely spread condition of chronic 
energy deficiency. In  India, as  anticipated, there was no seasonal cycling of the body 
weight. In Benin, both men and women lost an appreciable amount of body weight (4.8 
to 6.4%} in association with seasonal energy stress (food shortage compounded by high 
demand for physical work) in the pre-harvest period. The post-harvest gain of weight of 
the Benin's subjects was weakly but significantly associated with the pre-harvest loss of 
weight and also over successive years. 
The energy intake of  the Benin subjects showed some seasonal fluctuations, with lowest 
value  (9.8  MJ/day)  being  recorded  during the  pre-harvest  season.  Households with 
insufficient  cereal  stocks  during  the  pre-harvest  period  (taken  as  an  indicator  of 
household  food  security)  differed  in  their coping  behaviour from  households with 
sufficient stocks,  such  as  gathering wild foods, selling  livestock, seasonal  migration, 
reduction of number of daily meals and actual fasting. However, these differences were 
not reflected  in  differences in  seasonal  body weight loss and  there was no  relation 
between weight loss of individual household members and their household food stocks. 
In India, the energy intake was remarkably lower than in Benin throughout the year, with 
average intakes ranging around 7.1  MJ/day (about 1700 kcal, or about 1.5 x BMR) for 
women and 9.2 MJ/day (2200 kcal) for men. Expressing the results as energy/kg body 
weight, a value of about 155 kj/kg is obtained for women. There was little or no indication 
of a seasonal influence on energy intake. 
The energy turnover rate, measured under the standard conditions of basal metabolic 
rate, did not show any seasonal change in Benin, while there was a 10% increase in the 
level  of physical  activity (PAL)  and  longer time dedicated to field  work and  less  to 
domestic and resting activities during the pre-harvest period. 
In  India there was no difference in energy turnover, once the differences in body mass 
were adjusted by covariance analysis. Furthermore, the BMR values of these subjects 
was accurately predicted by internationally accepted equations, contrary to widespread 
belief of an  ethnic-specificity  of BMR  in  Asian  populations.  There  were  acceptable 
differences in the proportion of time used by the various categories of BMI in activities 
classified  as  being  low,  medium  or high  energy cost.  The  differences were  gender 
specific and consisted in  longer hours in gainful work, in domestic work, with lesser 
discretionary activity and rest for low BMI women, while in men the major differences 
were in longer hours in agricultural work, less gainful employment and somewhat less 
discretionary activity for the low BMI men as compared to the high t3MI  men. 
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There were only minor differences in the work capacity during the pre-harvest period in 
Benin; with a slight decrease of their work capacity, defined as the ability to perform 
muscular work under standard conditions, only in the high BMI women. In India the work 
capacity of low BMI women, but not of low BMI men, was inferior to that of  the high BMI 
subjects. On  the other hand, low BMI  men - but not women - had a somewhat lower 
hand-grip strength. 
The body composition was studied only in India, measured by the multiple compartment 
method, in order to establish whether they had suffered important losses of protein and 
muscles from their body. It was found that there were indeed ''significant compositional 
differences" as compared to normal BMI controls, with noticeable reduction of the mass 
of  muscle  as  well  as  of  internal  viscera.  The  losses  were  present  already  at  the 
intermediate BMI category, and reached a maximum in the severely depleted low BMI 
subjects. 
Discussion and conclusions 
It is obvious that "adaptation" to cyclic periods of  varying food availability might involve 
a  set  of functional variables - capacity to do physical work,  resistance  to  infectious 
diseases, reproductive competence, learning capacity and mental ability, and avoidance 
strategies of a social nature. The survival value of the various coping strategies depends 
on a complicated balance of concurring conditions, and it is impossible to anticipate a 
set response. It seems nevertheless self-evident that a reduction in the food accessible 
to an individual or a household will result in less food being eaten and in the syndrome 
now called "energy stress". This does not necessarily translate into a negative energy 
balance of the individual, since reciprocal and equivalent compensatory adjustments 
may reduce the requirement for energy, e.g. by reducing physical activity and therefore 
energy expenditure. This reduction has however an associated cost, i.e. the drop of work 
production, just at the time when more is required. On the other hand, physical activity 
and work productivity can only be maintained if body energy stores are used. It has been 
demonstrated that at low levels of body fat, increasing amounts of lean tissue are used 
as substrate to meet the energy demands of the body. Muscle is the main reservoir, but 
also internal organs will be  eventually depleted. This strategy will result, if sustained 
over a sufficiently long period of time, in multiple functional deteriorations, affecting 
work capacity and immunocompetence. It is reasonable to think that under conditions of 
short-lived shortage of food, especially if these are anticipated as  in regular recurring 
pre-harvest food  shortage, the community might have to choose to use  their body 
energy stores. 
44 
I 
I 
l 
i 
I 
I 
! 
j· 
I 
I 
! Contract number TS3*CT910026 
This appears to be a convenient option when- as in the case of  the Benin peasants-they 
enter the food crisis with normal or near normal body fat stores. They lose weight, which 
is promptly regained when food becomes available again after the harvest. It will be a 
much less desirable option if- as in the case of the Indian peasants- the amount of fat in 
their body is  such  that any recourse  it will inevitable cause  important losses of lean 
tissues.  In  such  cases,  the only feasible  option would be  a  reduction  in  the energy 
expenditure, by cutting down on physical activity. In the long term, this condition will 
result in  a community of low weight, stunted  individuals, whose physical  activity is 
reduced and whose body composition is deeply modified. This is often the only choice 
available to nutritionally marginal poor communities. Our results clearly suggest that a 
low weight adult should be  regarded  as  a priority target for support measures, and 
indicate also that even minor weight losses in these conditions should be avoided at all 
costs,  as  they risk  precipitating  major and  permanent functional  and  compositional 
damage. 
Partners 
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00178 Roma 
Italy 
StJohn's Medical College 
Dep. of Physiology 
560034 Bangalore 
India 
Wageningen Agricultural University 
Dep. Human Nutrition 
Bomenweg 2 
6703 HD Wageningen 
The Netherlands 
Universite Nationale de Benin 
Fac. des Sciences Agron., Section de 
Nutrition 
P.O.  Box 526 
Cotonou 
Benin 
Yorkhill Hospitals 
Dept. of Human Nutrition 
G3 8SJ Glasgow 
United Kingdom 
A. Ferro-Luzzi 
Tel: +39/6/504.26.  77 
Fax: +39/6/503.15.92 
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HEALTH SYSTEMS RESEARCH FOR THE IMPROVEMENT OF TUBERCULOSIS CONTROL 
IN ACEH PROVINCE, INDONESIA 
Period: 
Co-ordinator: 
General objectives 
January 1, 1994- March 30, 1997 
KONINKLIJK INSTITUUT VOOR DE TROPEN, 
Amsterdam, The Netherlands (P.R.  LEVER) 
•  To  contribute to the reduction of the incidence of tuberculosis in Aceh  Province, to 
such a level that it is no longer a public health problem. 
•  To contribute to the reduction to a minimum of physical and psychological suffering 
due to tuberculosis. 
•  To  contribute to the development of research  and  management capacities of the 
health staff of Aceh. 
Specific objectives 
•  To  determine  the  present  tuberculosis  problem  and  performance  level  of  the 
tuberculosis control programme. 
•  To  determine  factors  influencing  perceptions,  health  seeking  behaviour  and 
compliance to tuberculosis among Aceh ethnic communities. 
•  To  determine the factors influencing health services performance in detection and 
management of tuberculosis cases. 
•  To identify commonly agreed actions for the improvement of the tuberculosis control 
programme through the presentation and discussion of findings and conclusions of 
the study with the central and provincial health policy makers, the community leaders 
and the health services staff. 
•  To implement, monitor and evaluate the actions described in the objective above. 
•  To disseminate information on the research at national and international level. 
Activities 
The research  is action-oriented and  multidisciplinary, combining the expertise of the 
three partners in tuberculosis control, epidemiology, medical anthropology and health 
services management. Activities to address the above-mentioned objectives include: 
*  A description and analysis of the present tuberculosis problem in Aceh, making use 
of available data from reports and past surveys, and additional studies in a sample of 
health facilities. 
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*  Focus group discussions, interviews and observations of staff in a sample of district 
health  facilities  to  identify  the  factors  that  facilitate  and  constrain  an  effective 
functioning of the health service. 
*  Based on the research results to generate recommendations for the improvement of 
tuberculosis  control,  implement  these,  and  build  a  structure  with  the  local 
management  to  maintain  a  sustainable  managerial  cycle  of  implementation, 
evaluation and reprogramming. 
Training 
In the second year~ two suitable health services managers are given the opportunity to 
attend  international  courses  in  health  development  and  PHC  management  in  the 
Netherlands and in Italy. On  return they will support the provincial and district health 
services staff in ongoing research and improvement of health services. 
Results 
In  July 1995,  the  data  collection  phase  was  completed,  and  a  research  report was 
prepared.  Owing  to  the  postponed  implementation  of  the  Indonesian  National 
Tuberculosis  Control  Programme,  it  proved  to  be  impossible  to  implement  the 
recommendations based  on these findings, and  an  extension of 9 months has  been 
granted to the project. At present, the main activities are focused on improving health 
education, whereby the findings of the research serve as the basis for health education 
messages. One health service manager has attended the International Course in Primary 
Health Care Management at the lstituto Superiore di Sanita in Italy in 1995, and one is 
presently attending the International Course in Biomedical Research Development at the 
Royal Tropical Institute in the Netherlands. 
Partners 
Koninklijk lnstituut voor de Tropen (KIT) 
Mauritskade 63 
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The Netherlands 
lstituto Superiore di Sanita, ICHM 
Viale Regina Elena 299 
00161  Roma 
Italy 
Provincial Health Services 
Aceh Province 
Jl Prof A Madjid Ibrahim Ill, 23242 
Banda Aceh 
Indonesia 
P.R. Lever 
Tel: +31/20/693.92.97 
Fax: +31/20/668.08.23 
G. De Virgilio 
Tel: +39/6/444.01.14 
C.ldawani 
Tel: +62/65/12.18.35 
Fax: +62/65/12.27  .55 
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INTERVENTION  TRIAL  TO  REDUCE  MORTALITY  AND  IMPROVE  OUTCOME  OF 
HOSPITALIZATION  OF  THE  MOST COMMON SERIOUS  CHILDHOOD  INFECTIONS  IN 
MAPUTO, MOZAMBIQUE 
Period: 
Co-ordinator: 
Objectives 
October 1, 1994 - September 30, 1996 
UNIVERSIDADE NOVA DE  LISBOA 
INST. DE HIGIENE E MEDICINA TROPICAL, 
Lisbon, Portugal (P.  FERRINHO) 
This project has the following specific objectives: 
•  Determine the contribution  of subclinical  vitamin  A  deficiency to  immediate and 
delayed case-fatality for diarrhoeal diseases (00), cerebral  malaria (CM)  and acute 
respiratory  infections  (ARI)  among  hospitalised  children  suffering  from  these 
diseases. 
•  Test the potential of routine VitA supplementation at hospital admission with regard 
to survival complications and recovery during hospitalisation for DO, ARI and CM. 
•  Determine the outcome of children admitted with DO, ARI, and CM in the 6 weeks after 
discharge to test the hypothesis that VitA supplements given at the time of admission 
to hospital improve recovery and diminish morbidity and mortality. 
•  Compare different methods of assessing subclinical deficiency of VitA. 
Activities 
Three groups of children with either DD or CM, admitted to the paediatric wards of the 
Central Hospital of Maputo with the appropriate criteria will be assigned randomly to a 
control (placebo) or a supplementation (receiving VitA) group and will be visited 6 weeks 
after discharge. All efforts will be  made to adhere to current practices regarding criteria 
for admission  or discharge. A  fourth  group of children  will  be  studied separately to 
compare different methods of measuring subclinical deficiency of VitA. All efforts will be 
made to adhere to current practices regarding criteria for admission and discharge. The 
different tasks associated with this research project can be grouped in five main activities: 
*  Administrative co-ordination of the project- will be the responsibility of Portugal. 
*  Scientific co-ordination -will be the responsibility of Maputo. 
*  Clinical aspects of the trial - responsibility will be shared between Mozambique and 
Portugal. 
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*  Public health aspects of the trial - responsibility will be shared between Antwerp and 
Portugal 
*  Nutritional aspects of the trial - responsibility will be  shared between Mozambique 
and Belgium. 
Expected outcome 
We expect that this research project can contribute to new knowledge in the following areas: 
=> Methodological:  it will  add  the  limited  literature comparing  different methods of 
assessing subclinical VitA deficiency. 
=>  Nutritional: it will contribute to further clarify the relevance of VitA supplementation to 
reduce morbidity and mortality in hospitalised small children with severe infections. 
=>  Health  system  effectiveness:  it  will  contribute  to  clarify  the  role  of  Vit  A 
supplementation as  a  means to increase the effectiveness of hospital care  in the 
overcrowded hospitals of Mozambique. 
=>  Health policy: it will guide policy development and implementation on an  issue on 
which  there  has  been  debate  in  the  Ministry of Health,  with  attempts at  policy 
formulation but only limited implementation. 
Partners 
Universidade Nova de Lisboa 
Institute de Higiene e Medicina Tropical 
Rua Da Junqueira 96 
1300 Lisbon 
Portugal 
Faculdade Medicina 
Universidade Eduardo Mondlane 
Dept. de Pediatria 
Prac;a 25 Junho 
C.P. 257 
Maputo 
Mozambique 
Institute of Tropical Medicine 
Dept. of Public Health 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
P.  Ferrinho 
Tel: +351/1/363.21.41 
Fax: +351/1/363.21.05 
M. Julien 
Tel: +258/1/42.49.10 
Fax: +258/1/42.52.55 
P.  Kolsteren 
Tel: +32/3/247 .63.89 
Fax: +32/3/247 .65.43 
E-mail : pkolsteren@itg.be 
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COMPREHENSIVE  PREVENTION  AND CONTROL OF  STI/HIV IN HIGH-RISK GROUPS. 
COMMUNITY INTERVENTION STUDY ON CSWS IN SURABAVA, INDONESIA 
Period: 
Co-ordinator: 
Objectives 
December 1, 1994- November 30, 1996 
VRIJE UNIVERSITEIT AMSTERDAM, FACULTY OF MEDICINE, 
Amsterdam, The Netherlands (W. DEVILLE) 
+ To study the feasibility of setting up a participatory health education programme for 
commercial sex workers in Indonesia. 
+ To  change  practices  and  attitudes  towards  risk  behaviour  in  female  and  male 
commercial sex workers in Indonesia. 
+ To  limit transmission of sexual infections including HIV in commercial sex work in 
Indonesia. 
+ To set up a surveillance system for sexually transmitted infections in commercial sex 
workers in Indonesia. 
+ To study the possibility of measuring qualitative changes by quantitative surveillance 
data. 
Activities 
*  A  Sexually  Transmitted  Infection  (STI)/HIV  bimonthly  screening  and  control 
programme is set up and evaluated with active participation of female CSW and the 
NGO active in these communities through participation in workshops. 
*  Health seeking, sexual and  risk behaviour and socio-cultural determinants of male 
and a category of female commercial sex workers and if possible their clients, are 
studied by !<ASP-questionnaires, condom-diaries, focus group discussions and  in-
depth interviews. 
*  An appropriate health education programme targeted at a specific group of female 
commercial sex workers through training and active participation of peers belonging 
to the target population and NGOs working with this study population is organised by 
the participating NGO and the impact will be evaluated by comparing exposed and 
non-exposed CSWs. 
*  Surveillance of STI/HIV and changed sexual behaviour in the target group by the local 
health system within the study area is set up in collaboration with the public health 
authorities and their prevention and control programme for STI/HIV. 
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*  Training of microbiologist in new techniques; training of social scientists in qualitative 
data collection techniques. 
*  Final regional workshop to discuss research findings. 
Results 
=>While  about  750  women  were  interviewed  by  a  KABP-questionnaire,  651  are 
registered at the clinics: about 170 pertain to the comfort exposed to the Peer Health 
Education  programme  by the  NGO.  81%  came  back  for the  first treatment  and 
maximal 60% of women taken in visited the clinics again for the first screening visit 
after two months. The treatment visit after the first screening was attended by 34%. 
Percentages follow-up of  treatment 1, screening 1 and treatment 2 are respectively 90, 
89 and 23% in Bangunsari and 73, 66 and 60% in Tambakasri (treatment percentages 
are calculated on the number attending the visit). 
=>Microbiology: N.  Gonorrhoea V1  14.7%, V2 5.2%; C.  trachomatis; V1  18.5%, V2 21.2% 
=> Condom diaries are collected by 90 sex workers and 4 focus group discussions with 
sex workers and pimps were organised. 
Partners 
Vrije Universiteit Amsterdam 
Faculty of Medicine 
Dept. Epidemiology and Biostatistics 
Van der Boechorstraat 7 
1081  BT Amsterdam 
The Netherlands 
Airlangga University 
Faculty of Medicine 
Mayjen Prof. Moestopo 47 
60285 Surabaya 
Indonesia 
Institute of Tropical Medicine 
Dept. Infection and Immunity 
Div. Microbiology 
Nationale straat 155 
2000 Antwerpen 
Belgium 
W. Deville 
Tel: +31/20/444.81.66 
Fax: +31/20/444.81.81 
E-mail: W.Deville.Biostat@med.vu.nl 
J. Barabhak 
Tel: +62/31/594.85.97 
Fax: +62/31/52.24.72 
M. Laga 
Tel: +32/3/247.63.16 
Fax: +32/3/247 .63.33 
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ENSURING CLINICAL EFFECTIVENESS BY CLOSING THE GAP BETWEEN SCIENCE AND 
PRACTICE : A EUROPEAN/SOUTHERN AFRICAN COLLABORATION (PHASE I) 
Period: 
Co-ordinator: 
Objectives 
August 1, 1996-July 31, 1997 
UNIVERSITY OF ABERDEEN, HEALTH SERVICES RES. UNIT, 
Aberdeen, United Kingdom, (J.M. GRIMSHAW) 
•  To  establish whether common research  models and implementation strategies are  i 
applicable to both EC countries and Southern Africa.  1· 
•  To  link synergistically with a CA study funded by the BIOMED 2 programme entitled 
II Bridging the gap between science and practice: How to change health care provider 
behaviour through implementing clinical practice guidelines" (short title: Changing 
Professional Practice) and any other relevant INCO funded projects in the Southern 
African region. 
•  To build a network of mutually supportive researchers in Southern Africa and Europe 
(involving partners from at least three countries in the EC and three in Southern Africa). 
•  To  train researchers in  Southern Africa in the methodology of systematic reviews, 
guideline development, guideline implementation, rigorous evaluations of guideline 
implementation and dissemination of findings of implementation research. 
•  To publish the results of this process in peer reviewed journals and develop resource 
materials for training researchers (monographs, databases, E-mail discussion groups). 
•  To work with the Healthlink and Health  Net networks - with the intention of thereby 
supporting their further development. 
Activities 
*  Develop a network of mutually supporting researchers in Southern Africa and Europe. 
*  Organise three education and training workshops to bring together European and 
Southern African participants in a collaborative network to support the development 
of research protocols for implementation studies. 
*  Publish four newsletters in paper and electronic (via the World Wide Web) formats. 
*  Develop training materials for future implementation research. 
Expected outcome 
=>The establishment of an implementation research network. 
=>The submission of a further application to the EC for continued funding to support the 
conduct of individual projects. 
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=>The  publication  of  a  project  newsletters  (in  paper  and  electronic  formats),  a 
monograph, articles on implementation research in developing countries. 
=> Presentation of study findings at national and international meetings. 
Partners 
University of Aberdeen, Medical School 
Health Services Research Unit 
Foresterhill 
Aberdeen AB25 2ZD 
United Kingdom 
J.M. Grimshaw 
Tel: +4411224168.18.18 ext.53968 
Fax: +4411224166.30.87 
E-mail: j.m.grimshaw@aberdeen.ac.uk 
Univ. of Cape Town, lnst. of Child Health  M. Power 
Red Cross War Memorial Children's Hospital  Tel: +271211658.5111 
Ronebosch 7700  Fax: +271211938.0342 
Cape Town 
South Africa 
Medical Research Council 
PO Box 19070 
Tygerberg, Cape Town 7505 
South Africa 
m.power@ich.uct.ac.za 
M. Zwarenstein 
Tel: +271211938.0247 
Fax: +271211938.0342 
E-mail: mzwaren@eagle.mrc.ac.za 
Danish lnst. for Health Services Research &  F.  Boerlum Kristensen 
Development (Formely Danish Hospital lnst.)  Tel: +45135.29.84.42 
Dampfaergevej 22  Fax: +45135.29.84.99 
POB 2595  E-mail: fbk@dsi.dk 
1119 Copenhagen 0 
Denmark 
University of Newcastle upon Tyne 
Centre for Health Services Research 
21  Claremont Place 
M. Eccles 
Tel: +4411911222.6780 
Fax: +4411911222.6043 
Newcastle Upon Tyne  E-mail: Martin.Eccles@newcastle.ac.uk 
Northumbria NE2 4AA 
United Kingdom 
1st. di Richerche Farmac. 
11Mario Negri" 
Laboratory of Clinical Epidemiology 
Via Eritrea 62 
Milano 20157 
Lombardy 
Italy 
University of Zimbabwe 
Dept. of Obstetrics, The Medical School 
PO Box A178 
Avondale 
Harare 
Zimbabwe 
A. Liberati 
Tel: +39121390.1411327 
Fax: +39121332.00.231 
E-mail: liberati@imimnvx.irfmn.mnegri.it 
K. Mahomed 
Tel:+ 26314n41.542 1794.108 
Fax: + 26314n94.1 08 1  621.345 
E-mail: kmahomed@healthnet.zw 
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TROPICAL  MEDICINE  ON  TRIAL  :  PRODUCING  RELIABLE  REVIEWS,  DESIGNING 
BETTER  INTERVENTION STUDIES, AND USING SYSTEMATIC REVIEWS  TO  INFORM 
PRACTICE 
Period: 
Co-ordinator: 
Objectives 
October 1, 1996- September 30, 1999 
LIVERPOOL SCHOOL OF TROPICAL MEDICINE, 
Liverpool, United Kingdom (P.  GARNER) 
+ To produce and update reliable systematic reviews of randomised controlled trials in 
parasitic and tropical diseases, and other conditions relevant to the tropics. 
+ To  develop relevant research questions and trial protocols in  parasitic and tropical 
diseases. 
+ To develop and evaluate approaches using systematic reviews to improve clinical and 
public health practice in various professional specialities and regions. 
Activities 
*  Encourage,  support  and  produce  protocols  to  conduct  systematic  reviews  of 
randomised controlled trials in conditions relevant to the topics. 
*  Encourage, support and produce completed systematic reviews from these protocols. 
*  Encourage, support and ensure publication of  these reviews on The Cochrane  Library 
and in relevant specialist journals. 
*  Assist individuals to produce good research questions and trial protocols to answer 
these questions. 
*  Set up nodal points for networks stimulating the use of evidence to improve  clinical 
and public health practice. 
Expected outcome 
I 
I 
I, 
I 
I' 
=> Completed systematic review protocols produced within the network and published  j· 
on The Cochrane Library. 
=> Completed systematic reviews produced within the network and published on  The 
Cochrane Library and in journals. 
=> Full research trial protocols submitted for funding. 
=> Units will be established within developing countries with a range of dissemination, 
research and development activities promoting evidence-based health care. 
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HEALTH SYSTEMS RESEARCH IN URBANIZING AND RURAL SETTINGS IN THAILAND 
Period: 
Co-ordinator: 
Objectives 
July 1, 1992 -June 30, 1995 
INSTITUTE OF TROPICAL MEDICINE, PUBLIC HEALTH 
RESEARCH & TRAINING UNIT, Antwerpen, Belgium 
(H. VAN  BALEN) 
•  To develop a health care service model that is more effective and efficient. 
More specifically the project sets out: 
•  To find appropriate methods to support the development of a primary care model, by 
strengthening the general practitioner or family practice. 
•  To find ways to develop an integrated health system. 
•  To develop the research and management capacity of the health personnel. 
The  project is  designed  as  an  action-research  project with  a  pre-operational  phase 
(situation  analysis)  and  an  operational  phase  (implementing  decisions  treated  as 
hypotheses to be tested). Actors are involved at central level (planning unit), at academic 
level (Mahidol University) at Provincial Health Office level and at district level. External 
actors  are  situated  in  the  field  of  Public  Health  (Antwerp)  and  General  Practice 
(Edinburgh University and Lothian Health Board). 
Activities 
*  In the urban area of Ayutthaya, plan the coverage with Primary Care facilities (Health 
Centres headed by a medical doctor); set up a pilot Health Centre and expand to a 
second one before the end of the project period. Establish the necessary operational 
links with the town's Provincial  Hospital  in  order to move towards an  integrated 
system of health care delivery. 
*  In  peri-urban areas, upgrade the existing nurse-led Health Centres through regular 
and sustained supervision (conceived as continuing education) by hospital doctors. 
Identify training needs and establish referral and counter-referral instructions. 
*  In the rural district of Nakornluang, redraw a rational coverage plan for first line health 
services and strengthen selected  nurse-led Health Centres for higher curative care 
effectiveness through training and regular supervision. 
Results 
In Ayutthayatown, two Health Centres are operating now. They are functioning as pilot 
demonstration structures, used for developing the necessary management tools and for 
practical  training  purposes.  General  practice  concepts  are  incorporated  in  the basic 
management concepts of these health centres. A  revised financing and fee system is 
implemented, which appears to be sustainable. The Ayutthaya experience serves as the 
basis for a national health care reform project. 
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FORMULATION  OF  A  PARTICIPATORY  METHOD  FOR  PLANNING  SUSTAINABLE 
NUTRITION AND NUTRITION-RELATED COMPONENTS OF PROGRAMMES, PROJECTS 
AND  EXISTING  SERVICE  DELIVERY  SYSTEMS:  URBAN  AND  RURAL  SETTINGS 
CONTRASTED 
Period: 
Co-ordinator: 
Objectives 
February 1, 1992-July 31, 1994 
INSTITUTE OF TROPICAL MEDICINE, DEPT. OF PUBLIC HEALTH, 
Antwerpen, Belgium (P.  KOLSTEREN) 
The general objective of the study was the improvement of nutrition among deprived 
populations with emphasis on effective and sustainable development processes rather 
than  on  nutrition  interventions. The  study aimed,  in  particular,  at the development, 
testing and final formulation of a simple, comprehensive, participatory and sustainable 
nutritional  planning  methodology for urban  and  rural  settings. The  research  puts a 
strong emphasis on the development of methods to ensure genuine participation and on 
the adaptation of tools developed for programmes and projects to permanent service 
delivery systems. 
Activities 
The  project  built on  earlier  research  conducted  essentially  by the  same  teams,  on 
methods and tools for evaluating complex nutrition interventions. It explored to what 
extent the  approaches  and  tools used  in  evaluation  can  be  applied  in  planning.  A 
theoretical  component included  a  review of literature, the  analysis of past  nutrition 
planning experiences and the building of an  updated basis for nutrition planning. The 
field component was sub-divided into three sub-projects-two in the Philippines and one 
in  Indonesia. The field projects tested the provisional approach in  widely diversified 
settings. When needed, new tools were developed. The approach was, for the first time, 
applied  to  an  urban  setting.  Development of training  components  was  specifically 
included  in  the  workplan  of each  of the  field  projects  - as  necessary  steps  in  the 
development of  the planning method. Systematic use of lessons from consultancies and 
from teaching were explicitly referred to as one of the research methods to be used. 
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Results 
The  main  outcome  of the  research  is  a  comprehensive  and  participatory  planning 
methodology,  applicable  in  both  urban  and  rural  settings,  with  the  following 
characteristics: 
::::> emphasis on effective and sustainable development; 
==>  systematic use of models; 
==>the use of both qualitative and quantitative information; 
==> flexibility; 
==>  a strong learning component; 
==>  highly participatory. 
A proven advantage is both the usefulness and the feasibility (under certain conditions) 
of getting  genuine  participation  in  planning.  Another  important observation  is  the 
importance of a II pre-planning stage" for which principles and general rules have been 
developed. Underlying theoretical assumptions were also developed. 
The feasibility and readiness of the approach led to its high acceptance and three field 
sites. The research proved to be particularly relevant in the context of decentralisation. 
Substantial  insights were gained  in the use  of RAP  in  planning. PARCA,  an  adapted 
version of PRA, was developed by DAERS. An existing tool for selecting interventions on 
the  basis  of criteria,  but never  genuinely employed  on  the field,  was  applied  with 
success. A guide for the elaboration of technical documents as well as a set of prototype 
technical documents were also prepared. 
The  project has  resulted  in the production of an  important degree of Know How on 
implementing participatory planning, organisation of workshops and training of local 
governments both in the Philippines and in Indonesia. One of  the outputs of  the research 
was the production of training materials. The active educational procedures that were 
adopted went well beyond their initial purpose of training for planning. They became, 
through the stimulation of self-reliance, an educational approach to local development 
and empowerment. 
As  a result of the field work, three municipalities (2  in the Philippines, one district in 
Jakarta) have developed a municipal development plan with the support of the research 
teams. These plans were eventually implemented. 
In  the  context  of  the  urban  planning  exercise  in  Jakarta,  in-depth  studies  on 
determinants of urban undernutrition have been conducted. In addition, two annotated 
bibliographies on urban nutrition (one in English, one in Indonesian) were prepared. 
A number of outputs, not initially planned within the research, took place. The approach 
is now adopted by the BSF/IFAD programme as  its official planning approach (Belgian 
Survival Fund.  Programme Support Unit. BSF Joint Programme. Annual Report 1995. 
Rome: International Fund for Agricultural Development). 
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This adoption of the approach is the result of a number of consultancy missions which 
were  occasions  to  test  the  approach  in  genuine  field  situations  for  IFAD  (Kenya; 
Seychelles; Chad; Uganda) and other international organisations and NGOs (MEMISA, 
SCF, UNICEF). A nutritional assessment for UNICEF supported Area Based Child Survival 
and Development Projects) in the SUBASTA provinces in the Philippines was conducted 
by IHNF with support of NU-ITM. The DAERS research team has been invited by a large 
NGO  (MADICOR),  to  train  municipal  and  local  government  officials  from  different 
regions of the Philippines. IHNF actively participated in these courses. This permitted 
further refinement of the methodology, manuals, and teaching aids. In  Indonesia, the 
research has led to the design of an intervention on 
11Street foods" with a UNICEF/NGO 
11forum" and the NGO 
11Save the Children Fund". 
South  South  collaboration  has  been  strengthened,  mainly through  a  joint partners 
meeting which included visits to field realisations and, by invitations from other teams, 
to  planning  workshops  as  resource  persons.  Training  opportunities  for  the  junior 
researchers through active  interchange (both ways between  North and  South)  have 
been offered and fully taken advantage of. Teaching also benefited from the research: the 
various participants in the research teach the method and/or parts of it (steps, tools) at 
the international postgraduate courses of Amsterdam (ICHD), Antwerp (ICHD),  Ghent 
(ICFSN), Los Banos (FN"P) and Wagennigen (ICFSN). It is envisaged that the developed 
planning approach could be taught within a European Masters course in global nutrition 
with an emphasis on North-South collaboration. 
Finally, the approach is now being developed and adapted to specific country situations. 
In Uganda and Kenya, for instance, the approach is being adapted for use in intersectoral 
nutrition planning at district level. 
Dissemination of research results 
Research  results have been, and are still in the process of being, largely disseminated 
through  teaching  and  training  and  various  formal  presentations.  Although 
dissemination through more classical channels, i.e.  publications, is on-going, it is far 
from being achieved. In terms of scientific publications, two books (one on evaluation 
and one on planning) and about 25 interrelated working papers or journal articles are still 
planned on participatory planning and associated fields, in addition to material already 
produced (see references). Drafted or advanced outlines have been prepared. Scientific 
production  has  been  delayed  by  funding  problems,  communication  delays,  the 
unanticipated retirement of the project co-ordinator and the sudden death of a senior 
research collaborator. Additional funds for achieving publication work have by now been 
secured (outside CE funding) in 1997 and 1998. 
Conclusions 
=> The central hypothesis of the research, i.e. that the approach initially developed for 
evaluation would apply equally well to planning, has been confirmed. 
=> Most of the tools produced earlier have been adapted for planning purposes. 
=> Some local governments and organisations have adopted the approach. 
=> The approach proved to be workable in urban areas. 
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ACTION RESEARCH ON THE UTILIZATION OF HEALTH SERVICES IN BURKINA FASO 
Period: 
Co-ordinator: 
Objectives 
January 1, 1993- February 28, 1997 
UNIVERSITAT HEIDELBERG, INST. FOR TROPENHYGIENE 
& OEFF. GESUNDHEITSWESEN, Heidelberg, Germany 
(H.J. DIESFELD) 
The study focuses on four research questions related to the utilisation of health services 
in Burkina Faso. 
•  Which level of comprehensive care will influence which level of the state of health of 
the community? 
•  Does  low  cost  and  high  quality  of care,  along  with  availability  of  medicines, 
encourage the population to make further use of the health services? 
•  Does the participation of the community in decision-making and resource allocation 
increase the utilisation and improve the effect of the health care service? 
•  Can  health  personnel  be  motivated  by  focused  and  appropriate  training,  close 
supervision and/or quality assurance and availability? 
Activities 
This is an  action research project. A number of interxentions will be implemented and 
their impact evaluated. Community level interventions are: 
*  Organising community groups to develop and manage a pharmaceutical stock. 
*  Establishment of mechanisms for a functional communication between these groups 
and the health service system. 
*  Creation of mothers' groups to take charge of the home management of six target 
health problems of children (diarrhoea, ARI, malnutrition, malaria, measles, neonatal 
tetanus) in collaboration with health services. 
*  Training of a community health agent as an  informant and communicator to follow-
up the population in their charge. 
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Interventions in the health system are: 
*  Standardisation and rationalisation of the diagnostic methods in health care training 
programmes. 
*  Improvement  of the  relations  between  the  users  and  the  service  personnel  to 
integrate as  much as  possible the entire spectrum of preventive and curative care 
during their daily consultation. 
*  Reduction of the cost of health care. 
The  analytical  procedures examine the impact of these  interventions by longitudinal 
household studies in  3000  households in terms of change  in  age-,  sex- and  season-
dependent morbidity, mortality, cost of ill-health and service utilisation, completed by 
quality  interview-techniques  and  by  participatory  observation  of  health  services 
performances and utilisation. 
Expected outcome 
The project is expected to result in an  improved quality of care in the study sites, in a 
more cost-effective health care, and in increased community participation. 
Partners 
Universitat Heidelberg 
lnst. fur Tropenhygiene & Oeff. 
Gesundheitswesen 
lm Neuenheimer Feld 324 
69120 Heidelberg 
Germany 
Ministere de Ia Sante 
Direction d'Etude et Planification 
B.P. 7009 
Ouagadougou 01 
Burkina Faso 
Universite d'Ouagadougou 
Ecole Superieure des Sciences de Ia 
Sante 
B.P. 7021 
Ouagoudou 
Burkina Faso 
ORSTOM 
Dep. sur Ecologie Humaine 
Off. Rech. Outre-Mer 
Rue Lafayette 213 
75840 Paris Cedex 10 
France 
H.J. Diesfeld 
Tel: +49/622/156.53.44 
Fax: +49/622/156.59.48 
A.Zougba 
Tel: +226/30.72.97 
Fax: +226/31.45.52 
A. Traore 
Tel: +22/630.75.43 
Fax: +22/630.26.39 
M. Garenne 
Tel: +33/1/480.70.829 
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AUDIT BY ISSUE FOR HEALTH MANAGEMENT (AIHM): DEVELOPMENT OF A METHOD 
TO  INTEGRATE  HEALTH  INFORMATION SYSTEMS, DISTRICT  LEVEL  MANAGEMENT 
AND IN-SERVICE TRAINING IN TANZANIA 
Period: 
Co-ordinator: 
February 1, 1993- December 31, 1995 
LIVERPOOL SCHOOL OF TROPICAL MEDICINE, 
Liverpool, United Kingdom (P.  SANDIFORD) 
This project included three sub-projects: 
1.  Audit by issue for Health Management 
2.  Monitoring Equity during the Health Reform Process 
3.  The Public/Private Health Care Mix 
Audit by issue for health management 
Objectives 
To test the hypothesis that ''health care delivery can be improved by identifying existing 
problems through the analysis of available data". 
Activities 
*  An issue of importance to health care delivery is selected and an  a priori appraisal 
prepared of the scope for management intervention. 
*  An audit protocol is developed, tested and applied to generate information relevant 
to the issue identifying performance failings and guiding managers in their search for 
solutions. 
*  The  results  are  presented to a  meeting of the District Health  Management Team 
(DHMT), decisions are taken and a detailed plan of action is agreed upon. 
*  The  method is  a planning and evaluation  procedure, based  on the District Action 
Research  and  Evaluation  process,  but in  contrast employs strict criteria for issue 
selection, and  bases  decision-making on the information generated through prior 
analyses of relevant data. This data may come from the routine health information 
system or from ad hoc enquiries. Participants at AIHM meetings are carefully selected 
to guarantee involvement of key  individuals with the power to make or influence 
policy decisions on the particular issue under audit. 
*  Four  issues  were  tackled  in  a  series  of  overlapping  four-monthly  cycles:  the 
distribution of  trained staff among the district's dispensaries; immunisation coverage; 
the  allocation  of essential  drug  kits;  and  the  availability  in  health  units  of non-
pharmaceutical supplies and equipment. Detailed description of findings from these 
audits  have  been  published.  When  the  second  phase  of the  project  started  in 
September 1992, two audit issues from the first phase were ongoing. 
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Findings 
=> Poor management of health services is not primarily the consequence of insufficient 
or inadequate data. 
=>When  presented  with  information  demonstrating  inefficiency,  ineffectiveness  or 
inequity in health care delivery, managers may not always take measures to rectify the 
faults, even if  these lie within their power, and especially if  the decisions might involve 
some risk. 
=>  Managers will sometimes take decisions to improve health care delivery on the basis 
of information, but are more likely to do so where their actions are unlikely to lead to 
any discontent. 
=> Plans made are often not implemented, even if feasible. 
=>Within the existing system there are virtually no incentives for managers to make 
improvements nor sanctions for poor performance. 
=> Inaction is considered less open to reproach than failed action. 
=> Though AIHM  can  lead  to decisions and  actions which  improve health care,  it is 
doubtful whether this or any other planning and evaluation method would continue 
to be used without ongoing encouragement and funding from external parties. 
Monitoring equity during the reform process 
Objectives 
•  To  develop a  new socio-economic status  indicator based  on  the Wealth  Ranking 
technique. 
•  To establish the relevant 
•  To compare the performance of the new index against traditional methods. 
Activities 
*  Undertake wealth ranking exercises in 14 sites in Tanzania. 
*  Use the 5,900 rankings acquired to develop alternative indices. 
*  Undertake reliability checks of the eight indices employed. 
*  Check for validity using the convergent/divergent technique. 
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Findings 
~The  wealth-ranking technique provides an alternative means of developing indicators 
of socio-economic status. 
~To  identify the range and quality of activities/services provided by public, voluntary 
and private dispensaries. 
~To  perform cost-analysis of activities/services performed  by public, voluntary and 
private dispensaries. 
~  To assess perceptions of health providers (in-charges and health workers) on quality 
of their health services at dispensaries. 
~  To assess patients' satisfaction with health services delivered by public, voluntary and 
private dispensaries. 
~To  identify existing information systems in public, voluntary and private dispensaries. 
~  To  formulate  recommendations  on  public/private  mix policies  regarding  services 
provided at dispensary level. 
The Public/Private Health Care Mix 
Findings 
~  The  public  dispensaries  have  the  highest  capacity  in  providing  curative  and 
preventative services according to national guidelines. 
~  Public dispensary output and unit costs are the best among all sectors. 
~  Strengthening  the  public  dispensaries  and  renewing  their  mandate  to  continue 
providing these services is advised. 
~The  voluntary sector provides about one third of all health services in the country and 
has  a  high  capability  in  providing  outpatient services  in  terms of infrastructure, 
equipment and instruments. 
~  It is  hampered by shortages of trained clinical staff as  is partly evidenced by over-
prescription observed in voluntary dispensaries. 
~  Voluntary dispensaries performed well with EPI services which mainly dealt with the 
immunisation of children. 
~  The  private  sector  is  an  emerging  sector  in  the  provision  of health  care  at the 
peripheral level in Tanzania. 
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THERAPY CHOICE, UTILIZATION AND SATISFACTION IN KINSHASA 
Period: 
Co-ordinator: 
Objectives 
December 1, 1994- November 30, 1997 
KATHOLIEKE UNIVERSITEIT LEUVEN, DEPT.  FOR SOCIAL 
AND CULTURAL ANTHROPOLOGY, Leuven, Belgium 
(R. DEVISCH) 
This action-research concerns the identification of the local  health  needs as  they are 
expressed  and  lived  by  the  help-seekers  in  the  different  healthcare  settings. 
Furthermore,  for a  limited  number of common  psycho-social  health  problems, the 
research aims at discovering the etiological rationale underlying the networks of illness 
categorisations and recourse: on which grounds do patients prefer medical treatment 
and/or  ~~traditional"  treatment  (for two types  of culture-bound  idioms  of distress)? 
Wherein  does  the  specific  treatment  in  different  healthcare  settings  differ?  Which 
answers do they provide? What is the proper and particular role of  the public psychiatric 
hospital  and  of the  private  medical  clinic with  regard  to different psychosocial  and 
psychosomatic  complaints?  How  do  patients  value  the  (success  of the)  treatment 
provided? 
The major aim of the action-research is to improve medical (-psychiatric) healthcare by 
redefining its focus, etiological and therapeutic means, as well as the quality of care, in 
line with the local culture. Also to be improved is its accessibility according to principles 
of cultural rationale, equity and social justice. 
Activities 
*  Selection of key informants, namely professionals from among traditional healers, 
healing churches, and medical-psychiatric health-care, in Koongo-Yaka communities 
in neighbouring townships of Kinshasa. 
*  Identification of the ecological situation in the respective communities in relation to a 
limited number of common psycho-social health problems. 
*  Setting up a culturally and locally adapted methodology of questionnaires, interviews 
and rating instruments. 
*  Investigating the symptoms, the expression of distress, the family psychodynamics, 
the  explanatory  models  used,  the  different  forms  of  treatment  and  coping 
mechanisms, the etiological and therapeutic rationale. 
*  Developing a new set of integrated interventions. 
*  Setting up a workshop for training with a view to the implementation of the research 
and the intervention. 
Introducing the integrated pilot intervention model in the selected community. 
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*  Identifying 50 patients and 50 healthy persons in the communities. Investigation with 
psychiatric and  psychodynamic questionnaires, as well as through anthropological 
methods, both before, during and after the therapy. 
*  All partners evaluation of the results. 
*  Adapting the original psychosocial intervention programme. 
*  In-depth follow-up of 10 patients. 
*  Data-processing,  diffusion  of  scientific  results.  Research  activities  with  doctors, 
traditional and spiritual healers and their patients in two health zones. 
Context and method 
The general ecological and social situation in Kinshasa is characterised by the different 
effects of the  continuing  economic crisis  in  Zaire.  The  health  situation  is  extremely 
difficult to  investigate  because  the  official  services  are  unable  to  provide  reliable 
information. On the one hand, patients seek less and less help in hospitals and 
11Centres 
de sante" or stop their treatment and follow-up owing to lack of financial means. On the 
other hand, there is an increase of small private clinics and dispensaries. Pharmaceutical 
shops,  often  kept  by untrained  personnel,  can  be  found  in  every  street,  and  auto-
medication with all kinds of drugs is high. There is a tendency to take early medication 
for minor diseases with ampicillines, cibalgine, indocid, etc  .. The use of traditional types 
of health  care  through  professional  or non-professional  healing  or through spiritual 
healing is expanding. 
One has the impression that each family finds its own way in this chaotic and fragmented 
offer of care.  In  the  general  exploration  of this situation  no clear  patterns could  be 
described  by  the  key  or  lay  informants.  Lay  people  could  inform  us  only  on  the 
functioning  of the  health  system  on  the  basis  of their  individual  experience,  key 
informants (doctors, centres de sante, healers) had no grasp of  the patterns in the whole 
system.  It means that the solution to health  problems is  highly individualised and  is 
found by trial and error. 
The global investigation made also visible that three fields of healthcare are existing and 
are used in all the zones of Kinshasa: medical field, traditional recognised/not recognised 
field, field of healing churches. Patients easily move from one field to another. Traditional 
and  spiritual  healers  may  from  time to time  send  their  patients  to  a  hospital  for 
investigation or for specific medical care. 
It became clear during the first phase that patients and families do not search for care 
only in their own health area,  but often travel to a doctor, hospital, centre,  healer or 
church rumoured to provide successful treatments. We  have therefore not limited the 
research to healthcare providers to Ndjili and  Mont Amba. A questionnaire had  been 
designed  in  January-April  1995  that  could  be  used  for  interview with  healers  and 
doctors.  This  questionnaire,  in  Lingala  and  French,  uses  the  same  structure  as  the 
questionnaire designed for the random sample of patients and families. 
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It contains questions about (i) types of illness: description of symptoms, symptomatic 
behaviour,  body sensations  and  metaphors;  development and  prognosis of illness; 
explanatory model of cause; cultural and social factors; diagnostic classification system; 
explanatory model of different treatment procedures, rituals and interventions; results, 
model of evaluation of satisfaction; (ii) diagnostic procedures, conditions and price of 
treatment,  contact  and  attitudes  towards  previous  or  new  health-care  providers; 
possibilities of collaboration; (iii) therapeutic training and personal history of the healer. 
Focus 
This exploratory work with patients and  healers/doctors focused  on  three  particular 
clusters of illness-states: (i)  somatisation, depression and anxiety states; (ii) psychotic 
and dissociate states; (iii) epileptic and paroxystic states. 
They were selected because they may be cured in the three care-systems (traditional, 
spiritual and medical healers). These patients usually travel through these systems in 
their health-seeking  career.  All the  patients with these  illnesses that we  met in  the 
therapeutic context of  the healer, the healing church or the clinic as well as in the random 
sample  of Ndjili  and  Mbanza  Lemba,  had  different therapies  and  complex therapy 
histories. 
The category of somatisation, depression and anxiety has been treated first in a somatic 
medical  setting  because  multiple somatic complaints are  always  part of the  illness 
experience. Treatment consists of large prescriptions of symptom-focused medication 
after expensive investigation. Patients in these categories have to spend lots of money 
for their different treatments and often, when not cured, they become chronically ill and 
excluded from social life. 
The treatment of  these illnesses by traditional healers of healing churches is based on the 
explanation that an invading element (ancestral spirit, diabolic spirit) with a bad quality 
produced the illness and  has to be  removed. The patient is  a repository of disturbed 
· relations or transgressions in the family group. The treatment will consist of removing the 
bad  element,  recreating  the  boundaries  of the  person  and  restoring  the  disturbed 
relationships.  Herbal  therapy  is  often  used  and  is  specific  for  each  illness.  Group 
treatment  is  offered  in  the  healing  churches,  providing  support,  containment  and 
interpretation. 
In  the  medical  - psychiatric  setting  the  patients  are  treated  according  to  classical 
psychiatric  standards  of diagnosis  and  treatment.  Psychiatrists  or doctors who are 
psychodynamically oriented use concepts like repression and projection of guilt, sexual 
and aggressive drives. They help patients to have individual insight in their problems 
and become more individuated and autonomous. But most of the patients who come to 
them ask for treatment of the symptoms and consider that healers can treat the causes 
better. Doctors who reflect on the underlying culturally-based family dynamics, try to 
find ways to intervene at this level in their therapies. 
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Action-research 
In two settings, a committee has been formed from seniors and healers, who proceed to 
a detailed  collection  of information  about the  practices  of traditional  healers  in  the 
district. They transmit this information to people in need through formal and informal 
channels,  and  organise  meetings  of the  committee  with  traditional  healers.  With 
patients,  they  increasingly  handle  questions  about  control  of therapeutic  quality, 
diagnostic procedures, fees,  collaboration with health  centres  and  healing churches, 
network formation, and needs of  the community. We are trying to bring a medical doctor 
into these committees. 
Partners 
Katholieke Universiteit Leuven 
Dept. for Social and Cultural Anthropology 
Tiensestraat 102 
3000 Leuven 
Belgium 
Universite de Kinshasa 
Centre de Coord. Sciences Sociales 
BP836 
Kinshasa XI 
Congo 
Regionale lnstelling Ambulante 
Gezondheidszorg (RIAG) 
Parallelweg 47-49 
6221  BD Maastricht 
The Netherlands 
R. Devisch 
Tel: +32/16/32.60.07 
Fax: +32/16/32.60.00 
E-mail: 
rene.devisch@ant.kuleuven.ac.be 
L. Dimomfu 
J. LeRoy 
Tel: +31/43/29.96.1 0 
Fax: +31/43/29.96.56 
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INTERACTIONS ENTRE LES SVSTEMES DE  SANTE PUBLIQUE ET LES CONCEPTIONS 
ET PRATIQUES POPULAIRES RELATIVE A LA MALADIE 
Period: 
Co-ordinator: 
Objectives 
December 1, 1997- November 30, 2001 
ORSTOM, DEPARTEMENT SANTE, Paris, France 
(J.P. OLIVIER DE SARDAN) 
•  To  describe and  interpret the practices and  popular representations in connection 
with health and the illness in West Africa, and their interactions with the practices and 
representations of the health workers. 
•  To  use thus collected socio-anthropological knowledge to improve the quality of the 
care. 
Activities 
Activities will proceed in several languages of major extension, in particular bambara-
dioula, songhay-zarma, peul, hausa .... 
In each one of these cultural surfaces, six topics will be investigated. 
*  Complaint and language of the symptoms. One will give priority to an analysis of the 
dynamic of transformation of the semiology popular of the symptoms and of the 
''language of evils". 
*  Topic 2. Contagion, contamination, transmission. One will be attached to a systematic 
inventory of the local definitions of contagion, of contamination, of the epidemic, or 
of the other "methods of acquisition"  of the  illnesses,  as  well  as  of the popular 
practices of prevention and of hygiene which are dependent to them. 
*  Topic 3. The popular nosological entities. One will analyse in each culture the principal 
popular nosological entities, which appear like "hold-all" from a biomedical point of 
view, but which are endowed for the unit and coherence people. 
*  Topic  4.  The  management of fruitfulness  and  of sexuality.  One  will  carry  out a 
comparative analysis of  the representations and popular practices associated with the 
sexual act, with the pregnancy, with the failure and with the labour. 
*  Topic  5.  Health  and  logical  structures  of those  involved.  One  will  carry  out  an 
evaluation  of  programmes,  projects  and  health  actions  and  of  their  social 
registrations.  Each  health  site  will  be  regarded  as  sand  where  groups  of those 
involved confront themselves endowed with logics, with resources and with different 
interests. 
*  Topic 6. The health interactions of the countryside to the city. One will be attached to 
the analysis of the effects on the popular practices and representations of a series of 
variables connected with the urban way of life and of sociability. 
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Expected outcome 
~  course  of "anthropology of health  applies  to  public  health"  (from  West  African 
materials), bound for the health personnel (doctors, male nurses, midwives). 
~  teaching materials concerning the popular practices and designs in connection with 
certain priority pathologies. 
~  implementation, collaboration with members of the health professions, of inspired 
experimental  preventive  or  curative  actions  of  the  identified  conclusions; 
improvement of  the look after-looked after reports and of the education messages for 
health. 
~  production of articles and of scientific works. 
~  development of socio-anthropological evaluation methodology of the public health 
actions and of the projects in the health field. 
Partners 
ORSTOM/EHESS 
Centre de Ia Vielle Charita 
13002 Marseille 
France 
Fac. Med, Pharm & Odonto-stomatologie 
Unite d'Etudes et de Recherches en 
Anthropologie de Ia Sante 
BP 1805 
Bamako 
Mali 
lnstitut des Sciences Humaines 
Dept. d'Ethno-Sociologie 
BP 159 
Bamako 
Mali 
University of Heidelberg 
Abt. fur Tropenhyg. & Off. Gesundh. 
Ringstrasse 15 
69115 Heidelberg 
Germany 
Groupement lnterdisciplinaire en Sci.Soc. 
04 BP 293 
Abidjan 04 
Ivory Coast 
University College 
Dept. of Anthropology 
60 er Street 
London WC1 E 6BT 
United Kingdom 
J.P. Olivier de Sardan 
Tel: +33/4/91.14.07.53 
Fax: +33/4/91.91.34.01 
E-mail: sardan@chess.cnrs-mrs.fr 
v. Jaffre 
Tel: +223/23.43.52 
Fax: +223/22. 75.88 
V.F.  Kone 
Tel:+ 223/22.63.78 
R. Schumacher 
Tel: +49/6221/60.05.82 
Fax: +49/6221/16.43.10 
M. Kone 
Tel: +225/35.43.67 
Fax: +225/35.40.15 
M. Last 
Tel: +44/171/387.70.50 x 2446 
Fax: +44/171/380.77.28 
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AN  APPLIED  INTERDISCIPLINARY  RESEARCH  PROJECT  TO  INVESTIGATE  THE 
UTILISATION AND PERCEPTION OF HEALTH CARE SYSTEMS BY INFANTS AND THEIR 
FAMILIES 
Period: 
Co-ordinator: 
Objectives 
October 1, 1992- March 31, 1996 
CENTRE INTERNATIONAL DE L'ENFANCE ET DE LA FAMILLE 
(CIDEF), Paris, France (A. TURSZ) 
This  research  carried  out  in  four developing  countries  (Algeria,  Morocco,  Congo,  Togo)  by 
multidisciplinary teams combining the fields of epidemiology, anthropology or sociology, and 
economics, had the following objectives: 
•  To analyse the utilisation of diverse components of the health system by children under five. 
•  To analyse the users' and health professionals' views of illness and health care. 
•  Using the results from the above analysis, to promote sustainable and appropriate action and 
improve child care. 
Expected outcome 
The  project aimed  at strengthening the capacity of researchers to conduct multi-disciplinary 
research projects in the field of child-health. Based on the study results, reforms in health care 
were to be suggested, taking into consideration the economic, social and cultural dimensions of 
health care. 
Activities 
Data  from a descriptive first phase  had  been  gathered in the four countries during the STD2 
programme. This phase included an  epidemiological study of the use of the different types of 
health facilities caring for children, and an anthropological study in families both using and not 
using these facilities, as well as among health personnel (physicians and allied health personnel 
in the public sector, private physicians and nurses, and tradipractitioners). The research  began 
later in the Congo than in the other countries. It was carried  out with considerable difficulty 
because of serious social and political problems in three of the countries beginning in late 1992 
(Algeria, Congo, Togo). The work in this project was as follows: 
*  The completion of data collection of the first phase for the Congo. 
*  The  continuation  of  analysis  of  epidemiological  data  and  anthropological  information 
collected during the first phase. 
*  The development of specific research projects on topics identified during the first phase of  the 
research  (the  utilisation of medicinal drugs by children  in Togo, emergencies, therapeutic 
interventions, and behaviour of health personnel in Morocco). 
*  The development of training activities and applied research. 
*  The organisation of meetings on research progress. 
Teaching  activities  have  been  carried  out  primarily  in  Algeria,  and  have  consisted  of the 
development of innovative teaching methods using results from the anthropological study (the 
contents  of  interviews  with  families  on  health-seeking  behaviour  for  sick  children).  These 
activities have targeted  health  professionals in  initial training programmes (nurses)  or in the 
context of continuing education (interns and  residents  in  hospital departments).  In  Morocco, 
activities were carried out at the level of health centres and ''diagnostic centres" with the object 
of improving the  rate  of utilisation  of curative  facilities  and  of reducing  the  percentage  of 
"unjustified" emergencies and self-referrals. 
80 Results 
In  all the countries, results converged and demonstrate the association between problems of 
health-seeking  behaviour  encountered  by families  on  the  one  hand,  and  problems  of the 
functioning of health services on the other. At the family level, one is particularly struck by the 
length of the delay between first symptoms and consultation, and by the high frequency of self-
medication at home. Recourse to traditional practitioners appears to be of modest importance. It 
appears that, rather than there being a problem of incorrect use of health services by patients, 
there is a problem of delayed recourse to these services. Patients often arrive at hospitals late, 
after  complex  therapeutic  itineraries,  with  the  consultation  taking  place  under  emergency 
conditions and with sometimes high mortality among hospitalised children. Families have a good 
understanding of how the health system functions. It appears however that they are discouraged 
by the considerable problems posed  by social  relations and communication with health care 
personnel. A teaching programme such as the one developed in Algeria thus appears justified 
since it would allow professionals to understand the complexity of health-seeking behaviour and 
their own role in problems of health-system functioning. In Morocco, a relative failure of activities 
undertaken by the Moroccan team was attributed primarily to the lack of sociological input on the 
role of families and on interaction between them and health care personnel. 
A final seminar brought together all the participants in March of 1996. Future collaboration is 
planned: an  extension of training activities in the Congo and in Togo; development of a project 
on the use of drugs in Congo and Togo; activities at the level of health care centres in all the 
countries, with integration of results of this research into existing programmes, as is already the 
case with the National Plan for Health Development in Congo. 
Partners 
Centre Int. de I'Enfance & de Ia Fa mille (CIDEF) 
Chateau de Longchamp 
Bois de Boulogne 
75016 Paris 
France 
Institute of Tropical Medicine 
Public Health Research and Training Unit 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
In st. Nat. des Sciences Medicales d'  Alger 
16000 Alger 
Algeria 
In st. Nat. d'  Administration Sanitaire 
Km 5, Route de Casablanca 
Rabat 
Morocco 
Universite Nationale du Benin 
Faculte de Medecine, Service de Pediatrie 
BP 4657 
Lome 
Togo 
Ministere de Ia Sante 
Dir. de Ia Sante Maternelle et Infantile 
BP 13217 
Brazzaville 
Congo 
A. Tursz 
Tel: +33/1/44.30.20.00/30 
Fax: +33/1/45.25.73.67 
B. Dujardin 
Tel: +32/3/247.62.89 
Fax: +32/3/216.14.31 
J.P. Grangaud 
Tel: +213/227.97.86 
Fax: +213/227.97.64 
R. Belouali 
Tel: +212n/61.16.26 
Fax: +212n/69.10.82 
K. Assimadi 
Tel: +228/21.46.70 
Fax: +228/21.57 .06 
S. Nzingoula 
Tel: +242/83.55.53 
Fax: +242/83.62.44 
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IDENTIFICATION  DES  CONDITIONS D'AMELIORATIONS DE  LA REFERENCE/CONTRE 
REFERENCE DANS LES DISTRICTS DE SANTE 
Period: 
Co-ordinator: 
Objectives 
January 1, 1993- December 31, 1996 
INSTITUT NATIONAL D'ADMINISTRATION SANITAIRE, 
COLLEGE DE SANTE, Rabat, Morocco (A. LAABID) 
+ To  test the impact of the introduction of recognised technical tools (partogramme, 
reference/cross-reference cards) 
the emergence of a real dialogue between the two levels of district health 
professionals 
the quality of patient care 
+ To exchange experiences between the various partner countries and strengthen the 
institutions directly involved in the research. 
Activities 
1.  Morocco 
Study of the system of reference and cross reference (RCR) between health centres and 
reference hospitals (Sefrou and Khemisset provinces). 
Accompanying measures: staff training, revision of information system, strengthening 
of supervision activities, direct dialogue between the two levels of district doctors. 
Study of the behaviour of the professionals and the population as regards the reference/ 
cross reference. 
2.  Congo 
*  Study of the reference system between the integrated health centres and reference 
services (Makelekele and Dolisie districts) 
*  Accompanying  measures:  motivation  of the  personnel  and  the  user  population, 
exemption from fees of consultations and paraclinical examinations for the referred 
patients, staff training, outline of algorithm. 
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3.  Chad 
*  Study the system of reference and cross-reference between nurses and doctors in the 
district of Bousso 
*  Accompanying  measures:  introduction  of  curative  strategies  at  the  first  level, 
introduction of schedules for follow-up of first results?, staff training, team meetings, 
follow-up of referred cases. 
4.  Switzerland 
*  Study concerning the practitioners of the communication problems with the hospital 
(Jura Canton) 
*  Study of the clinics in two hospitals (Delement and Porrentry) on the decision making 
process  leading  to  hospitalisation  and  the  communication  between  doctor  and 
patient 
*  Analysis of the literature on reference and cross-reference. 
Results 
1.  Congo 
Despite  the  difficulties  encountered  in  the  implementation  of the  research  (socio-
political problems), the results recorded are encouraging. The  health system is  better 
known  by the personnel  and  by the users.  The  references  are  increasingly accepted 
thanks to the effort made to explain them, the cross references are being progressively 
installed, the quality of reception and the maintenance of an information support system 
are  significantly  improving.  False  pros  and  cons  which  characterise  the  curative 
consultation in the health centres tends to regress, notably with the introduction of the 
suitable management tools. Enthusiasm for research has been maintained and extended 
to other health structures. The school for public health distributes a model for the system 
of referencing and cross-referencing. 
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2.  Morocco 
In the two site districts of the project, the system of reference and cross-reference (RCR) 
has shown its relevance and its efficacy as a strategy to make management of  the district 
group more dynamic. Thus the objective of starting a dialogue between the doctors from 
the health centres and those from the reference hospitals has been relatively achieved. 
This has since resulted in a series of  chain reactions concerning the problems of RCR and 
relating to all the aspects which concern the managers: organisation of care, information 
system,  management  of  human  resources,  management  of technology,  continued 
training, research, etc. 
Among the problems identified with the aid of this new approach, a good number of 
them have been resolved, such as: 
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the workload of  the general practitioner has been lessened due to a the delegation 
of tasks to the nursing personnel 
the  lack  of  cooperation  from  referred  patients  has  been  improved  due  to 
appropriate reference criteria being established 
the non-adaptation of the existing information system concerning management 
of curative care  has  been  corrected  due to the introduction of a  new system 
adapted to local needs 
the lack of involvement of the hospital doctors in the supervision of the health 
centres has been partly overtaken Contract number TS3*CT920112 
Partners 
lnstitut National d'Administration Sanitaire 
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B. Dujardin 
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Fax: +242/83.01.07 
H. Gorgen 
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REDUCING MATERNAL MORTALITY AND MORBIDITY IN BOLIVIA: APPROPRIATE BIRTH 
PRACTICES IN THE FORMAL AND INFORMAL SYSTEMS OF PERINATAL CARE 
Period:  December 1, 1993- December 31, 1995 
Co-ordinator:  TRINITY COLLEGE, DUBLIN UNIVERSITY, 
DEPT. OF SOCIOLOGY, Dublin, Ireland (B. BRADBY) 
Objectives 
•  To identify culturally appropriate practices and technologies of birth for women in  highly 
traditional  rural  (Ouechua-speaking),  modernising  rural  (Aymara-speaking)  and  urban 
marginal (rural migrants). 
•  To study the range of factors which prevent childbearing women from participating in formal 
health care services. 
•  To produce baseline data on  knowledge and  practices  in  relation to pregnancy and  birth, 
which can then be monitored and updated. 
Activities 
The  project will  carry  out  data  collection  on  childbirth  practices,  and  on  complications  of 
pregnancy and birth, that will lay the basis for identifying the factors and circumstances that have 
such an adverse effect on the reproductive health of women. Existing knowledge is based almost 
entirely on statistics from the formal health care system. However, in rural Bolivia, 80% of births 
take place outside this system, and the project has elaborated methodologies that will allow data 
to be collected from the informal sector of birth care,  and collated with similar data from the 
official care sector. Three case study localities have been identified, with differing socio-economic 
characteristics: 
*  highly traditional rural (Quechua-speaking) 
*  modernising rural (Aymara-speaking) 
*  urban marginal (rural migrants) 
In  each  area, the project will work through local  health personnel and through local  research 
organisations which have themselves built up good networks in urban and rural communities. 
The baseline data collected will enable women and  health care  personnel to initiate concrete 
actions at the local level to improve service delivery in ways that are appropriate to the social and 
cultural circumstances of women and their caregivers. 
The  project involves six partner institutions, three from Bolivia, and three from Europe,  in  a 
complex pattern of co-operation, using specific professions and skills developed in the different 
contexts,  which  must be  used  together if such  a  project  is  to  be  successful.  These  include 
anthropology,  linguistics,  medicine,  and  midwifery,  as  well  as  popular-educational  and 
communications skills, necessary for adequate dissemination in non-literate cultures. The project 
includes a training element, both for local fieldworkers, in methods of  qualitative and quantitative 
data collection and analysis, and for community promoters, who will attend short orientation 
courses on the aims of the project and in communication skills. 
Expected outcome 
It is hoped that in relation to the problem of maternal mortality, the qualitative study will lead to 
greater  understanding  of the  reasons  for  under-utilisation  of existing  maternity services  in 
Bolivia, and to recommendations for ways of decreasing cultural barriers to service delivery. It is 
also  hoped that the findings will help programmes for training traditional birth attendants to 
develop in ways that are culturally appropriate, and which can  ultimately empower, rather than 
deskill, local people. 
The baseline data collected during the quantitative phase of the fieldwork should enable women 
and health care personnel to initiate concrete actions at the local level to improve service delivery 
in ways that are appropriate to the social and cultural circumstances of  women and their caregivers. 
The baseline study will also enable local networks of statistical collection to be put in place so as to 
enable to monitoring and updating of the practices and problems encountered in the study. 
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The project's objectives were to identify appropriate birth practices for rural and migrant women in 
Bolivia, and to look at the factors leading to under-use of existing health services, in the light of 
concerns about rates of maternal mortality which are high by international standards. The team of 
three Bolivian non-governmental organisations and two European institutions carried out studies 
in  rural  and  peri-urban  areas,  using a combination of qualitative methods and  a questionnaire 
survey. 
Part II of  the report documents traditional understandings of birth and of birth care, setting fertility 
and birth within the complex cosmic vision of the relationships between earth and sky. Principles 
such  as  upright positions in  birth and the clothing and warmth of the mother relate to these 
understandings of rain, earth, sun and regeneration. The metaphors are particularly elaborated 
around the placenta, and birth is seen as a dual process, involving the birth of both baby and the 
placenta,  its  ''soul". Hospital  birth  is  then  approached through the eyes  of these traditional 
understandings. Fear  of the Caesarean  structures and  migrant women's approach to hospital 
birth, leads to both passive resistance to hospital procedures by giving birth alone, and to active 
negotiation with hospital staff for other kinds of "help". The traditional prioritising of care in the 
birth of the placenta carries through into women's expectations of attention in hospital. 
Part Ill of  the report examines quantitative data from the project in relation to international health 
planners' agendas. It looks at the emergence of maternal mortality as a global problem in the last 
decade, and presents the current situation in Bolivia. It reviews the biomedical arguments on risk 
factors,  and  discusses  four principal  causes  of illness  and  death  in  childbirth.  The  view of 
traditional birth attendants in international programmes is examined in the light of the Bolivian 
government's training programmes. The results of a questionnaire administered to 298 women 
are assessed in terms of the effectiveness of reported practices from the points of view of  women 
themselves and of current international recommendations. 
Finally, there is an assessment of data on obstetric practices collected from institutional medical 
personnel,  which  are  evaluated  for  their  effectiveness  in  preventing  complications  and  in 
addressing women's needs. 
The project's recommendations fall into five areas: furthering dialogue between traditional and 
biomedical  services;  arresting  the  decline  of traditional  midwives;  allaying  cultural  fears  of 
hospital birth; systemic response to emergency care; and further research, including a large-scale 
study of different systems of placental management. 
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MATERNAL MORTALITY AND EMERGENCY OBSTETRIC CARE IN LONGITUDINAL 
POPULATION BASED STUDIES IN WEST-AFRICA 
Period: 
Co-ordinator: 
Objectives 
December 1, 1997- May 31, 1999 
ORSTOM, Dakar, Senegal (J-F ETARD) 
The general objective of this proposal is to promote interventions to reduce maternal mortality 
and serious maternal morbidity in different West African settings. Based on a situation analysis 
using a multidisciplinary approach, possible interventions will be designed in concertation with 
health authorities and specialists. 
Four West African countries where vital registration system of well-defined sub-groups of 
population have been under way for several years will participate. These sites are located in 
Senegal, Mali, The Gambia, Bissau-Guinea. 
Situation analysis 
- to assess the quality of care by performing a maternal audit of each maternal death and make 
technical recommendations for personnel, equipment and procedures for the management of 
obstetrical emergencies; 
- to assess the magnitude of maternal mortality and its consequences on the newborns, and to 
identify risk factors associated with maternal death; 
- to analyse the  relationship  between  pregnant/parturient women and  the personnel  in the 
health centers in charge of them; 
- to improve the policy environment for maternal health through a better understanding of the 
supply of and the demand for maternal health services and obstetrical care. 
Design possible interventions to reduce maternal mortality 
Activities 
Situation analysis 
Clinical activities 
Verbal autopsy of all deaths of women, aged 12-49, which occurred in past years and which will 
occur within one year after beginning of the project will be completed by interviewing relatives. 
Additional information in health services will be searched. 
An auditing committee will review all female deaths, classify deaths as  maternal or not and 
attribute the most likely cause of death; on this basis, unmet obstetrical needs will be assessed. 
Obstetricians  will  visit  references  centers  to  issue  technical  recommendations  on 
staffing/training, equipment and on procedures for the management of obstetrical emergencies. 
Epidemiological activities 
Epidemiologists  will  estimate  maternal  and  perinatal  mortality  indicators,  measure  the 
proportion  of  life-threatening  obstetrical  complications,  assess  the  survival  of  children  of 
deceased women and a case-control study on risk factors for female/maternal deaths in certain 
sites will be carried out. 
Anthropological activities 
A sample of women and  local specialists will be  interviewed to describe popular opinion and 
representations  of pregnancy and  delivery.  A  quantitative and  qualitative survey among the 
midwifery students will analyse their social identities and relationships. 
Health economics activities 
The supply and the demand of maternal health and obstetric services will be investigated through 
structured questionnaires passed respectively to providers and pregnant women recorded by the 
vital registration. Questions will be designed for a contingency-based assessment of willingness 
to pay and to participate in alternative service delivery and financing schemes. 
88 Design of possible interventions to reduce maternal mortality 
Possible  interventions will be  discussed  during workshop(s) to be  held  in  each  participating 
country involving researchers of the present initiative, regional and  national health authorities 
and obstetricians. 
Expected outcome 
==>  Site-specific and global situation analysis on maternal mortality 
==>  Possible intervention protocols 
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GENDER  AND  REPRODUCTIVE  HEALTH  IN  ZIMBABWE:  USER-PERSPECTIVE  OF 
FERTILITY-REGULATING TECHNOLOGIES AND SERVICES 
Period: 
Co-ordinator: 
Objectives 
January 1, 1994- December 31, 1996 
UNIVERSITY OF AMSTERDAM, 
MEDICAL ANTHROPOLOGY UNIT, 
Amsterdam, The Netherlands (A. HARDON) 
The long-term objective: 
•  To  set  parameters for a gender-aware and  need-oriented  reproductive health  and 
family-planning  programme  in  Zimbabwe  in  consultation  with  various  actors 
(including women's organisations, the Zimbabwe National Family Planning Council, 
and  traditional  healers'  associations)  involved  in  the field  of reproductive  health, 
based on an understanding of user-perspectives on fertility regulation and insight into 
socio-cultural factors affecting people's actual fertility regulation practices. 
Specific objectives: 
•  To  investigate what user-views are  on family planning services and contraceptive 
technologies; and how these services and technologies affect their day to day life and 
well-being. 
•  To study how user-views of safety, efficacy and acceptability of contraceptives differ 
from conventional biomedical definitions. 
•  To investigate how family planning services can be improved with respect to meeting 
reproductive health  needs of women and  men at various times in their lives, and 
upholding their reproductive rights. 
Summary 
=> The  research  action  envisaged  under this  project  will  combine  quantitative  and 
qualitative  research  methods  (used  in  demography,  community medicine  and  in 
anthropology) to obtain  understanding of user-perspectives on  fertility regulation 
technologies and  services;  and  to gain  insight of complex interrelations between 
socio-cultural determinants of fertility (such as age at marriage, education and status 
of women) and people's actually fertility regulation practices. 
=>Where studies on user-views of family planning have been done, these tend to focus 
on modern contraceptive methods. The current study will investigate all  (including 
indigenous methods such as child-spacing by means of breast-feeding, and the use 
of herbs as abortifacients), in their socio-cultural context. 
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=> The study will follow a bottom-up approach, starting at the community level. The 
evaluation of the quality of services will focus on those aspects of  the services that are 
considered important by users (for example the respect that providers have for their 
clients, the privacy observed), thus complementing earlier operational research on 
the quality of care that is generally medical in nature (looking into issues such  as 
knowledge of service providers, and the supply of contraceptive methods). 
=>The study will involve various actors involved in family planning and reproductive 
health care in Zimbabwe, including women's organisations, traditional healers, and 
the Zimbabwe National Family Planning Council. 
=> The research will greatly increase the understanding of and promote reform in the 
structure  of the family planning  programmes of Zimbabwe.  It  evaluates  existing 
family  planning  interventions  (such  as  the  information,  education  and 
communication  component  of  the  programme,  and  the  community-based 
distribution system) from a user-perspective, using an interdisciplinary approach. 
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DEVELOPMENT  OF  SILOS  MANAGERIAL  SKILLS  IN  BRAZIL:  RESEARCH  AND 
IMPLEMENTATION OF SUITABLE TOOLS  FOR  INTER-SECTORAL AND PARTICIPATIVE 
ACTIONS IN DEALING WITH MAIN LOCAL HEALTH PROBLEMS 
Period:  November 1, 1994- October 31, 1997 
Co-ordinator:  UNIVERSITA COMMERCIALE L.  BOCCONI, CTRO Dl 
RIC. GESTIONE ASS. SANITARIA, Milano, Italy 
(M. MENEGUZZO) 
Objectives 
The project has the following aims: 
•  To develop an innovative model for managing local health units to support strategies 
directed at decentralising health services in developing countries. 
Specific attention will be given to: 
developing the institutional framework for local health units; 
planning and programming processes at local level; 
resource allocation; 
relationship between decentralisation strategies and utilisation of health care. 
•  To  evaluate the role of decentralisation and institutional strengthening as a tool for 
solving the general crisis in public welfare in Brazil and in the two European countries 
involved in the project, Italy and Spain. 
•  To set out training programs for public managers. 
Activities 
*  Analysis,  comparison  and  systematisation  of  SILOS  (local  Health  Systems) 
managerial skills development, methodologies and tools in  each  specific national 
context; identification of a methodological approach for the three countries. 
*  Analysis and comparison between the different decentralisation experiences in the 
National  Health  Systems  of  Brazil,  Italy  and  Spain,  in  particularly  selection  of 
planning,  management  and  controls  tools  on  which  experimentation  must  be 
concentrated; choice of SILOS for research activity; introduction of research in local 
process,  and  definition  of project task  forces  and  working  laboratories  in  SILOS 
selected  by  the  participating  centres.  Three  different  interventions  will  be 
implemented: 
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Training and education of human resources directly charged with management 
responsibility on a SILOS level. 
Consulting, aimed at accompanying, analysing and systematising the decision-
making responsibility on a SILOS level. 
Evaluation of the research projects in their specific context. Contract number TS3*CT940321 
*  Evaluation of the research  project in the context of the National Public Health Care 
Systems  in  transition  decentralisation  processes,  and  settlement  of  a  proposal 
regarding the reproduction of the experience on a large scale, in different contexts, 
particularly in Latin American Countries. 
Expected outcome 
Improvement of managerial  effectiveness  for the  SILOS  which  are  involved  in  the 
research in terms of capacity of intersectoral response to community health problems 
and quality of health and social well-being. Strengthening of managerial methodologies 
and tools and requirements to their effective implementation at a local level. 
Preparation of a guideline regarding the evaluation of managerial skills on a SILOS level 
in order to allow for comparison between the different national contexts. 
Definition of methodological options which allow for transformation of local experiences 
in health policy for National or Mixed Health Systems. 
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COMMUNITY BASED PREPAYMENT AND HEALTH  INSURANCE SCHEMES IN RURAL 
BURKINA FASO AND GHANA: AN INTERVENTION STUDY 
Period: 
Co-ordinator: 
General objectives 
March 2, 1997- March 1, 2000 
UNIVERSITY OF HEIDELBERG, DEPT. OF TROP. HYGIENE & 
PUBLIC HEALTH, Heidelberg, Germany (R. SAUERBORN) 
To improve the health status of the general population in rural areas of Burkina Faso and Ghana 
by improving the quality of the health care system and ensuring equitable access to it through 
sustainable community-based prepayment and health insurance schemes. 
Specific objectives 
•  Improve  financial  access  to  essential  health  services  while  reducing  access  differentials 
between rich and poor as well as children and adults. 
•  Design two alternative prepayment schemes (with and without risk sharing: health insurance 
vs.  prepayment),  based  on  the  costs  of services  provision  and  the  schemes'  projected 
revenues (depending on the amount of contribution to the schemes and their coverage). 
•  Recover all recurrent non-salary costs of providing the essential care package. 
•  Improve the quality of care: 75% (up from 40%) of users are satisfied and 60o/o (up from 20%) 
of providers follow locally accepted diagnostic and therapeutic algorithms. 
•  Assess the effect of quality on participation in prepayment/insurance schemes. 
•  Measure the impact of the intervention on the economic burden of illness. 
•  Measure the impact of the intervention on morbidity and mortality. 
•  Evaluate  the  process  and  outcome  of  partnership  between  the  Ministry  of  Health  and 
autonomous church  affiliated providers in the implementation of a  rural  health  insurance 
scheme (Ghana). 
Summary 
User fees have been strongly advocated in sub-Saharan Africa as a means to mobilise additional 
financial  resources  badly  needed  for the  recovery  of the  recurrent costs  of health  services. 
Although the fees are an effective tool for resource mobilisation, research carried out under the 
ongoing STD programme has corroborated evidence from the literature that user fee schemes 
suffer from three weaknesses: 
=>  equity: they generally lead to a drop in  health care utilisation, and worsen already existing 
inequities in access to health care. 
=>  no risk-sharing: user fees put the entire burden of payment for health services on the sick. 
=>  link between the time of payment and use makes it difficult for the population to seek health 
services in the rainy season when the household is in a negative cash balance. 
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PrepaymenVhealth insurance schemes should offer remedies to all three weaknesses. 
The project will consist of three phases: 
=>  Phase  1:  Preparatory research  (12  months), to a)  design the modalities of insurance and/or 
prepayment scheme and  b)  establish the quality and  the distribution of health care  to be 
provided  under the  schemes.  Essential  care  packages  have to  be  defined, the  innovative 
financing options (prepaymenVhealth insurance) will be elaborated. Willingness and ability to 
pay studies, using contingent valuation method, will be realised, and a comprehensive tool for 
assessing quality of care (as perceived by the clients as well as defined by professionals) will 
be developed. 
=>  Phase 2: Study of the effect of prepayment and community health insurance (30 months). The 
following  questions  will  be  addressed:  How  many  and  which  households  to  enrol  to 
prepaymenVinsurance  scheme?  How  does  the  quality of services  influence  households' 
choice to enrol?  How do  rate  and  patterns of utilisation of health  services change?  Does 
community involvement and  resource generation for health services improve the quality of 
health care? To what extent do revenues from those enrolled cover the non-salary costs of 
providing the  essential  care  package  to them?  Does  prepaymenVhealth  insurance  reduce 
illness-related costs of households? Does the anticipated increase in access to quality health 
services  - especially  among  children  - have  an  impact on  age-specific  death  rates?  The 
research  tools  addressing  these  questions  are:  health  census,  vital  events  registration, 
sequential  household-surveys,  analysis  of  routine  health  services  information,  financial 
analysis  of  providers'  costs  and  the  revenue  of  the  prepaymenVinsurance  scheme, 
comprehensive assessment of quality of care (defined by clients and professionals) through 
observation and exit polls, focus group discussions. 
=>  Phase 3: Finalisation of data analysis, preparing of publications. 
Continuous feed-back of concerned audiences (research community, policy makers, public health 
staff, local communities) will be given. 
Partners 
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PUBLIC  PARTICIPATION  IN  URBAN  ENVIRONMENTAL  HEALTH  SERVICES:  A 
CONCERTED ACTION FOR SUB-SAHARAN AFRICA 
Period:  October 1, 1996- September 30, 1998 
Co-ordinator:  IRC INTERNATIONAL WATER AND SANITATION CENTRE, 
The Hague, The Netherlands (H. WIHURI/M. VEZINA) 
Objectives 
•  Improve  the  effectiveness  of  research  methods  and  techniques  to  collect  and  analyse 
indicators that correlate i)  people's state of physical health, ii) the conditions in their living 
environment  that  are  risks  to  their  health  and  iii)  the  operational  status  of  existing 
environmental health services in the community. 
•  Enable  resource  centres working in  sub-Saharan  Africa to advise  Local  Authorities in  the 
planning and monitoring of environmental health services in consultation with local residents. 
Activities 
*  Conduct three workshops, all of them hosted in Africa, two of which will convene researchers 
from European and African centres, and the third involves researchers from African centres. 
*  Partner institutions will host visiting-researcher(s) from research centres in Africa for a two 
week internships. 
*  Compile a compendium paper comprised of: 
-a comparative analysis of six case  studies indicating a set of site specific indicators and 
profiling the process to monitor and plan urban environmental services; 
- a short monograph on community managed urban services; 
-a catalogue of urban project profiles. 
*  Publish  a  procedural  manual  describing  the  steps  and  methods  in  conducting  public 
consultations and possible applications to monitoring and planning of environmental health 
services. 
*  Produce and distribute a series of newsletters or briefs to inform local authorities in Africa of 
research  findings and  in  view of organising a round table advocating the development of 
urban environmental health services and advising on how to do so. 
Expected outcome 
==>  A better assessment of urban environmental health risks across social strata and African cities 
through health risk assessments conducted in six different cities. 
::::>  The transfer of knowledge between partners (on monitoring environmental health risks and 
facilitating community involvement to plan environmental health services) by defining a set of 
methodological recommendations such as: 
-the relevant indicators, to be validated or refined in each location; 
-sampling procedures; 
-the structure of a questionnaire survey; 
-the us of a simple structured observations (such as spot checks); 
-the use of participatory communication techniques; 
- relevant physical tests; 
-what grassroots environmental concerns are to be discussed in focus groups. 
::::>  One  set  of procedural  guidelines to  operationalise  community  based  information  centre 
focusing  on  urban  environmental  health  and  implement  site-specific  information  and 
communication strategies. 
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=>  Demonstrated ability of European and African institutions to advise LAs on the practicalities of 
establishing  community based  data  collection  centres  and  implementing information and 
communication strategies. 
=>  Increased  awareness  of  LAs  and  international  organisations  about  community-based 
approaches to monitoring and plan environmental health service. 
=>  A  project proposal  involving European  and  African  resource  centres to conduct research-
action activities in the field of urban environmental health. 
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Tel: +229130.00.01 
Fax: +229130.12.88 
V. Nziou 
Tel: +3314fi2.43.85.56 
Fax: +3314fi2.43.85.21 
E-mail: nziou@urgc-hu.insa-lyon.fr 
M. Gaye 
Tel: +221122.09.42 
Fax: +221123.51.57 
E-mail: rup@enda.sn 
J. Songsore IS. Avle 
Tel: +233121150.03.94 
Fax: +233121150.03.10 
E-mail: rsau@ncs.com.gh 
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CONCERTED ACTION : HEALTH AND HUMAN SETTLEMENTS IN LATIN-AMERICA 
Period: 
Co-ordinator: 
Objectives 
October 1, 1997- November 30, 2000 
SOUTH BANK UNIVERSITY, SCHOOL OF URBAN DEVELOPMENT 
AND POLICY, London, United Kingdom (T.  HARPHAM) 
To  use the combined, existing knowledge of partners in a more concerted manner to 
develop  proposals  to  design  and  evaluate  interventions  to  improve  the  health  of 
disadvantaged urban populations. Specifically, the concerted action aims to: 
•  consolidate knowledge 
•  build capacity 
•  develop proposals 
•  enhance the impact of research on policy 
Activities 
The preferred approach is multisectoral with the aim of putting urban health issues on 
agendas that fall  outside the health sector.  Health is defined as  physical, mental and 
social  well-being  in  line with WHO's  definition. The environment is  equally broadly 
defined as incorporating physical and social aspects. The project brings together, for the 
first time, a wide range of urban health researchers in the North and South in order that 
they can co-ordinate their efforts over a three year period to maximise the effectiveness 
and  impact of research.  It focuses on  urban environmental health  and  urban  health 
services issues. Specific activities will involve: 
*  Holding two workshops 
*  Expanding the "Urbanisation and health" newletter (published by MRC, South Africa) 
*  Producing a "State of the art of urban health in Latin America" 
*  Carrying out exchange visits 
*  Carrying out project leader missions 
*  Producing three short reports on the activities of partner 
*  Mounting an urban health course in Latin America 
*  Producing research proposals 
*  Disseminating the activities of the concerted action 
Expected outcome 
=> Increased  reference to urban  health  in  strategic  international  public health  policy 
documents 
=> Increased understandig of urban health in Latin America and South Africa 
=> Increased training opportunities in urban health in Latin America 
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Partners 
South Bank University 
School of Urban Development and Policy 
202 Wandsworth Road 
London SW8 2JZ 
United Kingdom 
Universidade de Sao Paulo 
Escola Politecnica, Av. Prof. L.  Gualberto 
Travesa 3, Cidade Universitaria 
05508-900 Sao Paulo 
Brazil 
Central American lnst. for Health (ICAS) 
18 calle 11-18 zona 2, Ciudad, Nueva 
Guatemala City 01002 
Guatemala 
Medical Research Council 
Nat. Urbanisation & Health Res. Prog. 
P.O.  Box 19070 
7505 Tygerberg 
South Africa 
Centro de Estudos de Cultura Contemp. 
Rua Airosa Galvao 64 
05002-070 Sao Paulo 
Brazil 
Pontificia Universidad Catolica de Chile 
Institute de Estudios Urbanos 
El Comendador 1916 
Casilla 16002, Correo 9 - Santiago 
Chile 
London School of Hygiene & Trop. Med. 
Department of Public Health & Policy 
Keppel Street 
WC1 E 7HT London 
United Kingdom 
Stockholm Environmental Institute 
P.O.  Box 2142 
103 14 Stockholm 
Sweden 
Katholieke Universiteit Nijmegen 
Nijmegen Institute for Int. Health 
P.O.  Box 9101 
6500HB Nijmegen 
The Netherlands 
University of Manchester 
Department of Geography 
Oxford Road 
M 13 9PL Manchester 
United Kingdom 
T. Harpham 
Tel: +44/171/815.83.91 
Fax: +44/171/815.83.92 
E-mail: t.harpham@sbu.ac.uk 
E. Werna 
Tel: +55/11/818.54.49 
Fax: +55/11/818.57 .15 
E-mail: edwerna@pcc.usp.br 
K. Slowing 
Tel: +502/254.02.32 
Fax: +502/254.02.32 
E-mail: icas@guate.net 
J. Seager 
Tel: +27/21/938.04.17 
Fax: +27/21/938.03.42 
E-mail: JSeager@eagle.mrc.ac.za 
M. Akerman 
Tel: +55/11/871.29.66 
Fax: +55/11/871.21.23 
E-mail: akerman@opus.com.br 
M.E. Ducci 
Tel: +56/2/686.55.07 
Fax: +56/2/232.88.05 
E-mail: meducci@lascar.puc.cl 
C. Stephens 
Tel: +44/171/927.23.08 
Fax: +44/171/580.45.24 
E-mail: c.stephens@lshtm.ac.uk 
G. Me Granahan 
Tel: +46/8/24.75.33 
Fax: +46/8n23.03.48 
E-mail: seihq@nordnet.se 
F.  Barten 
Tel: +31/24/361.69.80 
Fax: +31/24/356.63.36 
E-mail: f.barten@aig.azn.nl 
S. Atkinson 
Tel: +44/161/275.36.47 
Fax: +44/161/273.44.07 
E-mail: sarah.atkinson@man.ac.uk 
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EVALUATION OF A STRATEGY TO CONTROL THE EPIDEMIC OF CAESAREAN 
SECTIONS IN LATIN-AMERICA 
Period: 
Co-ordinator: 
Objectives 
Main project: 
October 1, 1997- March 31, 2001 
UNIVERSITE LIBRE  DE BRUXELLES, ECOLE DE SANTE 
PUBLIQUE, Brussels, Belgium (S. ALEXANDER) 
To  evaluate, within the framework of a randomized trial, the effect of an  intervention 
aimed  at  reducing  Caesarean  section  (CS)  rates  in  Latin  America.  The  intervention 
consists  of  the  two  following:  (i)  systematic  second  opinion  before  surgery  (ii) 
practitioner education  about decreasing  CS  rates  through  alternative  guidelines for 
effective and safe management of childbirth. 
Furthermore: 
•  Exploratory assessment of rates and needs of CS in Africa and Asia 
•  Dissemination  of results  of a  study of maternal  needs  and  demands concerning 
childbirth 
Activities 
Main project: 
The efficacy of the intervention will be  assessed  in  a multicenter cluster randomized 
controlled  trial  with two  (three)  further  nested  studies:  (i)  assessment  of women's 
opinions (ii) care-giver's opinions (this survey is optional) and  (iii)  organisational and 
cost survey. 
In  maternity units randomized to the intervention arm, practitioners will systematically 
discuss the indication for caesarean section with a colleague before resorting to surgery 
(see  a second  opinion) and  fill  in  a special  form.  Educational  seminars on  ways of 
decreasing  CS  will  also  be  organised  for  the  care-givers  in  the  intervention  arm 
maternity units. The trial will be conducted in six Latin American countries: Argentina, 
Brazil,  Chile,  Cuba,  Guatemala  and  Mexico  contributing  a  minimum  of 17  pairs  of 
maternity units. 
The main outcome is CS  rate, secondary outcomes include measures of maternal and 
perinatal morbidity. Satisfaction, acceptability and economic aspects will be assessed in 
the nested studies. Because of the risk of contamination between intervention and non-
intervention units, CS levels will be assessed in all participating units prior to the study. 
Furthermore: 
*  Prevalence and needs of CS in Africa and Asia will be assessed. 
*  Translation and dissemination of a related previous study will be performed. 
Expected outcome 
The main project & appended proposals: 
The main project will assess the effectiveness of a package of co-interventions aimed at 
curbing the excess rate of CS  in Latin America. Should this prove effective, replicating 
the interventions should not be an  issue, as they are mainly behavioural, and therefore 
their extension to routine care  should be  neither costly nor complicated. Should the 
interventions not be effective within the framework of  this trial, further assessment of  the 
determinants of the failure will be essential and further in-depth work along the Brad by 
study would be recommended. 
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Finally it must be  remembered that the  Latin  American  CS  epidemic is  but one end  of the 
spectrum. In other regions there is a dearth of necessary caesarean section. This aspect will have 
been explored by the Ghent partners and we hope to be able to make sensible recommendations 
as to an approved bracket of CS rates, and as to measures to achieve this. 
Partners 
Universite Libre de Bruxelles 
Ecole de Sante Publique 
808 Route de Lennik 
1  070 Brussels 
Belgium 
Centro Latino Americana de Peri nat. (CLAP) 
Casilla de Correa, 627 
11000 Montevideo 
Uruguay 
lnstitut Nationale de Ia Sante et de 
Ia Recherche Medicale- INSEAM 
Unite de Recherches Epidemiologiques sur Ia 
Sante des Femmes et des Enfants 
123, Boulevard de Port-Royal 
75014 Paris 
France 
University of Uppsala 
Dept. of Obstetrics & Gynaecology 
University Hospital 
75185 Uppsala 
Sweden 
America Arias Hospital 
Epidemiology Unit 
Calle Linea y G, Vedado 
10400 La Habana 4 
Cuba 
Epid. Res. Centre in Reproductive Health 
General Hospital "San Juan de Dios" 
1A, Avenue 10-50, Zone 1, S-13 
01001  Guatemala 
Guatemala 
The Population Council- Latin America and 
Caribbean Office 
Esconida NO. 110 
Col. Villa Coyoacan 
Mexico, D.F. 04000 
Mexico 
Trinity College 
Department of Sociology 
Dublin 2 
Ireland 
University of Ghent 
International Centre for Reproductive Health 
University Hospital- Dept. Obs/Gyn 
P3- De Pintelaan 185 
4000 Ghent 
Belgium 
S. Alexander 
Tel: +32/2/555.40.63 
Fax: +32/2/555.40.49 
E-mail: salexand@ulb.ac.be 
J. Belizan 
Tel: +598/2/487.29.29 
Fax: +598/2/487 .25.93 
E-mail : belizanj@clap.edu.uy 
G. Breart 
Tel: +33/1/42.34.55.70 
Fax: +33/1/43.26.89. 79 
E-mail: breart@cochin.inserm.fr 
G. Lindmark 
Tel: +46/18/66.57.58 
Fax: +46/18/55.97.75 
E-mail: gunilla.lindmark@obstgyn.uu.se 
U. Farnot 
Tel: +537/32.94.85 
Fax: +537  /33.34.17 
E-mail: oma@incn.sld.cu 
E. Kestler 
Tel: +502/230.14.94 
Fax: +502/230.14.94 
E-mail: ciesar@ns.concyt.gob.gt 
A. Langer 
Tel: +525/554.86.10 
Fax: +525/554.12.26 
E-mail: alangerpc@laneta.apc.org 
B. Bradby 
Tel: +353/1/608.12.96 
Fax: +353/1/677.13.00 
E-mail: bbradby@tcd.ie 
M. Temmerman 
Tel: +32/9/240.21.11 
Fax: +32/9240.38.31 
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MEDICAL AND SOCIAL RISK FACTORS AND MAGNITUDE OF FIRST AND SECOND 
TRIMESTER, OBSTETRICAL COMPLICATIONS (ABORTION, MISCARRIAGES, ECTOPIC 
PREGNANCY) IN SIX DEVELOPING WEST AFRICAN COUNTRIES 
Period: 
Co-ordinator: 
Objectives 
December 1, 1997 - November 30, 1999 
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE 
MEDICALE, Le Kremlin Bicetre, France (P. THONNEAU) 
The general objective is to deploy an African network for research and analysis of human 
reproduction and maternal health in six West African countries. 
The specific objectives are to: 
•  Assess  the  magnitude  of  abortion  complications  in  several  maternities  of the 
following six West African countries:  Benin, Burkina Faso,  Cameroon, Ivory Coast, 
Guinea and Senegal. 
•  Describe the type of abortion complications and the health consequences in terms of 
maternal morbidity and mortality. 
•  Identify specific determinants of women seeking care for abortion complications. 
Project methodology 
The  methodology will  include  a  descriptive  (demo-epidemiological)  survey  with  a 
complementary qualitative (sociological) approach. 
Activities 
Point 1: 
Point 2: 
Point 3: 
Point 4: 
Point 5: 
- reception of the administrative and scientist agreement to participate 
- reception of the names of the coordinators and of the field workers 
-obtention of a first version of the register 
- results  of the  pre-test;  obtention and  print of the final  version  of the 
register 
- obtention of a brief description of each  site (medical and para  medical 
personnel, number of admissions, number of births per year, etc.) 
- obtention of a first data set after two months of data collection 
- results of the qualitative study 
- obtention of the complete data sets (from the registers) 
Expected outcome 
At the end of this project we expect to know the incidence of first trimester obstetrical 
complications (abortion, miscarriage, ectopic pregnancy), and be  able to describe the 
main causes of abortion complications for women admitted to maternities in different 
sites in the six African countries. The project will give a better understanding of the 
reproductive knowledge, attitudes and behaviour of women in several sites (urban and 
rural) of West and Central Africa. EU-African networking will be further developed and 
will be made available in the field. 
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Partners 
lnstitut National de Ia Sante et de Ia 
Recherche Medicale 
Hopital de Bicetre 
82, rue du General Leclerc 
94276 Le Kremlin Bicetre 
France 
University of Oslo 
Dept. of Medical Anthropology 
P.O.  Box 1130 Blidern 
0317 Oslo 
Norway 
C.H.U. Le Dantec 
Clinique Gynecologique & Obstetricale 
Avenue Pasteur 
300 Dakar 
Senegal 
Centre de Recherche en Reproduction 
Humaine et en Demographie (CRRHD) 
B.P. 386 
Cotonou 
Benin 
Centre Hospitalier Universitaire de Donka 
Service de Gynecologie & Obstetrique 
B.P. 214 
Conakry 
Guinea 
Centre Hospitalier National Souro Sanou 
Service de Gynecologie et Obstetrique 
B.P. 676 
Bobo-Dioulasso 
Burkina Faso 
University of Yaounde 
Dept. of Gyneco-Obst. 
Hopital Central, B.P.  1935 
Yaounde 
Cameroon 
Centre Hospitalier Universitaire de 
Yopougon 
Service de Gynecologie-Obstetrique 
Abidjan, 21 
Abidjan 
Ivory Coast 
P. Thonneau 
Tel: +33/1/45.21.20.75 
Fax: +33/1/45.21.20.73 
J.Sundby 
Tel: +47/22/85.05.98 
Fax: +47  /22/85.05.90 
F.  Diadiou 
Tel: +221/21.83.70 
Fax: +221/22.41.  72 
E. Alihonou 
Tel: +229/30.14.78 I 30.00.01 
Fax: +229/30.12.88 
B.Toure 
Tel: +224/44.23.63 
Fax: +224/41.43.21 
A.J. Bazie 
Tel: +226/97 .00.44 
R.J.I. Leke 
Tel: +237/22.36.17 
Fax: +237  /23.44.51 
C. Welfens-Ekra 
Tel: +225/46.61.70 
Fax: +225/43.27.73 
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HEALTH  AND  THE  CURRENT  ECONOMIC  CRISIS  IN  BRAZIL:  THE  IMPACT  ON  THE 
HEALTH AND CARE OF MOTHERS AND CHILDREN 
Period: 
Co-ordinator: 
Objectives 
January 1, 1993- December 31, 1995 
ESCUELA ANDALUZA DE SALUD PUBLICA, 
Granada, Spain (M.GARCIA CALVENTE) 
The objectives of the study are: 
•  To  describe  and  document the  political,  economic  and  health  policy changes  in 
Pelotas, Brazil, in the past decade. 
•  To document levels and trends in maternal and child health status and health care 
•  provision and utilisation between 1982 and 1992. 
•  To make policy recommendations based on the research conclusions. 
Activities 
Phase 1 will include three studies: 
*  A  study of changes in health  policies and  health care  provision with emphasis on 
maternal and child care. This study will provide data on recent trends in these areas 
to document historical changes in the city. 
*  Anthropological  studies  based  on  interviews  with  members  of different  groups 
involved in  health care.  The  aim here will be  to investigate the perception of the 
population and of the health providers regarding changes in health services. 
*  A  study on  socio-economic trends that is  intended to document the political  and 
economic changes which took place during the decade and how these have affected 
the quality of life. 
These Phase 1 studies will result in a detailed description of changes in the health sector 
and in the perception of the population and providers relative to these changes. 
Phase 2 of the study involves six separate studies focusing on maternal and child health 
indicators. The studies in this phase will include: 
*  a perinatal study in three maternity hospitals during twelve months. 
*  a  descriptive  infant  mortality  and  nested  infant  mortality  case-control  study,  to 
identify all deaths among cohort children and to ascertain causes and compare their 
characteristics with those of control children from the same birth cohort. 
*  a hospital morbidity study to provide data on the causes of all hospital admissions. 
*  a follow-up study to trace a 20 per-cent sub-sample of approximately 2000 children at 
6-12 months of age and 400 pre-term and/or low birth-weight children. 
*  Finally, a maternal study on health, fertility and family planning utilisation will provide 
data on past reproductive history. 
The data from these studies will be compared to data collected in a similar way in 1982 
to assess changes during the decade which will be analysed in the light of the overall 
scenario of economic and health sector changes. 
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Expected outcome 
The  project will result in  an  increased  understanding of changes in health care  in  the city of 
Pelotas in Brazil, and the effects of  these changes on the health and care of mothers and children. 
Results 
::::}  There was a reduction in the number of births in this period (6.011%  in  1982 and 5.04%  in 
1993), suggesting an  increased utilisation of contraceptives or abortions since there was a 
increase in the number of women of fertile age. A breakdown by socio-economic status shows 
that the reduction of 707 births in 1993 was not evenly distributed as there were about 1,000 
fewer births in the poorest groups and 300 more in the high-income strata. 
::::}  There were also important variations in the nutritional status of the mother in the decade the 
mean height increased from 156.4cm in 1982 to 159.9cm in 1993, and weight in the beginning 
of pregnancy  was  also  substantially  higher  in  1993,  62.1 kg  compared  to  58kg  in  1982. 
Antenatal care attendances also increased in 1993, with a mean of 7.6 attendances compared 
to 6.6 in 1982 and medical assistance during delivery increased from 61  per cent in 1982 to 88.3 
per cent in  1993. Despite these improvements the proportion of low birthweight (<2,500 g) 
showed a slight increase in the proportion of pre-term births (5.6 and 7.5 per cent, respectively) 
and  intra-uterine growth retardation  (15.0  per cent in  1982  and  17.5  per cent in  1993) The 
reason for these unexpected findings is still being analysed. 
::::}  There was an  important reduction  in  perinatal  mortality, from 32.2/1000  births in  1982  to 
22.1/1000 births in  1993, and the reduction of perinatal deaths was equally observed both in 
the foetal and in the early neonatal period. Regarding breastfeeding, there was an increase in 
the proportion of babies being breastfed in the first months of life. At three months of age, for 
example, the prevalence of full breastfeeding was 53 per cent in 1993 compared with about 33 
per cent in the previous decade. As far as nutritional status at 12 months of age is concerned, 
there were  changes  according  to the  indicator.  Thus,  there  was  a  slight  increase  in  the 
proportion of children with low height for age, 6.1  per cent compared to 5.3 per cent in 1982. 
On the other hand, a reduction was observed in the prevalence of low weight for age, 5.4 per 
cent in 1982 and 3.8 per cent in 1993, and of weight for height. Finally, an important progress 
was detected in the infant mortality rates, with a drop from 36.4/1,000 live births in 1982 to 
21.1/1,000 in 1993. The results of  this study will certainly contribute to the understanding of  the 
evolution of the health status of mothers and children during the last decade and in planning 
new preventive actions. 
Partners 
Escuela Andaluza de Salud Publica 
Apartado de Correos 2070 
18080 Granada 
Spain 
Universidade Federal do Pelotas 
Caixa Postal 464 
96001  Pelotas 
Brazil 
London School of Hygiene & Trop. Med. 
Dept. of Public Health and Policy 
Keppel Street 
WC1 E 7HT London 
United Kingdom 
M. del Mar Garcia Calvente 
Tel: +34/5/827.50.44 
Fax: +34/5/827 .05.51 
F. Barros 
Tel: +55/532n1.24.42 
Fax: +55/532n1.26.45 
P.Vaughan 
Tel: +44/171/927.24.31 
Fax: +44/171/637.53.91 
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PAYMENT  MECHANISMS,  EFFICIENCY  AND  QUALITY  OF  CARE  IN  PUBLIC  AND 
PRIVATE HOSPITALS IN THAILAND 
Period: 
Co-ordinator: 
January 1, 1995- December 31, 1997 
LONDON  SCHOOL  OF  HYGIENE  AND  TROPICAL  MEDICINE, 
London, United Kingdom (A. MILLS) 
Phase I of  data collection has been completed, including detailed sub-studies on the cost, 
activity and outputs of nine hospitals, three public, three not-for-profit, and three for-
profit. Data collection instruments included a bed census survey and survey of patient 
satisfaction. Results can be summarised under the headings of hospital characteristics, 
hospital clientele, and influences affecting hospital behaviour. 
Hospital characteristics 
In terms of staff, private for-profit hospitals made more use of staff with less training, 
particularly nurse aides, as compared with not-for-profit and public hospitals. Both types 
of private hospital paid doctors largely on a fee-for-service basis, not as  in the public 
sector where they were salaried. In terms of productivity of resource use, staff had a 
higher workload in the public sector and the private sector was not always more efficient 
in the use of capital, such as on operating theatres. Also the private sector had quite a 
low  bed  occupancy  rate.  Levels  of  unit  cost  were  consistent  with  international 
experience in ranking by ownership, with for-profit hospitals having the highest levels of 
unit cost, followed by not-for-profit, and then public. For-profit hospitals had particularly 
high drug mark-ups. All hospitals had lengths of stay that were very short in comparison 
to international experience, though ranking by ownership; for-profit hospitals had the 
highest levels of unit cost, followed by not-for-profit, and then public. Public hospitals 
had  longer lengths of stay and  private-for-profit the shortest.  Management systems 
tended to be stronger in the private sector, in particular being entrepreneurial, flexible 
and with better stock control, though in comparison to other developing countries public 
sector  management  appeared  notably  strong,  if  bureaucratic.  In  private-for-profit 
hospitals there was less specialisation than there might be in maternity or acute surgery 
than is found in many other countries. There were suggestions that technical quality was 
quite varied in the private sector, ranging from very good to not so good. One strength 
of the  public sector was the  existence  of explicit technical  standards,  for example 
hospital formularies and  standards for generic prescribing, which the private sector 
tended not to have. Patient-perceived quality was judged poorer in the public sector for 
the interpersonal skills of staff, but otherwise the ratings of public and private hospitals 
were remarkably close. 
Hospital clientele 
As would be expected, the private sector tended to serve more educated and higher-
income clients than the public sector. However, civil servants were a major user of public 
hospitals. Very few patients classified as local used any of the hospitals. 
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Influences affecting hospital behaviour 
Although the purpose of phase I was not to focus directly on the influence of payment 
systems, a fair amount of relevant information was collected. For example, all hospitals 
had  a remarkably high share of patients paying fees out of pocket, and this imposed 
some measure of  cost control on hospitals, particularly in the private sector, since if  their 
fees became unaffordable they would lose part of  their market. Hospitals were making a 
deliberate decision to focus on particular segments of the market - for example social 
security patients,  or the  privately insured,  or those covered  by employer schemes. 
Ownership seemed to have  some less  strong  influences on  hospital  behaviour than 
might be expected from experience elsewhere, partly because the dependence of public 
hospitals on fee income meant that all hospitals were influenced by the need to generate 
income from patients. Nonetheless, there were aspects of hospital behaviour that were 
clearly influenced by ownership. While there was evidence that payment practices were 
influencing hospital management practices (for example the bed fee was kept down 
because reimbursement of this fee item was limited) insurers did not appear to be, as 
yet, as active in seeking to influence hospital behaviour as in some developed countries. 
Some tentative policy issues arising from phase I include 
=> The danger of increasing inflationary pressures with the rising share of the elderly in 
the  population,  expansion  of  health  insurance,  and  fee-per-service  payment  of 
doctors. 
=> A strong client preference for the private sector which will increasingly affect the use 
of public hospitals unless public hospitals can be made more attractive. 
=> The vital importance of payment mechanisms in ensuring cost containment. There 
was some evidence that the capitation payment system adopted by the social security 
scheme  was  having  an  effect  on  cost  containment without  necessarily  affecting 
quality adversely. For example there were some suggestions that drug prescribing for 
social security patients was more cost-effective than for other types of patients. 
Phase  II  will explore in much greater depth the influence of payment mechanisms on 
patient treatment patterns. 
Partners 
London School of Hygiene & Trop. Med. 
Keppel Street 
London WC1 E 7HT 
United Kingdom 
Ministry of Public Health 
Health Planning Division 
Tivanont Road 
Muang District, Nonthaburi 
Thailand 11000 
University of Giessen 
Dept. of Medical Informatics 
Heinrich-Buff-Ring 44 
6300 G  iessen 
Germany 
A. Mills 
Tel: +44/171/927.23.54 
Fax: +44/171/637.53.91 
N.Sanguan 
Tel : +66/2/590.11.21 
Fax: +66/2/591.85.10 
C. Bunge 
Tel: +49/641no2.45.17 
Fax: +49/641n8.  788 
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INFORMAL HEALTH MARKETS AND FORMAL HEALTH-FINANCING POLICY 
Period: 
Co-ordinator: 
Objectives 
September 1, 1994- August, 31  1996 
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE, 
DEPARTMENT OF PUBLIC HEALTH & POLICY 
London, United Kingdom (8. MC PAKE) 
•  To  identify  and  describe  health  workers'  socio-economic  survival  strategies  in 
Uganda's public health sector. 
•  To  examine the implications of different socio-economic survival strategies on the 
public health systems in terms of accessibility and quality of care and health workers' 
motivation and standards of living. 
•  To  explain  health workers' choice of socio-economic survival strategy in  terms of 
environmental, health worker-related and policy variables. 
•  To  model the implications of alternative health-financing policy options and  other 
policy options on accessibility and quality of care in public health facilities. 
•  To make recommendations on health-financing policy and other health policy based 
on the above findings. 
Activities 
Phase 1 of this research has focused at public health facility level. Researchers spent one 
month  in  each  of  12  facilities  observing  activities,  completing  checklists  of facility 
records  and  talking  at  various  depth-levels  with  those  employed  there,  and  with 
community members of the locality. 
Phase 2 is underway. It is focusing on individual health workers, sampled on the basis of 
information gleaned in  Phase  1.  The focus of attention  is  on  the activities of health 
workers outside the public health facilities. 
Results 
Real incomes of health workers are, on average, 4 to 7 times the value of  their salaries and 
allowances. This average hides a wide variability between health workers. While informal 
activities are carried out by all health workers, more junior workers are constrained to use 
less  lucrative  ones  and  barely  survive,  on  inadequate  incomes  and  other  benefits. 
Informal incomes are largely monopolised by more senior health workers in each facility 
and are shared with district level workers. The two major sources of informal income are 
resale of drugs supplied to health facilities for free distribution to patients, and informal 
charges levied on patients over and above formal user-charge levels. Unaccounted formal 
user-charge revenues are also significant sources of income in some facilities. 
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Formal user charge policy has not been able to achieve benefits for patients in the form 
of improved quality and accessibility. The main reason for this is that the policy creates 
new interest groups within the  health  service  (health  unit management committee 
members) who also hope to earn an income on the basis of the resources of patients. It 
also erJables senior staff (both within the facility and the district) to exert more leverage 
on junior staff to skew the total income generation in their favour. 
The  quality and  accessibility of services  in  public health  facilities  is  very poor.  The 
''informal" activities of health workers are far more important in determining this result 
than the inadequacy of supplies to health facilities or the maintenance of health facilities, 
which have both been major focuses of donors is this country. 
Partners 
London School of Hygiene and Tropical 
Medicine 
Dept. of Public Health & Policy 
Keppel Street 
WC1 E 7HT London 
United Kingdom 
Koninklijk lnstituut voor de Tropen (KIT) 
63 Mauritskade 
1092 AD Amsterdam 
The Netherlands 
Makerere University 
Makerere Institute of Social Research 
P.O.  Box 16022 
Wandegeya, Kampala 
Uganda 
B. Me Pake 
Tel: +44/171/927  .24.86 
Fax: +44/171/436.36.11 
P.  Streefland 
Tel: +31/20/568.87.11 
Fax: +31/20/568.84.44 
D. Asiimwe 
Tel: +256/41/54.02.66 
Fax: +256/41/53.04.12 
115 Contract number TS3*CT940305 
HEALTHY  PEACE?  REHABILITATION  &  DEVELOPMENT  OF  THE  HEALTH  SECTOR  IN 
POST-CONFLICT SITUATIONS 
Period: 
Co-ordinator: 
Objectives 
November 1, 1994- October 31, 1995 
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE, 
DEPARTMENT OF PUBLIC HEALTH AND POLICY 
London, United Kingdom (A. ZWI) 
To  analyse  the  long-term  impact of conflict  on  health  with  particular  reference  to 
disability and childhood diseases in two post-conflict societies (Ethiopia and El Salvador) 
and using these conditions as tracers to: 
•  Analyse the development of health-related policies, plans and programmes aimed at 
rehabilitating the health system in the post-conflict period, and to identify the key 
factors determining policy choice and influencing implementation. 
•  Analyse the financing of health sector rehabilitation and development in the post-
conflict period and assess existing strategies with respect to their sustainability and 
equity. 
•  Analyse the role of international aid in post-conflict rehabilitation and development of 
the health sector, and to assess the long-term implications of alternative patterns of 
international assistance. 
Activities 
This project represents the first phase of a planned 3-year project, and lasts for a period 
of 1 year.  During this period a situation analysis will be  prepared  in  both countries 
comprising three components: 
*  Health needs in post-conflict situations: 
This component of the study will assess the impact of conflict on health status with 
particular reference to disability and immunisable diseases, and will analyse trends in 
patterns of morbidity. The emphasis will be on collection and comparative analysis of 
existing secondary data. In addition, rapid and participatory methods of health needs 
assessment will be  used to build health profiles in at least two districts, which have 
been differently affected by war. 
*  Health policy analysis: 
This component of the study will provide an historical analysis of the development of 
the health system in the two countries.  Particular attention will be  focused on the 
impact of conflict on the health policy environment during the periods of conflict, and 
its implications for the functioning of the health system. The focus for this aspect of 
the  study will  be  on  events  since  peace  has  been  secured,  and  on  the  role  of 
international  agencies  in  the  design  and  implementation  of  rehabilitation 
programmes. 
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*  Health financing components: 
This component of the study will provide a comprehensive review of changes in the 
health financing system during and immediately after the wars. It will provide the 
basis for an  assessment of the key financing issues facing the health sector in both 
countries, with particular respect to the future role of international aid. 
The two country studies will be analysed comparatively. 
Expected outcomes 
Reports  and  publications  documenting  the  research  findings  will  be  drafted  and 
circulated widely as  a contribution to current international debates concerning  post-
conflict recovery. 
It is anticipated that more detailed research proposals will be prepared to follow up on 
specific issues in the future. 
Partners 
London School of Hygiene and Tropical 
Medicine 
Dept. of Public Health and Policy 
Keppel Street 
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United Kingdom 
Escuela Andaluza de Salud Publica 
Apartado de Correos 2070 
Granada 
Spain 
Universidad Centroamericana Jose Simeon 
Canas 
Dept. de Salud Publica 
Autopista sur 01  168, Jardines de Guad 
Apartado (01) 168 
San Salvador 
El Salvador 
University of Addis Abeba 
P.O.  Box 1176 
Sidist Kilo Campus 
Addis Ababa 
Ethiopia 
A.Zwi 
Tel: +44/171/927.24.04 
A. Ugalde Blasco 
Tel: +34/58/27.50.44 
E.A. Selva-Sutter 
Tel: +503n3.44.00 ext 119 
A.B. Kello 
Tel: +251/1/12.32.30 
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DEMOGRAPHIC  AND  EPIDEMIOLOGIC  TRANSITION  IN  INDIA:  PREDICTION  AND 
VARIATION IN HEALTH CARE COSTS 1951-2001 
Period: 
Co-ordinator: 
Objectives 
May 1, 1995- May 31, 1996 
OXFORD CENTRE FOR ENVIRONMENT, ETHICS AND SOCIETY 
MANSFIELD COLLEGE, Oxford, United Kingdom (K.SEN) 
•  To undertake a situation analysis of the demographic and health transition in India. 
•  To ascertain variation in health care utilisation among older people by sex and by gender. 
•  To make projections of the economic costs of ageing and its impact upon the household. 
Activities 
Research undertaken during 1995-1996 consisted of four phases: 
The first phase involved an  extensive review of secondary data and literature on demographic 
and  epidemiologic transition.  It also  involved consultation with medical  and  social  scientists 
undertaking similar research in different regions of India. 
A pilot study of adult morbidity,and an  assessment of the sectoral distribution and patterns of 
utilisation of health care was undertaken in  phase 2.  This was in order to predict variations in 
patterns  of  utilisation  by  sector,  and  to  make  projections  of future  health  care  costs  for 
households in two districts of  West Bengal. The third phase involved data analysis in situ working 
closely with Indian partners to compare local findings with national trends in demographic and 
epidemiologic transition, noting similarities and  differences in trends over the specified time 
period. The fourth and final phase has consisted of liaising with the various partners to produce 
the final report, and to make arrangements for dissemination in Europe and in India. 
Results 
By the year 2001  there will be  over 76 million Indians over the age of 60 years.  While their 
proportion will remain at about 7 per cent of the total population, in absolute numbers they will 
equal nearly the entire population of Germany and twice the ageing population (60  years and 
above) in most European countries. 
~  Demographic and Health Transition and patterns of adult morbidity: 
Historically DT and ET are associated with economic development. In theory, the higher the 
proportion of aged persons in a country, the higher the level of development. The main finding 
of this study is that the traditional analogy between development and demographic change 
may not be  entirely accurate. If they are measured either by the traditional indices of 
11per 
capita incomes" or by the distribution of incomes and resources such as education and health 
care, many countries such as India may remain II underdeveloped" yet still experience DT and 
ET. 
This context appears very relevant for India where low per capita incomes coupled with a 
highly unequal  distribution  of education,  health  care  and  technology  resources  between 
different segments of the population, has not prevented an accelerated process of DT and ET 
over the past 3-4 decades. There non-communicable diseases increase in their prevalence but 
do not replace communicable disease, so reflecting a process of very uneven development, as 
progress is made towards industrialisation. 
The pilot study confirms this hypothesis and despite its exploratory nature has implications for 
the allocation of resources in the health sector. 
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=*  Health care utilisation and projections of costs: 
Health services in  India are composed of a variety of different providers practising a wide 
variety of traditional and modern medicines. Each  of these has its own specific organisation 
and modes of delivery. Despite the predominance of private sector provision the public sector 
has  until recently played an  important role in  basic health services, and  particularly in the 
treatment of acute and long term care, for the more vulnerable groups. A review of existing 
data shows that there has been a rapid expansion in private provision of health care during the 
past decade, paralleled by declining investment in the public sector. 
The two main observed effects of this are first a continuous decline in the quality of public 
health  care  provision,  especially  in  the  established  infrastructure  of primary health  care 
centres, which act as  an  important health resource for the majority of the rural population. 
Secondly, such a decline ensures that the fee-paying private sector remains the most easily 
accessible and that the economic burden of chronicity falls directly upon families. Projections 
of population ageing hand in hand with the emergence of non communicable-disease in this 
context, suggest that the experience of transition is likely to be a serious economic and social 
crisis for individual families looking after economically dependent adults and older people. 
The  experience  of  most  countries  of the  world  has  shown  that  health  care  costs  rise 
exponentially with age. Our projections showed that the per capita costs are likely to rise from 
the current 6.9 per cent of total household expenditure in  1995, by at least 4- 6 per cent per 
household per annum, over the next five years. This estimate is based on current inflation and 
assuming a fixed prevalence of chronic disease, with 1995 as the base line for measurement. 
We are aware however that in the absence of programmes of prevention and an  expanding 
ageing population, these rates are not likely to remain constant. 
Methodology and Health Policy 
The evidence also suggests that in order to comprehend the magnitude of the potential health 
burden upon households in the coming decades, allocations for health services, need to be based 
on a sound national database of morbidity patterns by age-specific ratios. With the exception of 
a handful of ad  hoc local level studies, a national disease profile or record of morbidity in the 
country is yet to exist. It is only when it does that exploratory studies such as this will be objects 
of real  concern  (as  they should  be)  to  national  and  international  policy-makers.  The  study 
emphasises the need in health system research to focus on the impact that old people have, not 
simply on  providers, but more significantly on  users in  particular among households and  on 
vulnerable individuals within them. 
Partners 
Mansfield College 
Oxford Centre for Env. Ethics & Society 
Oxford OX1  3TF 
United Kingdom 
Indian Statistical Institute 
Population Studies Division 
203 Barrackpore Trunk Road 
700035 Calcutta 
India 
Universidad Pompeu Fabra 
Dept. of Economics 
Balmes 132 
08008 Barcelona 
Spain 
K.Sen 
(see contract IC18*CT960036) 
S. Guha Roy 
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A  CONCERTED  ACTION  FOR  THE  DEVELOPMENT  OF  ESSENTIAL  DRUGS  (ED) 
PURCHASING OFFICES IN DEVELOPING COUNTRIES 
Period: 
Co-ordinator: 
Objectives 
December 1, 1996- November 30, 1998 
INSTITUTE OF TROPICAL MEDICINE, PUBLIC HEALTH DEPT., 
Antwerp, Belgium (W. VAN LERBERGHE/B. DUJARDIN) 
1.1 General Objective 
The general objective of this concerted action is twofold, namely: 
•  to facilitate and consolidate the setting up and the operation of ED purchasing offices 
in developing countries and 
•  to improve the general working of the essential drugs strategy 
1.2 Specific Objective 
The specific objective of this concerted action is to identify the positive and negative 
political, administrative, economic, legal ar:ad  technical factors affecting the success of 
the  creation  of  ED  purchasing  offices,  checking  their  frequency  and  importance, 
proposing  possible alternatives, and,  if possible,  identifying the  solutions that have 
given the best results. 
Activities 
The first phase of  this concerted action will cover a one to two-year period and consists 
of the following two main stages: 
First stage: 
*  Assessment  of experiences  with  purchasing  offices to  date,  and  a  search  for a 
consensus on the priority issues. 
*  Drafting of the two reports collectively (see par 1.2) 
*  Identification of research priorities for the second phase of  this concerted action. 
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This first stage will revolve around preparing for and holding a seminar for the concerted 
action's participants.  Resource  persons will be  invited, as  needed, according to their 
experience in specific areas. The topics that will be covered during this first seminar are 
given  under  par.  2  Objectives.  Analytical  grids will  be  drawn  and  sent  out to  the 
participants  and  resource  people.  The  results  of the  search  for consensus  will  be 
published in the two documents, while the specific threads of the seminar (the topics) 
will  be  published  in  the  form  of  ''questions  asked  - possible  alternatives  raised  -
evaluation of achievements". 
Second stage: 
Publication of the results of the discussions and searches for a consensus conducted 
during the first year. Setting up the specific programme of work for the second phase. 
This second stage will be devoted to different activities conducted in parallel. 
*  The first is the publication of the results of the search for consensus. Each  of the 
participating countries will be responsible for co-ordinating the publication of one of 
the  strands  defined  under  Specific  Objective  1,  according  to  its  experience  and 
interest. 
*  To  mark the end of the first phase of this concerted action, a seminar will be held to 
complete the publication and to assess the results of the first phase of concerted 
action. 
*  Finally, the priority will be for the specific work to be done to follow up this concerted 
action. 
Expected outcome 
Two reports will come out of this work: 
1.2.1  Evaluation of the purchasing office problem 
This document will consist of two sections: 
:::::} the  history  of  central  pharmacies  and  the  analysis  of  the  difficulties  that  are 
encountered. 
:::::}  an  analysis of interventions to date and  proposed alternatives (revitalising central 
pharmacies, setting up autonomous medical store offices) and the identification of 
factors of success or failure in each alternative. 
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1.2.2  How to improve the operation of a medical store office 
This document will be designed as a guide covering the following subjects: 
=> the legal status of purchasing offices : analysis of the pros and cons of varieties of 
status. 
=>  relations  between  purchasing  offices  and  government  bodies  (health  ministries, 
finance  ministries,  ministries  of trade,  drug  administration,  etc.).  Review  of the 
difficulties that are encountered. What are the alternatives? What are the solutions of 
consensus? 
=>  relations with private pharmacies : history of relations in each country, summary of 
conflicts, proposals of strategies for reaching a consensus 
=>  purchasing offices' financing policies : comparison of methods used for calculating 
magnitude of one's working capital fund, etc. Discussion of the pros and cons 
=>  must the ED  purchasing office be  responsible for distributing drugs and imported 
medical equipment ? Pros and cons, analysis of alternatives. 
Depending on each partner's requests and needs, exchanges concerning administrative, 
bookkeeping,  and  financial  management procedures,  stock  management,  computer 
programme exchanges, etc., will take place. 
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Partners 
Institute of Tropical Medicine 
Public Health Department 
Nationalestraat 155 
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Belgium 
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Zusammenarbeit 
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CAME 
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France 
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Centre International de I'Enfance et de Ia 
Famille (CIDEF) 
Chateau de Longchamp 
Bois de Boulogne 
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France 
University of Zimbabwe 
Dept. of Clinical Pharmacology 
PO Box A178 
Avondale, Harare 
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Tel: +32/3/247  .62.86 
Fax: +32/3/247  .62.58 
E-mail: wlerberghe@enov.itg.be 
C. Oepen 
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P.  Hessou 
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c/o J-P Noterman 
Tel/Fax: +242/83.77.13 
M. Kaddar 
Tel: +33/1/45.25.73.67 
Fax: +33/1/44.30.20.00 
N. Nyazema 
Tel: +263/4n9.16.31 
Fax: +263/4n2.49.12 
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COLLABORATIVE PROJECT ON COMMUNITY DRUG USE: ENHANCING THE IMPACT OF 
ESSENTIAL DRUGS PROGRAMMES 
Period: 
Co-ordinator: 
Objectives 
February 1, 1992- July 1, 1994 
UNIVERSITY OF AMSTERDAM, MEDICAL ANTHROPOLOGY UNIT, 
Amsterdam, The Netherlands (A. HARDON) 
The main objectives of the study are: 
•  To enhance rational drug use by consumers, by introducing more appropriate rational 
drug use interventions in Primary Health Care  programmes in the Philippines and 
Pakistan. 
•  To  make  recommendations  for  the  inclusion  of  rational  drug  use  interventions 
directed towards consumers in primary health care. 
The specific research questions the study seeks to address are: 
•  What is done in Primary Health Care and Essential Drugs programmes to enhance the 
rational use of drugs by consumers? 
•  What are the factors that affect activities intended to enhance rational drug use? 
•  What is the impact of rational drug use interventions conducted in primary health care 
programmes, in terms of more appropriate use of drugs. 
Activities 
The project will be carried out through the following steps: 
*  Research sites are purposefully selected in areas where relatively intensive rational 
drug use take place. 
*  The research teams in each country are trained in basic research methods. 
*  Exploratory research  on existing rational  drug use  interventions is  carried  out by 
reviews  of policy documents and  educational  materials,  and  interviews with  key 
informants. 
*  The preliminary analysis of what is done to enhance rational drug use  and on the 
factors  that  affect  these  intervention  is  undertaken  and  forms  the  basis  for the 
methodology for the second evaluation phase. 
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*  The evaluation phase is conducted, including: 
a comparison of actual self-medication patterns in programme areas and 
control areas; 
an assessment of the appropriateness of the health worker prescription; 
feed-back  sessions  (to  consumers  and  to  health  workers)  to  validate 
findings and formulate recommendations for action. 
*  On  the basis of the results of the analysis  more appropriate interventions will be 
developed to enhance rational drug use, and will be presented to policy makers. 
Expected outcome 
=::}The main outcome of the project will be: improved methods for the enhancement of 
rational drug use by consumers in the primary health care programmes in which the 
research is conducted. 
=::}  More general recommendations for the inclusion of rational drug use intervention will 
be  directed  towards  consumers  in  primary  health  care  and  essential  drugs 
programmes. 
=::}These outcomes will be reported in country reports in Pakistan and The Philippines 
and in a synthesis report. 
Results 
In the first phase of the Pakistan study a comparison of drug use patterns was made, 
comparing areas with PHC  programme and areas without PHC  programme, using the 
drug use  indicators developed  in  this research  project. The  results show that in the 
Pakistan  research  areas,  self-medication  is  not a  dominant practice.  Usually illness 
episodes  are  treated  with  health  worker advice.  The  health  workers  nearly  always 
prescribe modern pharmaceuticals. The health workers prescribe antibiotics relatively 
often  (around  one-third  of the cases)  but they rarely  prescribe  injections. The  most 
important difference between the PHC areas and the non-PHC areas is the use of ORS. 
This is significantly higher in both prescribed medication and in self-medication in the 
PHC  areas.  Health  education  in  the  PHC  areas  has  focused  on  the  use  of ORS  in 
diarrhoea. 
In  Pakistan the following specific rational drug use activities were evaluated: (1)  health 
education sessions (2) the training of community health workers and lady health visitors 
(3)  the information provided by lady health visitors and  CHWs  during patient-clients 
consultations. 
As  in  Pakistan, the Philippine study was carried  out in  four communities.  However, 
contrary to findings in Pakistan, the researchers noted no substantial difference in drug 
use between the communities covered by the community-based health programme and 
the communities not covered by the programme. In  all communities, self-medication 
was found to be  the predominant form of first treatment of illness-episodes (59%  of 
episodes). Use of ORS was very low (11%  of episodes). And antibiotics and injections 
were also found to be used very little (6% and 0.4% of episodes respectively). 
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To gain more understanding of the effects of rational drug use activities, the Philippine 
team evaluated seven different interventions. These were: (1)  Community Pharmacies 
(an  initiative of the Munoz Community Based  Health Care Project; Community Health 
Workers sell a limited range of generic and herbal drugs at a mark-up of 10% (2) Mothers' 
classes: health education for mothers (3) Training of CHWs (4) The promotion of herbal 
medicine (5) the Radio programme "Kalingan Buhay" (6) The supply and dispensing of 
drugs for predominant diseases  (diarrhoea  and  respiratory  infections)  by the  Rural 
Health Units (7) The use of generic drugs (in 1988 the Philippine government adopted the 
Generics  Law,  which  required  the  prescribing,  and  dispensing  of drugs  by generic 
names). 
The Philippine team also evaluated the supply and dispensing of drugs for predominant 
diseases (diarrhoea and respiratory infections) by the Rural Health Units. The evaluation 
revealed that the RHU  personnel have no clear orientation on RDU  concepts. They are 
mainly aware of  the adoption of  the generics law, and the subsequent changes in generic 
labelling, and the requirement to prescribe generics. They do not use the national drug 
formulae as a guide in prescribing. As a results the effect of  the programme in promoting 
the  rational treatment of diarrhoea and  respiratory infections is very limited, is  also 
reflected in the fact that only 11% of the diarrhoea episodes in the research areas were 
treated with ORS. 
Proposed interventions for action 
During  workshops  on  the  provision  and  use  of drugs  in  communities  there  was 
extensive  discussion  of the  development of more  appropriate  interventions  in  the 
research areas, of more general recommendations for the inclusion of rational drug use 
interventions directed towards consumers in  primary health care, and essential drugs 
programmes.  It  became  clear that the  participating country teams  (Philippines,  and 
Pakistan) intend to follow the principle of informed decision-making by the community, 
with interventions to be  developed and implemented in a participatory approach. It is 
noted  that  health-education  sessions  were  found  to  be  a  relatively  successful 
intervention in  terms of promoting the use  of ORS  (Pakistan)  and  the use  of herbal 
medicines (The Philippines). Self-medication is the predominant form of treatment in 
The Philippines, and people express great interest in information on treatment options. 
The teams also  recognise the importance of prescribers of drugs as  determinants of 
consumer behaviour. Drug use by consumers often mirrors drug prescribing by health 
workers. And drug prescribers are rarely aware of rational drug use principles. 
Proposed  interventions fall  into three main groups, the first consumer-oriented  (e.g. 
strengthening mothers' classes in The Philippines and improved health education for 
women and men in Pakistan.). Secondly they may be drug-seller-oriented (e.g. providing 
drug-sellers in Pakistan with up-to-date information on the drugs they sell and training 
drug-sellers in the local sari-sari stores in The Philippines). Thirdly they may be health 
worker-oriented  (e.g.  improving the  knowledge of CHWs  and  lady health  visitors  in 
respectively the Philippines and Pakistan). 
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PATTERNS  AND  DETERMINANTS  OF  PHARMACEUTICAL  DRUG  USE:  A  STUDY  OF 
URBAN COMMUNITIES IN INDIA 
Period: 
Co-ordinator: 
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January 1, 1993- December 31, 1995 
UNIVERSITE CATHOLIQUE DE  LOUVAIN, DEPT. OF 
EPIDEMIOLOGY AND PREVENTIVE MEDICINE, 
Brussels, Belgium (D. GUHA-SAPIR) 
For  decades,  single-minded  researchers  and  activists  have  been  trying  to  improve 
prescribing practices and to promote rational drug therapy in India. That this has been 
an  up-hill task probably goes without saying, but since perseverance is a quality that 
generally wins in  the end, this research  study has been  undertaken to stimulate the 
decision-making process by, taking the issue one small step further. 
The medicine market is composed of several elements: the pharmaceutical production 
sector,  the  governmental  regulatory  and  policy-making  machinery,  the  physician 
prescribers who choose what medicines are consumed, and last and usually the least, 
the patients or consumers. At least one of these elements has to be modified in order to 
introduce changes or improvements in the system. The objective of this study was to 
understand better the prescribing behaviour of physicians in urban settings of Calcutta 
and  Delhi  with the aim of identifying an  intervention that would effectively change 
irrational  or  undesirable  behaviour  (from  the  patients  perspective).  The  underlying 
assumption  was  that  although  economic  interests  may  be  expected  to  dominate 
behaviour,  some  irrational  prescribing  is  also  due  to  a  lack  of  non-commercial 
information and professional training. However, a basic understanding of the scale of 
irrational prescribing among urban doctors in  India was fundamental and this study 
aimed to address this need. 
Specifically, it aimed to: 
+ describe prescribing practices of public and private physicians in the urbanised areas 
of Calcutta and Delhi; 
+ compare these practices with national II guidelines" and with WHO  II recommended" 
rational therapeutic practices; 
+ estimate the cost of prescriptions by disease category; 
+ explore policy implications for over or sub-optimal drug use. 
Methods and materials 
The study was undertaken within the metropolitan areas of Delhi and Calcutta. A total of 
8901  prescriptions were collected and analysed from 209 randomly selected pharmacies 
stratified by administrative zones in each city to address the intra-zone socio-economic 
variation.  The  data  was  collected  by a  team  of doctors  specialising  in  community 
medicine at the All India Institute of Public Health and in pharmacology at the Maulana 
Azad  Medical College.  Most of these researchers used the material in their graduate 
work. Three separate training sessions were held in Calcutta and Delhi where the use of 
questionnaires, coding  procedures  and  study objectives were  discussed  along  with 
broader issues relating to drug use and physician behaviour. 
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Meetings of the Joint Advisory Committee of the four institutions involved in the study 
together invited experts have been held periodically over the past two years to agree on 
methodology, sampling and analyses. 
The  questionnaire was prepared  by physician/pharmacologists, social  scientists  and 
programmers,  and  pre-tested  in  ten  pharmacies  in  South  Delhi  and  Calcutta  in 
December. In Delhi there was a commercially published list of pharmacies, of which the 
last issue was dated 1990.  It included geographic zones. Calcutta did not have such a 
published list and therefore one had to be  constructed from registration forms in the 
Drug Controller's office. A systematic random sample was drawn by taking every tenth 
pharmacy listed.  If the  pharmacy did not exist or the owner was  not available, the 
researcher selected the nearest pharmacy to it instead. 
Fieldwork was completed in four months, using a letter of introduction from the Drug 
Controller's Office. The  investigator filled in  the form for each customer entering the 
pharmacy using both his/her prescription and questioning. The generic data collected 
socio-economic and demographic characteristics of the patient, diagnosis or symptoms 
as  indicated  on  the  prescription, and  the same  as  reported  by the  interviewee, the 
qualifications and the affiliation of the prescribing doctor (e.g. specialist, public sector 
hospital etc.), the contents of prescription including brand names, dosage, form and 
quantity, and the investigations advised. Diseases were coded using the lCD  (10  Rev. 
1992)  at  the  five  digit  level.  Prescription  drugs  were  coded  using  the  Anatomical 
Therapeutic  Chemical  (ATC)  Coding  System  (4th  edition  published  by  WHO 
Collaborating Centre for Drug Statistics Methodology, Oslo, Norway) recommended for 
international  drug  utilisation  studies.  Drugs were classified  according  to their main 
therapeutic use, with only one ATC code for each pharmaceutical preparation, but were 
given more than one ATC  code if it they were available in two or more strengths or 
formulations with clearly different therapeutic use. Different formulations for topical and 
systemic  use  were  also  given  separate  ATC  codes.  Combined  preparations  were 
classified according to two main principles - (  1)  two or more active components not 
belonging to the same therapeutic group were classified by using the 50 series and (2) 
combined preparations containing two or more active components not belonging to the 
same therapeutic 4th level were classified using the 5th level code. In the present study, 
coding for combined preparations has been slightly modified to accommodate the large 
number of fixed-dose combinations encountered. 
Certain  fixed-dose combination were difficult to code  e.g.  Respimox (Bromhexine & 
Amoxycillin) and Gramogyl (Nalidixic acid & Metronidazole) in a 7 digit code. These 
were  therefore  separately  coded.  Investigations  advised  on  the  prescription  were 
included in the study to provide an aid in diagnosis, as well as to judge the rationality of 
the prescription. An approximate estimate for investigations cost was prepared after 
averaging the rates of 4 different facilities in Delhi, which included two nursing homes, 
one  private  hospital  and  one  private  practitioners'  laboratory.  The  rationality  of 
prescriptions  was  assessed  by  a  team  of qualified  medical  doctors  specialising  in 
pharmacology,  they  used  WHO  guidelines  and  cross-checked  results  between 
themselves. About 39% of the prescriptions were not included in this analysis owing to 
inadequate information or the use of non-allopathic drugs. 
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The total cost of  the drugs was estimated with the aid ofthe Indian pharmaceutical guide 
(1994), Drugs Today (June 1994), Monthly Index of Medical Specialist and Current Index 
of Medical Specialists. The retailer's price of the drugs as applicable during the survey 
period from April 1994 to July 1994 was estimated for the individual drug from these 
guides. The cost of the prescribed drug according to its frequency of administration and 
duration was calculated. 
The total cost was estimated by summing up the individual prices of  the drug prescribed. 
Consultation fees were not included and neither was the cost of working hours lost due 
to illness. The  basis of the assessment was to define a rational  prescription as 
11the 
smallest possible number of drugs prescribed for an adequate duration of time so as to 
treat/cure the illness effectively.". This implied that the drugs prescribed did not have 
any pharmaco-kinetic or pharmaco-dynamic interactions amongst each other; were not 
prescribed  in  cumbersome  schedules  and  painful  or  unacceptable  routes  of 
administration  and  not  unduly  expensive  for  the  patient.  In  this  study  a  set  of 
instructions was developed based on the above, on the experience of  the pharmacology 
team  (8  practising  physicians  from  teaching  hospitals)  and  on  WHO  guidelines.  A 
decreasing score was given according to the following conditions: 
whether the drugs prescribed conformed to the definition of rational prescription 
given above; 
whether the drugs prescribed were deemed effective in treating the underlying 
condition but were not drugs of first choice for that condition, or might not be the 
most cost-effective alternatives; 
whether  the  drugs  prescribed  were  in  no  way  beneficial  to  the  patient's 
management or whether there were are some negative interactions amongst the 
various agents prescribed or over-prescribed, under-prescribed or prescribed in 
the wrong dosage schedule; 
whether the prescribing information in terms of diagnosis/symptoms complex 
was incomplete or unconventional forms of therapy (e.g.  Ayurvedic or others) 
have been prescribed. 
Limitations of the  study are  briefly described  here.  Firstly,  prescriptions could  give 
confused  and  incomplete  information  with  regard  to  diagnosis,  although  specialist 
physicians tended to note diagnosis. This factor reduced by a third the prescriptions that 
could be  included for rational analysis. Secondly the design of the study would have 
been  much  stronger  if data  could  have  been  gathered  at  source,  that  is  at  the 
consultation.  However, a pre-examination  indicated that the collaboration of doctors 
would be excessively biased with only a certain group participating, and precisely those 
most likely to mis-prescribe opting out. 
Prescriptions could also have been collected at home but it was thought that catching 
them at the pharmacy ensured better recall and was closer to the time of illness, very 
often  catching  the patients or their guardians as  they left the doctor's consultation. 
Methodological choices for prescribing studies that require full co-operation of doctors 
and whose object is to evaluate effectiveness of  their performance are not numerous and 
this was retained as a best compromise between quality of data and cost. Finally, since 
the data collection was pharmacy-based the study population excluded the poor who 
generally cannot afford to consult a doctor. In  addition, the study also  left aside the 
whole issue of self-medication, traditional medicines or those who obtain medicines 
from non-pharmaceutical sources. 
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Results 
About 60%  of the total  sample was from the  18-45  years  age  group and  only  11o/o 
belonged to paediatric age  groups (1-12  years).  Since  most paediatricians and child 
clinics dispense their own medicines, relatively few juvenile cases come to pharmacies 
with prescriptions. 
Priority related to sex with regard to patients for whom these prescriptions were written 
was  clear  with  nearly  60o/o  of the  prescriptions  for  males.  The  average  cost  of a 
prescription  was  Rs.  58  while  the  average  rational  cost  would  have- been  Rs  37. 
Investigations were advised in relatively few cases (7 .9%). The calculated cost was Rs. 
275 + 1066. Antibiotics were present in a third of  the prescriptions, the commonest being 
beta-lactum  penicillin's (27.2%)  followed by quinolones (22.4%).  About two-thirds of 
systemic antibiotics prescribed in the present study were found to be irrational. Very few 
(8o/o)  prescriptions  cited  drugs  by  their  generic  name.  Diarrhoeal  disease  was  a 
particularly worrisome category where treatment was considered rational in only 11% of 
the  cases.  ORS  was  rarely  prescribed  and  more  than  a  third  of  the  diarrhoea 
prescriptions recommended unacceptable treatment. 
Only  10%  of  the  total  prescriptions  were  classified  as  rational,  not  only 
pharmacologically but also with regard to the use of cheaper alternatives or generic 
drugs. A third of the prescriptions contained one or more drugs judged unnecessary or 
dangerous. Most of  the irrational prescriptions were those in which a clear diagnosis had 
not been  reached  and  it was those that also  had the highest numbers of drugs per 
prescription (mean 2.73 drugs) and probably symptomatic therapy had been instituted. 
Nearly two-thirds of the prescriptions came from specialists, indicating a trend towards 
specialised health care, and they also prescribed on an average, significantly more drugs 
for a specific condition than general practitioners. More importantly, prescriptions from 
specialists also accounted for a significantly higher proportion of irrational prescriptions. 
Over 35% of specialist prescriptions contained at least one superfluous drug. For a best 
case  scenario, this may simply reflect the over-cautious approach of more qualified 
practitioners in taking care of every symptom reported by the patient. With regard to 
diarrhoeal diseases, the bulk of the prescriptions termed irrational had a co-prescription 
of anti-bacillary and anti-amoebic agents. While there may be some proponents of this 
therapy in  paediatric  practice,  in  adult patients this is  unwarranted.  By  history and 
clinical  examination  or  at  most  by  stool  microscopy,  distinction  between  the  two 
categories can  be  easily made.  Only 69  patients (23.5o/o)  were prescribed rehydration 
formulae for their complaints (which would be valid and rational for cholera though not 
for all cases of acute gastro-enteritis). 
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Also 71  patients (24.2%) were advised only antipropulsives. While these can  bring quick 
relief, they could be dangerous at times, especially in infective diarrhoeas and immune-
compromised hosts. Therefore, in the absence of specific host and disease factors, many 
of these prescriptions were included in the category /I difficult to rationalise". Pulmonary 
tuberculosis,  mainly treated  by  specialists,  had  a  significant  proportion  of irrational 
prescriptions, mainly due to wrong dosage or schedule. For India, where pulmonary-TB is 
endemic, WHO recommendations are of 4-drug regimen to avoid resistant strains from 
appearing. Since the study included prescriptions only from first visits, regimes other than 
3-4 drug (e.g. 1-2 drug regimes for maintenance) were considered irrational. Prescriptions 
of other multivitamins preparations, appetite stimulants and cough mixtures (other than 
cough suppressants for hemoptysis) were also regarded as irrational. 
None  of the  bronchial  asthma  cases  was  advised  pulmonary function  tests.  While 
diagnosis of this disease  is  more confidently made in children  and young adults,  it 
becomes difficult (without investigations)  in the  older patient population, especially 
among smokers.  Of the total  number of patients studied, very few were prescribed 
inhalational agents, the most rational form of therapy for this disease. Routine use of 
antimicrobial in acute exacerbations of asthma was frequently encountered. 
Cough  suppressant or expectorants were also  seen  to be  prescribed  in  quite a few 
patients, without any specific indication. Disorders affecting the oesophagus, stomach 
and duodenum, related to a high acid/pepsin state, were clubbed together. 
A number of prescriptions bore a diagnosis of gastritis or duodemitis even though as a 
histological  diagnosis  they  required  at  least  endoscopic  examination  for  their 
evaluation. Most patients with the diagnosis of acid peptic disease received non-specific 
therapy such as pain-killers (for heart-burn), anti-emetic agents or unconventional forms 
of therapy. Prescribed antacids were frequently in insufficient doses (>70  ml/day) and 
one or more agent was co-prescribed in most of them. 
In  addition  symptomatic therapy for the  pain  of acid  peptic  disease  was  used  in  a 
significant number of patients even though it is counter-productive. Quite a few patients 
were prescribed antacids with proton pump inhibitors - which is again quite irrational 
since  an  alkaline  milieu prevents these  drugs from inhibiting the desired enzyme  in 
parietal cells. Agents which increase the tone of lower oesophageal splinter are useful in 
management of diseases of the oesophagus but not in peptic ulcers or other related 
diseases. Their empirical use in all such conditions is clearly unwarranted. 
Conclusions 
The study indicates a serious extent of irrational prescribing especially among specialists 
and in particular for common illnesses such as diarrhoea and those affecting the upper 
gastro-intestinal tract. The problem is clearly due to both a tendency of patients to consult 
specialists by passing G.P.s, and also of a clear under-use of modern therapeutic regimes 
such as those developed by WHO but clearly not sufficiently promoted even at major 
urban city levels. The prescribing conditions of towns or villages further away from peer 
information  can  only be  worse.  The  average  cost  of prescriptions  was  also  clearly 
substantially higher than it needed to be, even in existing conditions. 
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This can  only be  attributed to commercial  pressures from the pharmaceutical sector 
without any public sector counter measures for balance.  Lengthy discussion around 
these prescriptions by the large medical team  also  indicated that the undergraduate 
medical curriculum did not prepare even the young professional in prescribing practices, 
and still less those who had left the University many years ago. It may be concluded from 
the  results  of the present study that the most important and cost-effective  areas  of 
intervention would be an  active nation-wide promotion of generic names for essential 
drugs, the popularisation of essential drug concepts and the preparation of therapeutic 
guidelines. In addition, the rational use of drugs and essential drug concepts should be 
included in the undergraduate medical curriculum. At the policy level, the Government 
should ensure  increased  availability of good quality essential  drugs and  therapeutic 
guidelines for common disorders; it should also regulate drug advertising by enforcing 
guidelines strictly, to provide unbiased information on drugs. 
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A  STUDY  OF  POLITICS,  HEALTH  AND  PHARMACEUTICAL  IN  THE  PEOPLE'S 
DEMOCRATIC REPUBLIC OF LAOS IN THE CONTEXT OF THE DECENTRALISATION AND 
ECONOMIC CHANGE AFFECTING THE WHOLE HEALTH SYSTEM OF LAOS 
Period: 
Co-ordinator: 
Objectives 
October 1, 1992 - September 30, 1996 
ORSTOM, DEPARTEMENT SANTE, Paris, France 
(8. HOURS) 
The main objectives of the study are: 
•  To identify and analyse the Laotian health syster.1 within the context of its economic, political 
and historical constraints, and to define the background and prospects for health sector reform. 
•  To analyse the process of  decision-making and management of  the health system at the centre 
and the periphery. 
•  To articulate relations between the State, the health system and the population. 
Activities 
Four main research areas are identified: 
*  The administration and management of the health service system 
Special  emphasis  will  be  paid  to  the  effects  of  administrative  decision-making  and 
decentralised financing on the operations of the health programmes. Quantitative data will be 
complemented  with  qualitative  data  from  interviews  with  key  health  policy-makers  and 
administrators at the central and local levels of health care systems. 
*  The economy of the health system and production of medical drugs 
This  includes  a  macro-economic  research  project  on  the  financing  of  imports  and  the 
marketing of drugs by central and provincial institutions. In addition, an anthropological study 
of two public sector pharmaceutical factories under autonomous management is undertaken. 
*  The health service structures 
This is studied in two district hospitals in the provinces of Vientiane and Pakkading. This part 
of the study focuses on a project which has been launched for the recovery of  costs. The study 
attempts to identify the views of the health  personnel on the cost-recovery initiative, their 
professional constraints and motivations. 
*  The Population's views on health and health care 
The anthropological qualitative study is focused on the social actors of the system: health 
personnel  and  patients.  Each  category  is  investigated  through  its  social  logic,  practices, 
expectations, and dissatisfaction. The relationship between health care providers and users is 
evaluated in depth. 
Expected outcome 
The research is expected to contribute to the strategic decisions that have to be taken in the 
health sector reform in Laos, concerning human resources, cost recovery, the development of 
a private health care sector, and the production and sales of essential drugs. 
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Results 
Three kinds of results have been obtained: 
:::)  In terms of management, scarce resources are spent and controlled without a clear rationality. 
A  general  lack  of  global  health  policy  is  observable.  Bureaucracy  and  heavy  political 
constraints have a negative impact on performances. Sectorial activities are not properly co-
ordinated. The management capacity is poor. Central and provincial co-ordination is not yet 
satisfactory. 
Investments are  largely from foreign  aid sources. The  MoH  does not control this aid  to a 
sufficient extent. Planning methods are too bureaucratic and vertical to constitute an efficient 
tool for the health sector reform. This is implemented piece by piece, with a certain lack of 
capitalisation.  The  decision-making  process  is  particularly  inefficient  because  making  a 
decision is a political risk, which is avoided as far as  possible. Local situations, political and 
family links play a great role. When a decision is taken, after a long delay, a number of social 
devices may be used to turn around the decision taken. 
:::)  As a social system, the Lao health system appears empty of patients. The two district hospitals 
studied, with 25 personnel, are receiving 6 patients a day. A similar disequilibrium is common 
in the study area, personnel are unproductive for 78% of their time. The health system crisis is 
therefore characterised  by very low attendance rates  and  widespread over-staffing, where 
motivation suffers in consequence. Attendance is  particularly low since private pharmacies 
are  multiplying. Many private pharmacists are  ex-health  personnel. Health care  delivery is 
poorly  appreciated  by  the  patients,  especially  since  cost-recovery  mechanisms  are 
implemented in public hospitals. For the same cost they prefer to consult a private doctor or 
go to nearby Thailand. 
:::)  An investigation into two state owned drugs factories was carried out showing the contrast 
between factory n°2 which is developing in the context of economic liberalisation, and factory 
n°3, which appears unable to adjust to the new constraints of the open market. Management-
profiles have been analysed in detail explainir.g such a contrast, with reference to the previous 
politico-economical context of bureaucratic socialist central planning. Economic changes have 
been  observed  concerning  the  drug  market.  A  drug  policy was  recently  established  but 
controls are inefficient and the quality of drugs variable. Non-pharmacists are free to open a 
pharmacy, prices are free. The state does not seem able to implement the drug policy to any 
large extent. Market regulation is not efficient. 
Health and pharmaceutical policies do not seem to be sufficiently implemented in Lao  LOR. 
The  health system  is  socially, economically, and  politically in  crisis.  Resources  and  better 
management will not be enough, without global reforms changing the image of  the State, and 
the perception of public health services with a corresponding increase in the confidence of  the 
citizens. 
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TOWARDS GOOD PHARMACY PRACTICE (GPP) IN THAILAND AND VIETNAM -A  MULTI-
INTERVENTION  APPROACH  TO  RATIONALISE  DRUG  USE  THROUGH  PRIVATE 
PHARMACIES 
Period: 
Co-ordinator: 
January 1, 1997- December 31, 1999 
KAROLINSKA INSTITUTE, DIVISION OF INTERNATIONAL 
HEALTH CARE RESEARCH, Stockholm, Sweden 
(G. TOMSON/T. FALKENBERG) 
Measurable, specific objectives 
•  To  analyse  and  compare the historical  development of the  regulatory system for 
private pharmacies and its implementation in Thailand and Vietnam. 
•  To  develop evaluation tools to describe the situation of drug distribution practices 
(dispensing, prescribing, informing, advising and storage in private pharmacies). 
•  To analyse factors which may influence drug distribution practice such as government 
regulation and provider knowledge. 
•  To  develop a conceptual framework on the basis of findings describing the inter-
relationships between drug distribution practices and influencing factors in Thailand 
and Vietnam. 
•  To  develop  a  context-specific  multi-component  intervention  package  including 
enforcement of regulation, education and peer-influence strategies. 
•  To  evaluate the effectiveness of each  intervention on  drug distribution practice  in 
private pharmacies through a randomised control trial (modified time-series design). 
•  To  develop  a  comprehensive  package  of  evaluation  tools  and  context-specific 
interventions to be proposed to policy-makers in order to improve drug use in private 
pharmacies. 
Activities 
*  Analysis  of  regulatory  processes  (objective  1  ).  Conducting  an  historical  policy 
analysis  of the  contextual  factors  which  have  affected  the  development  of the 
regulatory system  for private  pharmacies  as  well  as  of actors taking  part in  the 
process, whether as stakeholders or in opposition to policies. The focus will be on the 
process of  translating policy into successful implementation in Vietnam and Thailand. 
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*  Provider  drug-distribution  knowledge  (objectives  2  &  3).  Provider  knowledge  in 
relation to Good Pharmacy Practice (GPP) including case management will be studied 
from a formal point of view through official visits to pharmacies using a pre-tested 
questionnaire and  through  interviews assessing  pharmacy staffs'  knowledge and 
conceptions. These questions will focus on the pharmacists' own practice and their 
knowledge and attitudes towards case management and GPP, including the essential 
drug (ED)-concept and  adverse drug reaction  (ADR).  Knowledge of the use of oral 
steroids for lower back pain treatment and of the use of short courses of antibiotics 
for viral infections will be assessed. 
*  Provider drug-distribution practice (objectives 2 &3). Trained research assistants will 
present histories of e.g. ARI, STD, and infant diarrhoea at the pharmacy, posing as 
patients or parents asking the drug outlet staff for advice on treatment, i.e. surrogate 
patient survey methodology. Low back pain case management and the use of short 
term  courses  of antibiotics will  also  be  assessed.  The  drugs sold will  be  noted, 
including their quantity, formulation, strength, price to client,  presence of generic 
name and information given. 
*  Provider  system  for  stocking,  etc.  (objectives  2  &  3).  A  stock  inventory will  be 
conducted using a pre-tested protocol, monitoring essential drug selection and drug 
registration,  labelling  (presence  of  generic  name),  proportion  of  banned  and 
combination drugs, number of drugs beyond expiry date, unit cost from wholesalers, 
price to buyer, availability, quality, etc. 
*  Conceptual framework and interventions (objectives 4,  5 &  6).  The results of these 
investigations will provide the basis for the development of a conceptual framework 
describing the interrelationship between drug-distribution practices and influencing 
factors.  A  context-specific  multi-intervention  package  including  enforcement  of 
regulation,  education/persuasive  information and  peer-influence strategies will  be 
developed. The feasibility and effectiveness of the interventions on drug distribution 
practice in  private pharmacies will be  assessed through a randomised control trial 
with 40 pharmacies in each country. The interventions will be applied sequentially in 
a modified time-series design with a parallel control group. 
*  Exploitation and dissemination (objective 7). The results will be disseminated through 
publications  in  national  and  international  scientific  journals,  mass  media,  and 
relevant  professional  organisations.  The  conclusions will  be  disseminated to  key 
actors and organisations involved in health system research, drug policy-making and 
health  sector  reforms.  The  project  will  seek  ways  to  improve  the  feasibility  of 
implementing the project innovations within a specific political context. 
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Expected outcome 
~  The study will provide an analysis of drug distribution practices in private pharmacies 
in Thailand and Vietnam. 
~The study  will  evaluate  the  feasibility  and  effectiveness  of  a  multi-component 
intervention on drug-distribution practices. 
~The  intervention and monitoring instruments of GPP developed in this study will be 
adapted to the health services. 
~The  results will provide .policy-makers with a scientific basis for decisions relating to 
national drug-policy reform includir~J privatisation of the drug-distribution system as 
part of the health sector reform. 
~The  project will result in capacity building and research training which, will be useful 
for the development of GPP in the Asian region. 
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Partners 
Karolinska Institute 
Division of International Health Care 
Research 
171  76 Stockholr.1 
Sweden 
London School of Hygiene and Tropical 
Medicine 
Dept. of Public Health and Policy 
Health Policy Unit 
Keppel Street 
WC1 E 7HT London 
United Kingdom 
Health Systems Research Institute 
Mental Health Dept. Building, 5th floor 
Tiwanon 4 Road 
Nonthaburi 11000 
Thailand 
Ha Noi College of Pharmacy 
Dept. of Social Pharmacy and Drug 
Information Centre 
13-15 Le Thanh Tong Street 
HaNoi 
Vietnam 
G.Tomson IT. Falkenberg 
Tel: +4618151.77.66.29 
Fax: +4618131.15.90 
E-mail: torkel.falkenberg@fyfa.ki.se I 
staff@phs.ki.se 
G. Walt 
Tel: +4411711927.24.31 
Fax: +4411711637.53.91 
E-mail: g.walt@lshtm.ac.uk 
S. Chunharas/S. Wibulpolprasert/ 
S. Ratanawijitrasin 
Tel: +6612195.11.286 
Fax: +6612195.11.295 
E-mail: suwir@health.moph.go.th I 
somsak@health.moph.go.thl 
rsauwako@chula.ac.th 
N. Thanh Do 
Tel: +8414182.48.703 
Fax: +8414182.51.879 
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A  PROPOSAL  TO  ASSESS  THE  IMPACT  ON  FAMILIES  AND  STATE  OF  TRAUMATIC 
INJURY  RELATED  DISABILITY  AMONG  ADULTS  IN  LEBANON  AND  THE  OCCUPIED 
TERRITORIES. 
Period: 
Co-ordinator: 
General objectives 
September 1, 1996- June 30, 1999 
UNIVERSITY OF CAMBRIDGE, DEPT. OF COMMUNITY MEDICINE, 
Cambridge, United Kingdom (K. SEN) 
This study seeks to identify the psycho-social, economic and epidemiologic burden of 
injury morbidity in  the  aftermath  of conflict  in  support of the  EC's  policies  in  the 
Mediterranean region. 
Both Lebanon and the Occupied Territories are coping with health systems that are being 
reorganised following a period of prolonged conflict. The main focus of this study is on 
the evaluation of specific services  being  provided to vulnerable populations among 
disabled adults (in  Lebanon)  and  elderly people  (in  the Occupied Territories).  Multi-
disciplinary and multi-sectoral collaboration will ascertain the prevalence of disability 
and of population-based needs, in specific services. The study hopes, through scientific 
collaboration, to provide insights into the overall costs of disability in terms of quality of 
life and  foregone incomes for disabled adults,  older people and  their carers,  in the 
aftermath of conflict. 
Specific objectives 
•  To  assess  the nature and  prevalence of disability (of mental  and  physical  health) 
leading to loss  of functional  autonomy amongst adults  (in  Lebanon)  and  elderly 
people (in the OTs) 
•  To examine the causes of disability and to estimate the impact of war (in Lebanon) on 
the prevalence of disability. 
•  To  examine current social care arrangements and available support focusing on the 
interface between private and public sector health and social care provision, and their 
efficacy in meeting the needs of disabled adults and elderly people in the aftermath 
of conflict. 
•  To explore where feasible the economic and social burden of disability by estimating 
the costs of maintaining adults with impaired functions by the household in terms of 
lost earnings and quality of life factors. 
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•  To  evaluate  and  contrast  current  approaches  to  health  and  social  support  (i.e. 
rehabilitation centres, family aid, extension workers, one to one support) in terms of 
family preferences, costs equity and effectiveness. 
•  To disseminate findings as widely as possible in the region and internationally on the 
needs of vulnerable adults, older people and their carers in the aftermath of conflict, 
making recommendations for specific interventions. 
Activities 
In the Occupied Territories we are in the process of devising an  instrument to ascertain 
physical and mental well-being among a cross-sectional population sample of adults over 
55 years of age in selected rural and urban areas. We are planning to use the SF36 which 
is a well-validated health status measure currently undergoing international testing to 
ascertain  its  appropriateness for  use  with  elderly  people.  Following  translation  and 
adaptation, this instrument will be validated for use among Palestinian elderly people. 
In-depth  interviews will follow, among a sub-strata of this population, to determine 
linkages if any between service provision and quality of life for both carers and those 
with functional disability (Activities of Daily Living (ADL) and Instrumental Activities of 
Daily Living (IADL) in the main). Socio demographic and economic variables that may 
have an  impact upon quality of life according to perceived effect will also be explored. 
The in-depth research will run concurrently with an  audit of service provision, current 
and for the past 5 years (1991-1996), to assess the inter-face between public and private 
sector  provision  with  an  historical  perspective  (reconstruction  in  the  aftermath  of 
conflict), followed  by an  evaluation of access,  equity and  effectiveness  vis a  vis the 
population with disabilities and their families. Recommendations for service provision 
for  older adults with  disabilities will  be  made  on  the  basis  of our findings  on  the 
appropriateness and accessibility of current services 
In  Lebanon, the study plans to ascertain the prevalence of war-related injury morbidity 
for both physical and mental health. A cross-sectional study of adults is proposed among 
a sample of the population, with the use of the General Health Questionnaire (GHQ) to 
ascertain  physical  and  in  particular  emotional  well-being.  A  sub-stratum  of those 
identified with disabilities will be involved in in-depth interviewing and screening with 
instruments (Composite International Diagnostics Instrument (CIDI-10)) to detect post-
trauma stress disorder (PTSD) to determine linkages if  any, between emotional state and 
the ability to perform IADL, and the impact upon quality of life where PTSD exists, by 
socio-demographic and economic variables. The prevalence studies will be followed by 
an  audit and  evaluation of current service  provision in  public, private and voluntary 
sectors, especially with regard to the efficacy of impact, upon measures of perceived 
quality of life of disabled persons and their carers. 
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Recommendations will be made on the expansion (or contraction) of current services on 
the basis of our findings. These findings will reinforce the major common thread of both 
studies which is to examine the impact of services for adults and  older people with 
disabilities. Integral to both parts of this study is training for all partners involved, not 
only in terms of refining  and  developing cross-national  research  tools,  but also for 
improved mutual understanding of the service needs of people with disabilities in the 
aftermath of conflict and on the impact of injury-related disability on the quality of life -
training which is of global interest. Regional and international dissemination is planned 
during the final phases of the project. 
Expected outcome 
Given  the  nature of the region,  and  in  particular its isolation  due to conflict,  many 
challenging  methodological  issues will  be  raised  in  the  process  of undertaking this 
research. It is essential to bring researchers and health practitioners into the debate on 
issues of disability and rehabilitation through mutual learning. A carefully selected multi-
disciplinary team of local and European expertise has been brought together to deal with 
the task of linking the findings of research with service provision and service usage, with 
a focus on the needs of users and their families, where appropriate. This has been done 
in  order to  highlight linkages  between  the  psycho-social  and  economic  benefits  of 
providing appropriate support to vulnerable populations in the aftermath of conflict. 
The expected outcomes are as follows: 
=>  Provide an estimate of the nature, type and economic consequences of disability. 
=>  Provide an evaluation of current services in terms of equity, effectiveness and cost. 
=>  Provide an indication of population need and demand. 
=> Support  long-term  networking  among  researchers  in  the  region  and  European 
partners through publications and one regional meeting between providers and user 
groups, to discuss issues raised by the study. 
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Partners 
University of Cambridge 
Dept. of Community Medicine 
Forvie Site 
Robinson Way 
Cambridge CB2 2SR 
United Kingdom· 
The American University of Beirut 
Department of Health Sciences 
Bliss Street 
P.O.  Box 11-0236 
Beirut 
Lebanon 
Aid to the Aged (ATTA) 
Harhash Building 
PO Box 21358 
Beit-Hanina 
Jerusalem 
Occupied Territories 
lnstitut National d'Etudes Demographiques 
27 rue du Commandeur 
75675 Paris Cedex 14 
France 
K.Sen 
Tel : +44/1223/330.300 
Fax : +44/1223/330.330 
E-mail : reh32@medschl.cam.ac.uk 
A. Sibai 
Tel: +961/1/350.000 ext. 4647 
Fax: +961/1/212.444.5801 
M. Sansur 
Tel: +972/2/81.20.32 
Fax: +972/2/81.20.32 
M. Khlat 
Tel: +33/1/42.18.21.49 
Fax: +33/1/42.18.21.99 
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DEVELOPMENTS  REACHED  BY  THE  HEALTH  SYSTEM  IN  EL  SALVADOR  AND 
NICARAGUA IN THE POST-WAR PERIOD (1990-1995), FOCUSING ON THE EFFORTS OF 
CIVIL SOCIETY 
Period: 
Co-ordinator: 
February 1, 1997- January 31, 2000 
UNIVERSIDAD NACIONAL AUTONOMA DE  NICARAGUA, 
CENTRO DE INVESTIGACIONES Y ESTUDIOS DE  LA SALUD, 
Managua, Nicaragua (G. RICARTE GUTIERREZ) 
In  Nicaragua and El  Salvador the period 1990-1995 can be characterised as a post-war 
period in which structural adjustment programs were implemented. State reform and 
health sector reform were central elements of  these programmes, but their impact on the 
health  status  of the  population  and  the  health  service  organisation  has  not  been 
analysed. Furthermore the health sector reform of the state was complemented by a 
series  of  local  initiatives  in  civil  society,  to  respond  to  the  growing  needs  of the 
population. 
Objectives 
The general objective of this research  project is to analyse the stage of development 
reached  by the  health systems in  El  Salvador and  Nicaragua  in  the  post-war period 
(1990-1995), focusing on the efforts of civil society. 
Activities 
*  An inventory of these local health initiatives will be made and systematised. 
*  These initiatives will be placed in an overall analysis of the specificity of health sector 
development in these two countries. 
*  The possibilities of a multiplication of the best experiences will be examined on the 
basis of a detailed evaluation of these experiences. 
This evaluation of local experiences in health sector development by different actors of 
civil  society  will  focus  on  their  effectiveness,  their  sustainability,  the  degree  of 
participation by the population, and their capacity to enhance the autonomy and equity 
in health services delivery. Special emphasis will be put on the relationship between the 
public service  and  the  non-profit private sector,  their complementarity and  conflicts 
during this complex period of post-war reorientation and structural adjustment. 
Expected outcome 
This research project is expected to develop guidelines to improve the impact of local 
initiatives in the health sector. An exchange of successful experiences will be organised 
within civil society and between civil society and the public sector. At the health policy 
level, elements for the incorporation of local initiatives in the national health policy will 
be identified. 
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Partners 
Universidad Nacional Autonoma de 
Nicaragua 
Centro de Investigaciones y Estudios de Ia 
Salud 
Radial Santo Domingo 
De los repuestos Ia 15, 75 Varas al Sur 
Managua 
Nicaragua 
Facultad de Medicina 
Universidad El Salvador 
Final 25 Avenida Norte 
Ciudad Universitaria 
San Salvador 
El Salvador 
Institute of Tropical Medicine 
Dept. of Public Health 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
University of Nijmegen 
Faculty of Medical Sciences 
Nijmegen Institute of International Health 
Erasmus Laan  1 
P.O.  Box 9101 
6500 HB Nijmegen 
The Netherlands 
G. Ricarte Gutierrez 
Tel: +505/2n8.36.88 1  77.15.45 
Fax: +505/2n8.67.  75 
E. Espinoza 
Tel: +503/25.83.18 
Fax: +503/25.88.22 
P.  Van Der Stuyft 
Tel: +32/3/247.62.97 
Fax: +32/3/247 .62.58 
F.  Barten 
Tel: +31/24/361.69.80 
Fax: +31/24/366.63.36 
E-mail: F.Barten@aig.azn.nl 
145 Contract number IC18*CT9601 08 
HEALTH SECTOR REFORM:  COPING STRATEGIES AND PROFESSIONAL IDENTITY OF 
PRIMARY HEALTH CARE CLINICIANS IN MOZAMBIQUE AND SOUTH AFRICA 
Period: 
Co-ordinator: 
Objectives 
December 1, 1996- November 30, 1998 
MEDICAL UNIVERSITY OF SOUTHERN AFRICA, DEPT OF FAMILY 
MEDICINE, Medunsa, South Africa (S. FEHRSEN) 
The present research proposal aims at a deeper understanding of the coping strategies 
of health  professionals,  their  consequences  and  determinants,  including  structural 
determinants. Based on this understanding it further aims to influence the strategies of 
development and implementation of health personnel norms and policies. The fields for 
this research are Mozambique and South Africa. The purpose is however to develop a 
framework of analysis allowing to address these questions to be  addressed in other 
societies. 
The underlying hypotheses are: 
•  That the coping strategies of health professionals are among the key elements for 
attempts at health sector reform. 
•  That  the  structural  conditions  that  affect  these  coping  strategies  include  the 
characteristics of the organisation of the health care  system as  well as  the social, 
cultural and economic environment of the society, and the way history and politics 
have shaped the development process and its impact in the process of socialisation 
of students and young professionals. 
•  That in order to make coping strategies of individual health personnel compatible 
with the objectives of the health care system it is essential to promote the existence, 
acceptance and  interiorisation of a role model of a generalist practitioner (patient-
centred,  community-oriented  and  guided  by  the  universal  principles  of  family 
medicine) as a cornerstone of health sector reform. 
•  That even  in  an  adverse  social  environment it is  possible  and  feasible to create 
favourable  conditions  that  allow  health  personnel  to  adopt  coping  strategies 
compatible with equity and quality health care  delivery, while responding to their 
aspirations for survival, social status and professional satisfaction. 
Measurable objectives 
•  To  identify historical factors of relevance to the transformation of the health sector 
over the past 20 years in Mozambique and South Africa; 
+ To identify present coping strategies, role-images and profession-identity patterns of 
medical practitioners medical assistance and nurse practitioners in Mozambique and 
South Africa; 
146 Contract number IC18*CT960108 
+ To identify the extent to which Primary Health Care clinicians are aware of, interpret 
and adhere to the principles of family medicine in their day to day practice; 
•  To  identify the positive and  negative associations of these coping  strategies with 
indicators of quality of care; 
+ To  identify  positive  and  negative  consequences  of  these  coping  strategies  as 
perceived by the users and as contrasted between the different sectors of health care 
(public, private); 
•  To  identify alternative coping  strategies that limit the negative consequences and 
favour the positive consequences of health care delivery, and the structural conditions 
under which these alternative strategies can thrive; 
•  To test and demonstrate the feasibility of these alternative coping strategies in select 
settings; 
+ To  develop  a  conceptual  framework  for  analysing  and  influencing  such  coping 
strategies that takes  into account the  structural  conditions  related  to health  care 
organisation issues, and to the social context and the process of development; 
+ To formulate recommendations for health authorities and development agencies, that 
allow them  to  deal  with  health  personnel  issues  in  ways  compatible  with  the 
development and reform of the health sector, resulting in greater efficiency, rather 
than in ways that favour the dysfunctioning of the health personnel. 
Activities 
*  To  identify historical factors of relevance to the transformation of the health sector 
over the past 20 years, in Mozambique and South Africa 
*  Analysis of available documents and literature related to: 
-the overall process of development 
-the history of the modern health sector 
- health policy issues 
- health personnel demographic data 
- health services organisation 
- health services utilisation 
- social position of different health professionals in society 
-training curricula of medical and nursing practitioners and medical assistants 
- role of professional associations 
- past and present characteristics of traditional healers 
This will be complemented by structured interviews of key informers (e.g. 
ex-ministers of health). 
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*  To  identify present coping strategies, role-images and professional identity-patterns 
of medical practitioners, medical assistants and nurse practitioners and students in 
Mozambique and South Africa. 
A sample of medical practitioners, medical assistants and nurse practitioners  and 
students in Mozambique and South Africa is to be selected from existing registers. 
Selection  criteria  will  be  considered  according  to  sex,  urban/rural  residence, 
ambulatory/hospital care, private/public sector, years in practice, social visibility. Data 
to be  collected according to standard interview schedules adapted to each  country 
and professional category. Questions will include open and closed answer options. 
The  above  information will  be  complemented  by an  analysis  of the schedules  of 
complaints of the Medical and Nursing Councils in South Africa and the Ministry of 
Health in Mozambique. In Mozambique there has been an intense debate in the written 
press,  on  the issue of professional coping strategies. This will be  reviewed.  Some 
health facilities have a box for complaints and suggestions, and these will be analysed. 
This  information  will  be  used  at  the  selected  sites  to  develop  an  in-depth 
understanding by a participatory action-research approach. 
*  To identify the extent to which PHC clinicians are aware of, interpret and adhere to the 
principles of family medicine in their day to day practice. 
Participant observation will take place at a number of selected PHC settings to identify 
structural, organisational and relational factors in the care process. 
Clinical  records  will  be  reviewed  according  to  a  standard  check  list to  evaluate 
completeness and comprehensibility of clinical record, comprehensiveness of care 
provided (curative, preventive, promotive, rehabilitative) adherence to protocol, use 
of essential drug list/drug formulary, continuity of care. Taped consultations will be 
analysed to measure patient-centredness. 
*  To  identify  positive  and  negative  associations  of  these  coping  strategies  with 
indicators of quality of care: 
Monitoring of tracer diseases and sentinel events (identified in a participatory way), 
measurement  of  Patient-centredeness  through  scoring  of  tapes  and  patient 
satisfaction interviews, measurement of waiting times, measurement of ratios of new 
to  repeat  patients,  case  studies  of  wards  and  clinics  or  health  centres.  This 
information  will  be  compared  for  private  and  public  sector  activities  and  for 
practitioners grouped according to the most important coping strategies identified. 
*  To  identify the positive and  negative consequences of these coping strategies as 
perceived by the users and funders (MOH health insurers) and as contrasted between 
the different sectors of health care (public, private and traditional). 
Focus group discussions will make use of projective techniques, stakeholders and key 
informer structured interviews. If necessary use will be made of consensus promoting 
techniques that guarantee anonymity (Delphi technique), on the basis of the above. 
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*  To  identify alternative coping strategies that limit the negative consequences and 
favour the positive consequences of health care delivery, and the structural conditions 
under  which  these  alternative  strategies  can  thrive;  to  generate  hypotheses  of 
change; the negotiation of change with field actors and authorities. 
This will be done at a series of workshops for the researchers, and for the researchers 
together  with  key  people  in  policy-making  institutions  and  on  sites  selected  as 
potential field stations for the action-research phase. If necessary, use will be made of 
consensus-promoting techniques that guarantee anonymity. 
Expected outcome 
=>  development of the framework referred to in objective 8; 
=>  local action for change through the participatory action-research approach; 
=>  policy recommendations for local, national and international health 
=>  authorities; 
=>  publications; 
=> capacity building and training in research methods, management and in the 
=>  principles of family medicine. 
Partners 
Medical University of Southern Africa 
Dept. of Family Medicine 
P.O.  Box 222, Pretoria 
G. S. Fehrsen 
Tel: +27/12/529.43.14 
Fax: +27  /12/529.45.32 
0204  E-mail: family@mcd4330.medunsa.ac.za 
South Africa 
Universidade Eduardo Mondlane 
Faculty of Medicine 
Av. Salvador Allende, 38 
P.O.  Box 257 
Maputo 
Mozambique 
Institute of Tropical Medicine 
Public Health Research and Training Unit 
Nationalestraat 155 
2000 Antwerp 
Belgium 
Universidade Nova de Lisboa 
Institute de Higiene e Medicina Tropical 
Rua  Da Junqueira 96 
1300 Lisbon 
Portugal 
M.L.R. Julien 
Tel: +258/1/42.49.1 0 
Fax: +258/1/42.52.55 
E-mail: mjulien@health.uem.mz 
W. Van Lerberghe 
Tel: +32/3/247 .62.50 
Fax: +32/3/247 .62.57 
E-mail: Wlerberghe@ITG.BE 
P.  Ferrinho 
Tel: +351/1/363.21.41 
Fax: +351/1/363.21.05 
E-mail: paurosat@mail.telepac.pt 
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RESEARCH ON POLICY ISSUES IN REFUGEE HEALTH CARE IN SUB-SAHARAN AFRICA 
Period: 
Co-ordinator: 
Objectives 
October 1, 1996- September 30, 1999 
MAKERE UNIVERSITY, FACULTY OF MEDICINE, 
Kampala, Uganda (G. BUKENYA) 
The main objectives of the project are : 
•  to study the health effects on refugees of different approaches to refugee reception, 
ranging from integration in the host population to encampment and separation from 
the host population.  • 
•  to  make  policy  recommendations  to  host  governments,  donors  and  relief 
organisations on how to improve the reception of refugees and the organisation of 
health services for refugees in Africa. 
•  to  identify means to empower local  actors  in  a  field  now largely dominated  by 
international actors. 
•  to strengthen the research and training capabilities of the institutions involved. 
1.2. The underlying hypotheses are : 
•  Hypothesis A : When refugees are integrated in the host population they fare better 
than if they are separated from the host population and confined to camps. 
•  Hypothesis B : The health services of the host country can play an important role in 
the reception of refugees; in the process of doing so, these services are strengthened. 
•  Hypothesis C: An integrated approach to health service delivery for refugees is more 
cost-effective than organising parallel refugee health services. 
1.3. The research work will be organised around 3 research questions : 
•  Question 1 : What are the effects of different approaches to refugee reception on the 
health  status of the refugees?  What is the role  of the health  services of the host 
countries?  What  are  their  costs?  Under which  conditions  are  they  adequate  or 
inadequate? 
•  Question 2 : Why are refugees now most often concentrated in camps, with parallel 
health services organised for them? and why they are sometimes allowed to settle 
freely and use the health services of the host country? 
•  Question 3 : Is it possible to influence the process which leads to the separation of 
refugees from the host population and the organisation of parallel health services of 
refugees? 
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Activities 
*  Intensive  training  period  at  the  Refugee  Studies  Programme  in  Oxford  for  the 
researchers involved 
*  Extensive literature study on Refugee Health Care 
*  Resource mapping : gathering of existing data on the different refugee-affected areas 
in Kenya (Kakuma, Dadaab,  ... ) and Uganda (Arua, Moyo, Kitgum, Masidi,  ... ) 
*  Workshops and field conferences involving all  academic and  operational  partners 
(Government institutions, UN agencies, NGOs, etc.) 
*  Specific data-collections on health status of refugees in different settings; including 
surveys to determine welfare-status and level of uprootedness 
*  Examine  if policy changes  are  possible through  in-depth  discussions,  interviews, 
focus group discussions 
Expected outcome 
~  A  better understanding of effects of different settlement patterns on  refugees,  of 
determinants and actors in refugee situations 
~  Empowerment of local actors (government, national academic institutions) 
~  Strengthened research and training capability in the field of refugee health care for 
the partners involved 
~  More diverse and locally appropriate settlement and assistance policies 
Partners 
Makere University 
Faculty of Medicine 
PO Box 7072 
Kampala 
Uganda 
Institute of Tropical Medicine 
Public Health Department 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
University of Oxford 
Refugee Studies Programme 
Queen Elisabeth House 
21, St. Giles 
Oxford OX1  3LA 
United Kingdom 
Moi University 
Centre for Refugee Studies 
PO Box 3900 
Eldoret 
Kenya 
G. Bukenya 
Tel: +256/41/53.00.20 
Fax: +256/41/53.10.91 
W. Van Lerberghe I W. Van Damme 
Tel: +32/3/247 .62.86 
Fax: +32/3/247.62.58 
E-mail: wlerberghe@enov.itg.be 
B.E. Harrell-Bond 
Tel: +44/1865/27.07.25 
Fax: +44/1865/27.07.71 
E-mail: hbond@vax.ox.ac.uk 
J. Okumu 
Tel: +254/321.43001 
Fax: +254/321.43047 
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MEASURING  AND  MONITORING  THE  PERFORMANCE  OF  REFORMING  HEALTH 
SYSTEMS 
Period: 
Co-ordinator: 
Objectives 
November 1, 1996 - October 30, 1999 
INSTITUTE FOR HEALTH SECTOR DEVELOPMENT, 
London, United Kingdom (P.  SANDIFORD) 
•  To identify the various forms of utility that are being provided, or that could be offered 
by health systems. 
•  To identify the types of utility and social benefits that are not currently being obtained 
from health systems. 
•  To document the stated and unstated objectives of health sector reform programmes. 
•  To contrast the goals (stated and unstated) of health sector reform programmes with 
the desires and expectations of tax-payers and users of health services. 
•  To develop quantifiable indicators of each form of health system-derived utility. 
•  To develop a technique for weighing the indicators of each source of utility such that 
their sum measures total health system derived utility or benefit. 
•  To  test the value of the techniques as  tools for policy formulation, taking  as  the 
concrete example options for rationing and prioritising health services, including the 
establishment of 'basic packages'. 
•  To develop tools that allow funders, purchasers and users to monitor performance of 
decentralised health district or regions in terms of their full range of social benefits. 
Activities 
*  Ten  focus group discussions, two in each  of the countries (Mexico, Guatemala, El 
Salvador,  Nicaragua,  Costa  Rica)  interviewing  extremely  diverse  socio-economic 
groups of different age and sex composition as to the different forms of utility that 
they currently obtain from the health system in their country, and other forms of utility 
that they are not currently obtaining, or would like to gain to a greater extent. 
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*  Quantitative surveys in each of  the five developing countries to determine the relative 
importance given to the different forms of health service-derived  utility identified 
through activity 1. 
*  Document review and semi-structured interview with key informants to determine the 
stated  and  unstated  aims of health  sector  reform  programmes and their relative 
priorities. 
*  Analytical desk-work contrasting the implications of results from activities 2 and 3 in 
terms  of  the  congruence  or  incompatibility  of  government  and  donor  policy 
objectives for the health sector with the desires of the population as  a whole and 
certain key subgroups within it (the poor, women, ethnic minorities etc.). 
*  Series  of pre-tests  and  pilot studies to identify a  set  of objective  and  subjective 
indicators which can  be used to obtain quantitative measurements of the extent to 
which the major forms of health system-derived utility are  being produced by the 
health  sector.  Analysis  to  assess  the  consistency  and  validity  of these  various 
indicators. 
*  Experimentation  with  trade-off,  willingness  to  pay,  standard  gamble  and  other 
methods for measuring utility, in order to develop a technique which would enable 
the indicators developed in activity 5 to be weighted so that their sum provides a valid 
composite index of total health system-derived utility. 
*  Application  of  the  utility  measurement  and  weighing  techniques  developed  in 
activities 5 and 6 to the definition of a lbasic package' of health services which when 
provided by the public sector would maximise total health system-derived utility. This 
will be  done by in-depth interviews with the 10 different social groups identified in 
activity 1. The composition of such a package will be compared and contrasted with 
other existing or proposed packages defined by policy-makers or technicians seeking 
to maximise health gain. 
*  Application  of  the  utility  measurement  and  weighing  techniques  developed  in 
activities 5 and 6 to a quantitative assessment of  the aggregate health system-derived 
utility  for  a  defined  population  within  each  of  the  five  developing  countries 
participating  in  the  study.  This  would  entail  a  population-based  survey  using  a 
structured questionnaire. 
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Expected outcome 
=> A greater understanding of the full range of benefits that health systems can and do 
produce, the relative importance given to ,each, and how much peoples' assessment 
of what  is  important  for  a  health  system  to  produce  varies  between  different 
population subgroups. 
=>An indication of  the areas where health systems in developing countries are failing to 
produce the benefits expected of them by the population, and whether governments' 
or donors' objectives  in  health  sector  reform  programmes  accurately  reflect  the 
expressed desires of the population. 
=> Development of techniques for measuring the full  range  of benefits  produced  by 
health systems including methods to enable different forms of utility to be weighed 
against one another. 
=>A test of the applicability of these new techniques as means to measure and monitor 
the  health  system  performance  of different countries,  health  systems  or regions 
within countries in terms of the utility they generate. 
=>A test of the applicability of these  new techniques to the development of policies 
which will maximise aggregate health system utility. 
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Partners 
Institute for Health Sector Development 
27 Old Street 
London EC1V 9HL 
United Kingdom 
Centro de Estudios en Economia de Ia 
Salud y de Ia Politica Social 
Sa rdenya 229-237 
Barcelona 08013 
Spain 
Fundacion Mexicana para Ia Salud 
Periferico Sur 4809 
Col. El Arenal 
Tepepan, Tlalpan 14610 
Mexico, D.F. 
lnstituto Centroamericano de Ia Salud 
18calle 11-18 zona 2, Ciudad Nueva 
Guatemala City 01002 
Guatemala 
Institute Centroamericano de Ia Salud 
Apartado 229 
Salvadoran Office 
Managua 
Nicaragua 
Institute Centroamericano de Ia Salud 
Apartado 6 
Costa Rican Office 
Zapote 
San Jose 
Costa Rica 
P. Sandiford 
Tel: +44/171/253.22.22 
Fax: +44/171/251.44.04 
E-mail: 1  06255.2425@compuserve.com 
J. Rovira 
Tel: +34/3/402.42.50 
Fax: +34/3/231.35.07 
E-mail: 1  00754.376@compuserve.com 
M.A. Gonzalez Block 
Tel: +525/655.90.11 
Fax: +525/655.82.11 
E-mail: block@funsalud.org.mx 
K. Slowing Umana 
Tel: +502/254.02.32 
Fax: +502/254.02.32 
E-mail: icas@guate.net 
E. Zeledon 
Tel: +506/221.52.78 
Fax: +506/258.39.43 
E-mail: icas@ibw.com.ni 
J.M. Villasusu 
Tel: +506/221.52.78 
Fax: +506/258.39.43 
E-mail: icascor@sol.racsa.co.cr 
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CONCERTED ACTION : SCIENTISTS FOR HEALTH AND RESEARCH FOR DEVELOPMENT: 
SHARED 
Period: 
Co-ordinator: 
General objectives 
August 1, 1996-July 31, 1998 
DEUTSCHE GESELLSCHAFT FUR TECHNISCHE 
ZUSAMMENARBEIT GTZ GMBH, 
Eschborn, Germany (R.  KORTE) 
•  To enhance availability and exchange of information on health research with and in 
Developing Countries. 
•  To promote partnerships in research through international equitable networking. 
•  To  improve the relevance of health research for development through enhanced co-
ordination with the health sector. 
Specific objectives 
•  To co-ordinate the establishment of a database networking system. 
•  To  maintain and operate databases with relevant information for rational decision-
making on health research  and health care amongst European Countries and their 
partner-Developing Countries. 
•  To  improve  access  to  European  data  on  health  research  and  International  Co-
operation on health issues, in order to promote optimal use of existing resources. 
•  To  harmonise and  rationalise  reporting  on  health  research  and  development co-
operation activities. 
•  To conduct case studies on research issues and on country research programmes. 
•  To  convene  meetings of the core  group network participants  in  order to discuss 
strategic issues emerging from the SHARED activities. 
•  Actively  to  promote  the  contribution  and  participation  in  SHARED  of all  actors 
involved in health for development. 
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Activities 
To achieve the goals, first and foremost a structural and updated knowledge is needed 
of "what everybody is  doing, where and  how". A  reciprocal  and  gradual  process of · 
information exchange is promoted by SHARED. 
The initial partners of SHARED will start by putting together information available on 
projects of  their own national research and development authorities and of  the European 
Commission. Because of the vast differences between the different data sets, a minimal 
set of "core" information will be standardised, while other information will be optimal 
and/or  not  standardised.  Information  will  be  published  via  Internet  in  searchable 
databases. 
At the same time SHARED will actively search for additional partners and attempt to 
convince them of the mutual benefits of collaboration. 
Several meetings are planned for enhancement of and reflection on the network. 
SHARED  will also  perform several  in-depth case  studies; on the basis of the general 
information available in SHARED  about a specific topic, country or region, a team of 
experts can make an analysis, draw conclusions and make recommendations. 
Expected outcome 
~To  bring together a critical mass of resources and capabilities of Member Countries 
(MCs)  in  the European  Union (EU)  and  in  Developing  Countries (DCs)  for health-
related research and interventions. 
~To  provide a structural basis to enhance collaboration among the countries involved 
in international research and development co-operation entities. 
~To  provide the scientific community with  better access  to the various supporting 
mechanisms  available  for  health  research  and  practical  applications  of scientific 
findings, both in the EU and in the respective countries concerned. 
~To promote a  European  approach  in  health  research  for development,  based  on 
mutually beneficial partnership with developing countries. 
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Partners 
Deutsche Gesellschaft Fur Technische 
Zusammenarbeit; GTZ; GmbH 
Postfach 5180 
Dag-Hammarskold Weg 3 
65726 Eschborn 
Germany 
NWO Medische Wetenschappen 
131  Laan van Nieuw Oost India 
Postbus 93138 
2509 AC The Hague 
The Netherlands 
Universidad de Valencia 
Departamento de Parasitologia 
Facultad de Farmacia 
Av. Vincent Andres 
Estelles S/N 
46100 Burjassot- Valencia 
Spain 
Escuela Andaluza de Salud Publica 
(EASP) 
Campus Universitario de Cartuja 
Aptdo de Correos 2070 
Granada 18080 
Spain 
lnstitut National de Recherche en Sante 
publique (INRSP) 
Dep. Sante Communautaire 
BP 1771 
Bamako 
Mali 
Centre Regional pour le Developpement 
et Ia Sante/Soins de Sante Primaires 
(CREDESA/SSP) 
BP 1822 
Cotonou 
Benin 
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R.Korte 
Tel: +49/6196n9.12.24 
Fax: +49/6196n9.71.04 
E-mail: Rolf.Korte@gtz.de 
E. Klasen 
Tel: +31n0/344.07.48 
Fax: +31n0/344.07  .49 
S. Mas-Coma 
Tel: +34/6/386.42.98 
Fax: +34/6/386.47.69 
E-mail: S.Mas.Coma@uv.es 
A. Fernandez Ajuria 
Tel: +34/58/16.10.44 
Fax: +34/58/16.11.42 
E-mail: 1  00433.2527@compuserve.COM 
M. Traore 
Tel: +223/22.60.45 
Fax: +223/23.19.99 - 22.92.69 
E.Aiihonou 
Tel: +229/30.00.01 
Fax: +229/30.12.88 Contract number IC18*CT960062 
Partners 
Ministry of Health and Child Welfare 
Blair Research Institute 
Joseph Tongogara 
Avenue/Mazowe Street 
PO Box CY 573 
Causeway-Harare 
Zimbabwe 
Institute of Tropical Medicine 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
Statens Serum lnstitut 
Office of International Health 
5 Artillervej 
2300 Copenhagen 
Denmark 
University of Heidelberg 
Institute of Tropical Hygiene and Public 
Health (ITHOG) 
lm Neuenheimer Feld 324 
69120 Heidelberg 
Germany 
S.S.K. Chandiwana 
Tel: +263/4n9.27.47/9 
·  Fax: +263/4n9.24.80 
B. Gryseels 
Tel: +32/3/247 .66.66 
Fax: +32/3/216.14.31 
S.Jepsen 
Tel: +45/32/68.32.68 
Fax: +45/32/68.38.68 
H. J. Diesfeld 
Tel: +49/6221/56.53.44 
Fax: +49/6221/56.59.48 
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THE  CONSEQUENCES  OF  THE  MARRAKECH  AGREEMENTS  (1994)  ON  THE 
PHARMACEUTICAL SECTOR OF NORTH AFRICAN COUNTRIES 
Period:  October 1, 1997- September 30, 2000 
Co-ordinator:  CLUB DU  MEDICAMENT, Rabat, Morocco (L. JAIDI) 
Objectives 
The general objective of the research is to analyse how the application of the Marrakech 
agreements  (conclusion  of the  GATT/TRIPS  and  creation  of the  WTO  in  1994)  can 
reconcile respecting the terms of these agreements on the one hand and developing 
local  pharmaceutical  production on the other, while at the same time, satisfying the 
needs of the population. 
Specific objectives consists mainly for each country in: 
•  measuring  the  potential  impact  of  the  GATT/TRIPS  agreements  on  the  local 
pharmaceutical industrial sector and drugs availability, prices and affordability, 
•  observing the dynamics induced by these international agreements and the project of 
creating a free trade zone in the Mediterranean countries, 
•  outlining different scenarios of the possible evolution of the pharmaceutical sector 
after complete implementation of these agreements, 
•  proposing  measures  to  develop  new  partnerships  in  the  pharmaceutical  field 
between the European Union and North African countries (Egypt, Algeria, Morocco, 
Tunisia). 
Activities. Research phases 
After completion of the preliminary phase (definition of research tools and methods, 
inventory of regional  and  international experiences and  analysis of the international 
literature), the research will consist of 3 main phases, followed by a final phase (writing 
of the final report) : 
1st phase  (September,  1997  - June,  1998)  : Assessment of the situation concerning 
pharmaceutical channels in each country. How does the pharmaceutical sector organize 
itself and how does it answer to needs? To what degree does it fit into the regional and 
international context? 
2nd phase (July,  1998- April, 1999) : what is the impact of the Marrakech agreements? 
What perceptions do the different actors have of the strategies elaborated and current 
policies? 
3rd phase  (April,  1999  - May,  2000)  :  hypotheses,  change  scenarios,  and  proposals 
towards a new partnership between Southern and Northern Mediterranean countries. 
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Four coordination seminars will be  held. The research  problems will be  elaborated in 
common, the research  tools and  methods will be  defined and the work carried  out, 
presented and discussed. Each Southern Team will be responsible for the research in its 
own country; the Northern Teams will study the factors originating in their countries that 
influence the countries in the South. In each country in the South, a steering committee 
bringing together managers, industrialists and researchers, will facilitate and support 
the research. 
Expected outcome 
The project aims, in general, at : 
=> strengthening  the  capacity of researchers  and  decision-makers to conduct multi-
disciplinary research on an  issue at the cross-roads of public health, pharmaceutical 
industry and financial policy. 
=> proposing possible alternatives and, if possible, selecting out the solutions that have 
given the best resu Its. 
Three sets of reports will come out of this research : 
First phase: reports by country to assess the performances of the pharmaceutical sector. 
=>Reports of countries of  the South: the reports will make it possible to measure in each 
country  of  the  South,  the  capacity  of  the  pharmaceutical  sector  to  meet  the 
population's basic needs in drugs on the one hand, and, on the other hand, to take up 
challenges brought about by an altered international and regional context. 
=> Reports of countries of the North (France,  Italy, Spain) are  aimed at assessing the 
ongoing dynamics concerning relations between Italy, France and Spain (the major 
European trade partners of North Africa) and countries of the South selected by the 
survey : what is the situation in the following areas : government and trade accords, 
exports, cooperation, technology transfer, trade and  industrial strategies, financial 
flows ... 
Second phase: the impact of GATT[[RIPS on the pharmaceutical sector and of accords 
with the European Union 
Reports on each country will have to answer the following guestions : 
=>What  are  the  efforts  already  recorded  of the  Marrakech  agreements  or  of the 
negotiations with the European  Union on the production, trade, prices, range and 
technology related issues? 
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=> What are the expected effects or effects felt by the various actors of South and North 
Mediterranean countries, possible repercussions of GATT/TRIPS and of accords with 
EU? 
=> What are the desired or possible response strategies and what are the measures now 
under drafting (alteration of pharmaceutical regulations or laws on patents, pricing 
policy, ... ? 
On  the various items, reports will have to assess divergences and consensus at both 
national and international levels to understand the dynamics of decisions already made 
or being made. 
Third  phase  on  possible  subseguent  development  scenarios  and  alternative 
recommendations : 
Country reports will deal with the following questions : 
=>  identifying in  each  country of the  South, the  likely situation at the  end  of TRIPs 
agreements,  resulting from the other GATT/TRIPS  agreement (example  of import 
monopoly in Tunisia, protection of local production in Egypt and  Morocco, ... ) and 
resulting from accords with the European Union (measures for the creation of a free 
trade zone, ... ) 
=> analyzing  measures accompanying decisions to liberalize exchanges and  steps to 
level local industries, 
=>  identifying possible manoeuvring room and  uncertainties looming on the future of 
pharmaceutical sectors in countries of the South, 
=>  drafting scenarios and validation of hypotheses 
=>  drafting proposals for a new partnership. 
A final report will propose a summary of statements, analyses and proposals made by 
research teams and will come out, if possible, with action lines to be  proposed to the 
various partners involved in the implementation of GATT  !TRIPs accords and association 
of South Mediterranean countries with the European Union. 
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Partners 
Club du Medicament, Casablanca 
Cite AI Qods 03 
Rabat 
Morocco 
Sous-Secretariat d'Etat aux Affaires 
Pharmaceutiques 
Ministry of Health and Population, Cairo 
9 Rostom Street, Suite 13, Garden City 
Cairo 
Egypt 
Direction de Ia Pharmacie et du 
Medicament, Tunis 
Ministere de Ia Sante Publique 
Bab Saadoun -Tunis 
Tunisia 
Oran University 
Institute of Economics and Affairs 
PO 1524 
Oran El M'naouer 
31000 Algeria 
Centre International de I'Enfance et de Ia 
Fa mille 
Carrefour de Longchamp - Bois de 
Boulogne 
75016 Paris 
France 
Centre for Health Economics (CESAV), 
lstituto di Ricerche Farmacologiche 
"Mario Negri" 
c/o Villa Camozzi, Vie G.B. Camozzi, 3 
24020 Ranica (BG) 
Italy 
SOIKOS 
University of Barcelona 
Sardenya 229-237-6°-4° 
Barcelona 
Spain 
L. Jaidi 
Tel: +212n/60.22.66 
Fax: +212n/60.22.66 
H. Salah 
Tel: +20/2/355.86.79 
Fax: +20/2/354.80.42 
E-mail: hasanddm@brainyl.ie.com 
A. Toumi 
Tel: +216/1n9.68.24 
Fax: +216/1/38.87.50 
K. Tahari 
Tel: +213/6/41.96.51 
Fax: +213/6/41.96.51 
M. Kaddar 
Tel: +33/1/44.30.20.00 
Fax: +33/1/45.25.73.67 
E-mail: 100631.1101@Compuserve.com 
L. Garratini 
Tel:+ 39/35/51.65.17 
Fax: + 39/35/51.03.21 
E-mail: cesav@cyberg.it 
J. Rovira 
Tel: +34/3/231.42.17 
Fax: +34/3/231.35.07 
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ANALYSING  THE  IMPLEMENTATION  OF  HEALTH  FINANCING  REFORM  IN  SOUTH-
AFRICA AND ZAMBIA 
Period: 
Co-ordinator: 
Background 
November 1, 1997- October 31, 2000 
UNIVERSITY OF THE WITWATERSRAND, CENTRE FOR HEALTH 
POLICY, DEPT. OF COMMUNITY HEALTH, Johannesburg, 
South Africa (J. DOHERTY) 
This project will analyse the impact of the key health care financing reforms in South 
Africa and Zambia on critical health system goals, and the factors mediating that impact. 
The health care financing reforms chosen as the initial foci of  the project are: (a) reforms 
which mobilise new resources, namely, user fees, pre-payment schemes (Zambia) and 
social  health  insurance  (South  Africa)  and  (b)  reforms which  re-allocate  resources, 
namely, processes for re-distributing resources between geographical areas and levels 
of care. 
Objectives 
•  Strengthen  the  implementation  of critical  financing  reforms  in  South  Africa  and 
Zambia, through analysis of these countries' experience. 
•  Through  comparative  analyses  of  the  two  countries,  deepen  international 
understanding  of the factors  mediating  the  effective  implementation of just and 
rational financing reforms, and so generate appropriate policy recommendations. 
•  Develop  generalisable  approaches  to  monitoring  the  implementation  of  health 
financing reforms. 
•  Develop capacity in South African and Zambian Departments/Ministries of Health and 
university-based research units to evaluate health financing reform. 
•  Foster close long-term collaboration between South African, Zambian and European 
health research institutions. 
Activities 
Phase  1 will last one year and will be a retrospective evaluation of the evolution of the 
reforms of focus and of the factors influencing policy development and implementation. 
It will also develop a framework for the prospective monitoring and evaluation of reform 
in Phase II, which will: facilitate understanding the linkages between reforms; specify the 
explicit, societal goals of reform (such as equity, access, efficiency and sustainability) and 
identify indications with which to measure the extent to which reforms achieve these 
goals;  identify the  critical  factors  that affect  reforms through  their influence  on  the 
processes  of policy  development  and  implementation;  and  identify  mechanisms to 
maximise the objectivity of  the research despite the involvement of  the researchers in the 
process of policy development and of government planners in the evaluation process. 
The methods used in Phase I will include: analysis of international literature, analysis of 
existing  country-specific  documentation;  key  informant  interviews;  focus  group 
discussions; and facility-based record reviews. 
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Phase  II  will  be  a  prospective  evaluation  over  two  years  of  the  processes  of 
implementation and the effectiveness of the reforms in achieving their goals, using the 
framework developed in Phase I. The methods used will include: utilisation of ongoing 
data  efforts  undertaken  outside  the  study;  sample  facility  studies/surveys;  action 
research studies; and qualitative surveys. 
Expected outcome 
:=) The  publication  of detailed,  country-specific  and  comparative data,  analyses  and 
recommendations. 
:=) The  publication  of  the  framework  used  in  monitoring  the  development  and 
implementation of the reforms in focus, with the aim of drawing out appropriate 
lessons for other low and middle income countries and demonstrating the value of a 
comprehensive research approach. 
:=) The involvement of Departments/Ministries of Health in the research process and in 
workshops  which  analyse  findings  and  develop  recommendations,  and  the 
integration of the activities of the research  partners in a balanced way to create a 
cohesive research team. 
:=)The development of new research proposals which include the collaborating partners 
and researchers from an historically black university in South Africa. 
Partners 
Centre for Health Policy 
Dept. of Community Health 
University of Witwatersrand, c/o SAIMR 
P.O.  Box 1038 
2000 Johannesburg 
South Africa 
Health Economics Unit 
Dept. of Community Health 
University of Cape Town 
Anzio Road, Observatory 
7925 Cape Town 
South Africa 
Health Policy Unit 
London School of Hygiene & Trop. Med. 
Keppel Street 
London WC1 E 7HT 
United Kingdom 
Dept. of Economics 
University of Zambia 
P.O.  Box 32379 
Lusaka 
Zambia 
The Swedish lnst. for Health Economics 
P.O.  Box 2127 
220 02 Lund 
Sweden 
J.Doherty 
Tel: +27/11/489.99.39/6 
Fax: +27 /11/489.99.00 
E-mail: doherty@wn.apc.org 
D. Mcintyre 
Tel: +27/21/406.65.37 
Fax: +27/21/448.81.52 
E-mail: dimac@anat.uct.ac.za 
A. Mills 
Tel: +44/171/927.23.54 
Fax: +44/171/637.53.91 
E-mail: a.mills@lshtm.ac.uk 
M. Ndulo 
Tel: +260/1/29.04.75 
Fax: +260/1/29.04.75 
K. Odegaard 
Tel: +46/46/32.91.00 
Fax: +46/46/12.16.04 
E-mail: ko@ihe.se 
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CONCERTED ACTION : METHODS FOR INTERVENTIONS ON MENTAL HEALTH IN SUB-
SAHARAN AFRICA 
Period: 
Co-ordinator: 
Objectives 
November 1, 1997- December 31, 2000 
SOUTH BANK UNIVERSITY, SCHOOL OF URBAN DEVELOPMENT 
AND POLICY, London, United Kingdom (T. HARPHAM) 
To  establish a network to facilitate the development of methods for interventions on 
mental ill-health in Sub-Saharan Africa. Specifically: 
•  to measure the burden of mental ill-health in developing countries 
•  to identify, develop and disseminate effective methods of detecting and managing 
common mental disorders 
•  to co-ordinate the development of proposals 
•  to advocate further action and research to address mental ill-health in Sub-Saharan 
Africa 
•  to enhance the links between research outputs and policy decisions and programme 
design 
•  to provide information on the context and constraint related to public health in the 
participating developing countries 
Activities 
The approach will involve facilitating a network of currently dispersed researchers who 
are at the forefront of the fields of mental health in developing countries . All partners 
are applied researchers and have close links with implementing agencies. Particular care 
will be  taken  to develop methods which are  sensitive to the specific  health  seeking 
behaviour  associated  with  mental  ill-health  in  different  settings.  The  fact  that  the 
partners include both social scientists and medical/psychiatric researchers will ensure 
that different patterns  of health  seeking  behaviour are  considered  when  designing 
interventions and methods to evaluate their effectiveness. Specific activities will involve: 
*  Holding two workshops 
*  Carrying out exchange visits 
*  Carrying out project leader missions 
*  Producing three short reports on the activities of partner 
*  Producing research proposals 
*  Disseminating the activities of the concerted action 
Expected outcome 
=>  Increased  reference to mental health  in strategic international public health  policy 
documents 
=>  Increased  knowledge  of  the  burden  of  mental  ill-health  and  identification  of 
vulnerable groups 
=> Appropriate research methods made available to those interested 
166 Contract number IC18*CT970230 
Partners 
South Bank University 
School of Urban Development and Policy 
202 Wandsworth Road 
London SW8 2JZ 
United Kingdom 
University of Cape Town 
Dept. of Psychiatry 
Bremner Building 
Lover's Walk 
7700 Rondebosch 
South Africa 
University of Zimbabwe 
Dept. of Psychiatry 
Medical School 
P.O.  Box A 178, Avondale 
Harare 
Zimbabwe 
University of Zambia 
School of Medicine 
Dept. of Psychiatry 
National Mental Health Resource Centre 
P.O.  Box 30043 
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THE  ADOLESCENT  REPRODUCTIVE  HEALTH  NETWORK:  HEALTH  SYSTEM  AND 
HEALTH PROMOTION RESEARCH IN EASTERN AND SOUTHERN AFRICA (ARHNe) 
Period:  October 1, 1997- March 31, 2001 
Co-ordinator:  UNIVERSITY OF OSLO, INSTITUTE FOR NUTRITION 
RESEARCH, Oslo, Norway (K-1  KLEPP) 
Objectives 
The following specific objectives have been identified: 
+ To  provide  a  setting  for  exchange  of  expertise  and  collaboration  between 
participating research groups through annual meetings & workshops. 
+ To  provide information regarding appropriate graduate and post-graduate research 
training in Africa or in Europe for African candidates. 
+ To focus on a number of research issues of relevance to all participants, including: 
- Examine and analyze the cultural relevance of existing theories on adolescent 
health behaviours and practices, as well as the social and cultural context of such 
practices; 
- Examine and  analyze  qualitative research  methods relevant and appropriate 
when studying adolescent health services, adolescent health and behaviours; 
-Examine and analyze research instruments employed in quantitative studies of 
adolescent  health  seeking  behaviours,  adolescent  health  and  sexual  and 
reproductive health-related behaviours; 
- Examine and analyze various settings for health promotion among adolescents; 
+ Based on experiences and findings from ongoing projects included in the network, 
develop  guidelines  for  culturally  relevant  and  appropriate  health  promotion 
programmes. 
+  Based on experiences and findings from ongoing projects included in the network, 
develop guidelines for culturally relevant and appropriate evaluation strategies for 
health promotion programmes. 
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Activities 
The main activities are organized around annual meetings and workshops. The first such 
meeting was conducted October 5-10,  1997  in  conjunction with the 8th  International 
Congress of the World Federation of Public Health Associations in Arusha, Tanzania. 
Topics to be addressed during the annual meetings/workshops include: 
=>  Behavioural and social science theory with special emphasis on reproductive health 
and problem behaviours 
=> Qualitative and quantitative methods for research on health related behaviours 
=> Health promotion strategies in developing countries 
=> Practical network activities (including electronic communication/World-Wide-Web) 
Expected outcome 
Improved  coordination,  as  well  as  theoretical  and  methodological  qualities  of the 
involved  projects.  The  project  will  create  an  arena  for  critical  discussion  and 
dissemination of information regarding effective intervention strategies in the area of 
adolescent reproductive health. A number of collaborative scientific publications and a 
joint book presenting results and experiences from the included projects in a format 
accessible  to  health  workers,  educators,  youth  workers  and  activists,  as  well  as 
community leaders throughout the region. 
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HEALTH  SECTOR  REFORMS:  AN  EVALUATION  OF  IMPACT  UPON  PATTERNS  OF 
UTILISATION AMONG VULNERABLE GROUPS IN THREE INDIAN STATES 
Period: 
Co-ordinator: 
Objectives 
December 1, 1997- March 31, 2001 
INDIAN STATISTICAL INSTITUTE, POPULATION STUDIES 
DIVISION, Calcutta, India (S. GUHA ROY) 
In  India the role of the state has historically been essential to public health and disease 
eradication programmes. Recent evidence suggests that this function is changing in the 
face of multiple social and economic pressures which have led to structural adjustment 
and changes in the financing of health and social sectors. However evaluation of the 
impact of the reforms upon access to public health services and the quality of care, in 
both public and private health services have been few and far between. Those which 
exist in other regions, have tended to focus either on single outcome measures or on 
technical economistic criteria related to organisational changes. 
Activities 
This study proposes to assess the extent to which a ''safety net" constituting an integral 
element  of the  reforms  is  working  as  an  effective  means  of promoting  allocative 
efficiency as part of the changes that have taken place in India. Such an evaluation in a 
major developing country will enable better global understanding of some of the effects 
of the current reforms, so little known and gauge its gains and losses to enable policy 
interventions. 
Expected outcome 
=> Provide estimates of the prevalence of morbidity and explore the relationship if any 
to patterns of health care utilisation. 
=> Provide  an  evaluation  of  current  service  prov1s1on  and  the  nature  of  changes 
accompanying health sector reorganisation, over a period in time. 
=> Establish to what extent a safety net has been operative in the context of changes 
introduced to assess equity and effectiveness. 
=>  Provide  some  indication  of population  need  and  demand  for  a  range  of health 
services: preventive care, and care of communicable and non communicable disease. 
=> Publication and dissemination to document and discuss the experiences of health 
sector reform in a major developing country. 
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CONCERTED  ACTION  :  SUPPORTING  COLLABORATIVE  RESEARCH  ON  PUBLIC-
PRIVATE RELATIONSHIPS IN HEALTH CARE :AN INTERNATIONAL NETWORK 
Period: 
Co-ordinator: 
Objectives 
September 1, 1997- August 31, 2000 
CENTRE FOR HEALTH POLICY, UNIVERSITY OF THE 
WITWATERSRAND, Johannesburg, South Africa 
(N. SODERLUND) 
To  link researchers and policy makers in 14 countries for the purposes of initiating and 
supporting research on the public-private mix in health care in developing countries. 
Specifically, the network will concentrate on support for research in two areas : 
- Regulation and incentive setting for private health sector players 
-The selective involvement of private sector players to achieve public policy goals 
through contracting arrangements, allowing private practice  by public sector 
doctors, and expanding the role of private practitioners in the delivery of public 
health services. 
Activities 
The following activities will be undertaken by the network to meet its research support 
goals. 
*  The development of internet connections to facilitate exchange of ideas, circulation of 
research methods and results, and the dissemination of key findings in this field. This 
will be done using text-based automatic mailing systems (known as 'mailbases') and 
an interactive World Wide Web site. 
*  Structured  meetings  between  all  participants  to  share  research  ideas,  work  in 
progress or results, facilitate support for new research, provide access to technical 
experts, and inform dissemination strategies and approaches to improve the impact 
of work on policy. 
*  Staff exchange visits to provide support to researchers in the field. 
*  Preparation of methodological reviews to guide current and future work in this area 
internationally. 
Expected outcome 
Firstly, the network will increase the volume and quality of research into public-private 
mix issues  in developing countries.  It will also  provide a streamlined  route for new 
entrants to this field to access available literature and human resources, and, by means 
of a project register,  reduce duplication of existing work. Finally, the network should 
increase the profile of research results around public private mix issues for both national 
and international policy makers, and thus improve health care organisation, financing 
and provision practice in developing countries. 
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MEASURING  AND  MONITORING  STAFF  PERFORMANCE  IN  REFORMING  HEALTH 
SYSTEMS 
Period: 
Co-ordinator: 
Objectives 
October 1, 1997- September 30, 2000 
LIVERPOOL RESEARCH CONSORITUM, LIVERPOOL SCHOOL OF 
TROPICAL MEDICINE, London, United Kingdom (J. MARTINEZ) 
The management of human resources is an  essential component of an  effective health system 
and  can  be  the most important factor influencing success  or failure of health  sector reform. 
Traditionally much emphasis has been attached to the areas of  work force planning, management 
training  and  design  of supervision  systems  as  a  means to  improve  overall  health  systems 
performance.  While competency in these  areas  is  necessary  it is  not sufficient to  meet the 
challenge  of reprofiling  human  resources  in  the  context of broad-based  developments  and 
reforms, such as demographic change, decentralisation, new partnerships with the private sector 
and changes in the financing of health services. 
General and specific objectives 
The general objective of this research  is to identify, document and adapt systems to measure, 
monitor and enhance the performance of health staff working in the public sector of developing 
countries  which  are  undergoing  health  care  reforms.  The  sources  for  the  performance 
enhancement systems to be developed will be models and experiences being currently used in 
developing and  European  health  systems, as  well as  any innovative approaches that can  be 
identified from a sample of private sector health and service organisations. 
Specific objectives of the research are: 
I.  To  identify methods used to monitor and  enhance performance in a sample of health 
systems from developing countries and European countries; 
II.  To compare methods being used within public and private (for profit and not for profit) 
sector health and service-oriented organisations in developing and European countries: 
Ill.  To categorise and disseminate the variety of methods identified and put this knowledge 
at the disposal of policy makers and practitioners with responsibilities for human resource 
management in health systems; 
To assess the potential applicability and utility of identified performance enhancement and 
monitoring systems by pilot testing a sample of them in a developing country situation; 
Activities (including methods of research) 
The investigation will consist of five phases with a total elapsed time of 36 months. Phases 1 and 
2 can be seen as Step 1 : gathering information to develop models of Performance Management 
Systems; and phases 3-5 as Step 2: developing and testing PMS models. Phase 1, the Preliminary 
phase will last for 3 months. This phase will attempt to identify and map out the options in the 
use of staff performance management in health systems, and will provide the context for detailed 
case studies in phase 2. 
Phase 2 will last for 9 months and will examine the current practice of monitoring and managing 
staff performance  in  health  and  other service  industries  in  both  developed  and  developing 
countries, and  in the public and  private (for profit and  not-for-profit) sectors. This phase will 
address Research Objectives I and II. 
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systems. This phase will address Research Objective Ill and will last for 2 months. 
Phase 4 will be the testing of the models. This part of the investigation has a clear regional focus 
with studies carried out in Zambia, Ghana, South Africa and Mozambique. 
Expected outcome 
The  overall  aim  of the  project  is  to  identify  methods  of  managing  and  monitoring  staff 
performance  which  have  greater  applicability  and  utility  to  health  systems  in  developing 
countries.  It  is  anticipated that there will be  considerable demand from  ministries of health, 
managers and researchers both for the output from the review and categorisation of approaches, 
and for the results of  the pilot testing of approaches in the four developing countries. To meet this 
demand, and ensure that dissemination is comprehensive, it is planned to publish the output of 
the  literature  review and  results of the first workshops complemented  by the publication of 
articles in relevant international and country journals. 
Partners 
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HEALTH  CARE  SYSTEM  REFORM 
CARIBBEAN 
POLICY  CONTENT  AND  PROCESS  IN  THE 
Period: 
Co-ordinator: 
Background 
January 1, 1998-June 30, 2001 
THE UNIVERSITY OF THE WEST INDIES, 
FACULTY OF MEDICAL SCIENCES, 
Champs Fleurs, Trinidad and Tobago (E. HAQQ) 
Many developing countries are engaged in considering health reform options and are 
attracted to some of the policies in  place  in  developing countries, such  as  universal 
health  insurance  and  the  separation  of purchaser from  provider of health  services. 
However,  there  has  been  little evaluation  of the  relevance  of these  policies to  less 
wealthy  countries,  and  there  is  the  possibility  that  policies  may  be  transferred 
inappropriately. Moreover, there is little understanding of the process by which policies 
are formulated and  implemented and  of the role and  influence of the various actors 
involved. In particular, it is unclear who ultimately benefit (and who loses) as a result of 
these reforms. Policies may be so altered in the process of implementation that the initial 
objectives may not be met. 
The Caribbean presents unique opportunities for research in health care system reform. 
Caribbean countries are embarking on health sector reform programmes which include 
the  decentralization  of management,  strengthening  of primary health  care,  greater 
private  sector  involvement  in  health  care  delivery,  and  the  introduction  of  health 
insurance  and  user  fees;  although  many similarities  exist  among  countries,  health 
systems have distinct differences depending on their political and colonial history. There 
is considerable desire to learn from each  other and regional mechanisms exist which 
could support collaboration. Little research has been carried out on health care systems 
to date and exchange of experiences has been limited. 
This  research  is  innovative  in  combining  study of both  policy content and  process 
focusing on a package of reforms and not single isolated policy changes, and also in its 
multidisciplinary nature  drawing on  sociology,  economics,  epidemiology and  policy 
analysis. The study focuses on evaluating crucial policies such as decentralisation, social 
insurance, and regulation of the private sector. 
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Objectives 
The overall objectives are as follows: 
•  To increase understanding of  the impact on efficiency and equity of reform of selected 
policies relating to the financing, organization and structure of health care systems. 
•  To produce information that will support the process of reform of health care systems 
in the Caribbean  . 
•  To strengthen the capacity of the Faculty of Medical Sciences, St. Augustine, Trinidad 
and the Faculty of Medical Sciences, Anton de Kom  University of Suriname, to do 
research relevant to health care systems. 
•  To foster closer long-term collaboration in health care system operational research 
between European health research institutions and the Faculties of Medical Sciences 
in Trinidad and Suriname. 
Activities 
The project is divided into two phases: 
Phase 1: 
This phase involves study of influences on the historical development of health services 
in order to understand the nature of the health care system inherited at independence 
(or similar period), subsequent changes,  and the current situation.  Investigation will 
focus  on  demographic,  epidemiological,  political,  social,  economic  and  legislative 
influences, and trends will be determined. Selected aspects of  the health systems will be 
reviewed  covering  areas  including  sources  of finance,  organization  of public sector 
health  services,  structure  of health  services  in  relation  to  levels  of care,  and  the 
public/private provider balance. Two main conceptual frameworks will be drawn on: 
i)  categories of health system 
ii)  process of policy formulation and analysis 
Where  documentation  of  crucial  decision-making  and  influences  is  not  available, 
interviews will be held with those who were part of the decision-making process of that 
period. 
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Phase 2: 
Three policy areas will be evaluated in depth in this phase as follows: 
a)  the new approach to public sector management (Trinidad & Tobago) 
b)  the adoption of principles of social insurance as the basis for funding the 
health care system (Suriname & Martinique) 
c)  government's approach to the private sector (The Bahamas) 
The  results  of these  studies will  be  compared with the  results of Phase  1 for each 
country/island. Policies will be  evaluated according to the criteria including allocative 
efficiency, technical efficiency, equity, accountability, acceptability, and affordability. 
Expected outcome 
Increased understanding of the impact on efficiency and equity of those policies relating 
to the  financing,  organisation  and  structure  of health  care  systems  relative  to the 
contextual development of the system. It is expected that information will be produced 
to support the process of reform of health care systems in the Caribbean. 
The capacity of the Faculties of Medical Sciences, St. Augustine, Trinidad and Anton de 
Kom University of Suriname will be strengthened to do research relevant to health care 
systems, and long term collaboration in health care operational research between the 
European  research  institutions  and  the  Caribbean/South  American  partners  will  be 
established. 
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Erasmus University 
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HEALTH SECTOR REFORM :TOWARDS A MORE GLOBAL APPROACH OF CHILD HEALTH 
Period: 
Co-ordinator: 
General objective 
December 1, 1997- May 31, 2001 
UNIVERSIDAD PERUANA CAYETANO HEREDIA, UNlOAD DE 
NUTRICION, CENTRO DE SALUD PUBLICA, Lima, Peru 
(L. BENAVENTE) 
The  research  proposal aims to develop and  apply an  holistic approach  by which the 
health  services  would  rationalise  health  care  delivery towards the  health  problems 
children face in a community. 
Specific objectives 
•  To identify health risks children face during their growth and development in general 
and in the particular study areas (Peru, Bolivia), with the participation of the parents 
and the community. 
•  To  identify prevailing representations of child development and  health of both the 
health professionals and the community. 
•  To  identify activities  which  can  be  implemented  in  the  given  contexts  of health 
delivery. 
•  To define criteria for the selection and the modification of existing activities directed 
at the safeguard of child health. 
•  To develop support mechanisms to increase parental participation. 
•  To increase the competence and the attitude of the health staff. 
•  To identify obstacles in the implementation of  these activities in the health system and 
for the participation of the parents. 
•  To measure the improvement in quality of care and coverage, after rationalisation of 
the various specific activities. 
•  To evaluate the changes in autonomy and caring practices of the parents with regard 
to the health and development of their children. 
Activities 
Two major phases can be distinguished in the overall research : a descriptive phase and 
a participatory phase. The descriptive phase will consist first in the identification of the 
risks children face during their growth and development. The identification of the risks 
specific for a given geographical area will be done in the study areas, using sociological 
and anthropological tools to ensure participation of the parents. 
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This will result in an  operational plan describing the necessary changes in the existing 
health system and identifying the role of the parents and the community. 
The participatory action research  phase is a collaborative research between the health 
providers, the population and the supporting institutions. It implies the implementation 
and  evaluation of the operational  plan. The evaluation will be  based  on  quantitative 
aspects of health provision and on the quality of the service offered. Rapid sociological-
anthropological tools will also be used. 
Expected outcome 
The expected outcomes are in relation to the specific objectives formulated, and implies 
the implementation of the results at the research  setting : a holistic approach by the 
health services towards the health problems of the children. An attempt will be made to 
translate the methodology and results beyond the local research level. 
The  results  will  be  published  in  regional  and  international  journals,  presented  at 
international  workshops  and  integrated  in  national  and  international  public  health 
courses. 
Partners 
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Casilla 3119 
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Bolivia 
ORSTOM 
Laboratory of Tropical Nutrition 
911  Avenue Agropolis 
B.P. 5045 
34032 Montpellier Cedex 1 
France 
Institute of Tropical Medicine 
Dept. of Public Health 
Nationalestraat 155 
2000 Antwerpen 
Belgium 
L.  Benavente 
Tel: +51/1/48.20.302 
Fax: +51/1/48.24.353 
E-mail: lbe@upch.edu.pe 
E.A. Sejas Vera 
Tel: +591/42/51.543 
Fax: +591/42/51.543 
B. Maire 
Tel: +33/4/67.41.61.68 
Fax: +33/4/67.54.78.00 
P.  Kolsteren 
Tel: +32/3/247  .63.89 
Fax: +32/3/247 .65.43 
E-mail: pkolsteren@itg.be 
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BIOMONITORING OF NITROARENES IN CHINESE WORKERS 
Period: 
Co-ordinator: 
Objectives 
October 1, 1997 - September 30, 2000 
LUDWIG-MAXIMILIANS-UNIVERSITAT, WALTHER-
STRAUSS-INSTITUT FUER PHARMAKOLOGIE UND 
TOXIKOLOGIE, Munchen, Germany (G. SABBIONI) 
Research in the field of molecular toxicology has been exponentially growing in the last 
few years.  Several  studies  have  been  undertaken  to  associate  disease  to chemical 
exposure.  The  association  has  been  found  only for  a  few compounds.  Therefore, 
investigations of highly exposed workers are needed, which include the state of the art 
techniques in the field of molecular toxicology. This will improve the predictive value of 
the measured parameters. 
Activities 
Workers  in  Chinese  chemical  industries  are  exposed  to  high  concentrations  of 
arylamines  and  nitroarenes.  These  compounds  cause  major  occupational  health 
problems. The  aim of the present study is to investigate a  large cohort of exposed 
workers to 2-nitrotoluene, 4-nitrotoluene and 4-chloronitrobenzene in a dye factory in 
Dalian  (Province  of Liaoning,  China).  The  major adverse  health  effects  among  600 
workers are hepatomegaly (40-60 cases), neurasthenia, and splenomegaly. In addition, a 
cohort of TNT workers in Fuxin City in the Province of Liaoning, will be studied. High 
incidences of cataract have been registered among these workers. The workers will be 
identified as  high,  intermediate and  low exposure groups, and  a group of matched 
referents will also be included. Thirty workers per group and compound will be studied. 
Air levels,  urine  metabolites,  albumin  and  hemoglobin  adducts,  DNA adducts from 
exfoliated urothelial bladder cells and chromosome aberrations in lymphocytes will be 
determined. The obtained values will be correlated to the health status of the workers 
and to the epidemiological data at the work site. In addition, individual susceptibility of 
the workers will be studied by genotyping the known polymorphic enzymes involved in 
the detoxification of the nitroarenes. 
The levels of biomarkers found in the workers will be compared with levels measured in 
non-exposed  groups.  To  establish  an  acceptable  level  of  exposure  to  the  above 
mentioned chemicals the following parameters will be measured: 
External dose (air measurements); internal dose (urine metabolites); biological effective 
dose  (blood  proteins, DNA adducts in  exfoliated  urothelial  bladder cells);  biological 
effects (chromosomal aberrations); and individual susceptibility genotypes (glutathione 
S-transferase  M1,  glutathione  S-transferase  T1,  N-acetyltransferase  2  and  N-
acetyltransferase 1  ). 
Health monitoring of the exposed people will be carried out by occupational physicians. 
They will assess,  a)  disease  related to the exposures such  as  aplastic anemia, toxic 
hepatitis, and  cataracts, and  b)  frequency of non-specific symptoms such  as  ·fatigue, 
headache  etc.  Finally,  individuals  from  China  will  be  trained  to  assess  the  work 
environment, and to analyze  exposure enabling them to implement an  occupational 
hygiene regime. 
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Partners 
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ENVIRONMENTAL AND OCCUPATIONAL CANCER IN MERCOSUL COUNTRIES 
Period: 
Co-ordinator: 
Objectives 
December 1, 1997- November 30, 2000 
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, 
UNIT OF ENVIRONMENTAL CANCER EPIDEMIOLOGY, 
Lyon, France (P.  BOFFETTA) 
•  To  carry out an  international  multicentric population-based  study of occupational 
factors of laryngeal cancer. 
•  To organize an international conference on occupational and environmental cancer in 
developing countries, with emphasis on Latin America. 
Activities 
The proposed approach is a multicentric case-control study of exposure to occupational 
and  other environmental risk factors, taking into account also  HPV  infection, genetic 
susceptibility and  mutations in  critical genes. The study will be  conducted in  Rio  de 
Janeiro, Sao Paulo, Pelotas and Porto Alegre (Brazil), Montevideo (Uruguay) and Buenos 
Aires (Argentina).  It will include approximately 1200 cases  of laryngeal cancer and  a 
similar  number of controls.  A  detailed  occupational  questionnaire  will  be  used  to 
interview cases and controls, and will then be interpreted on an  individual basis by a 
team  of local  experts,  which  will  assess  exposure to a  list of known  or suspected 
occupational  laryngeal carcinogens in terms of probability, frequency and  level. The 
preliminary list of exposures to  be  assessed  includes  asbestos,  man-made  min~ral 
fibres, wood dust, strong inorganic acid  mists, diesel engine exhaust, environmental 
tobacco  smoke,  other  sources  of  PAHs,  chromium,  nickel,  arsenic,  formaldehyde, 
infection with  HPV,  infection with animal viruses.  A  blood sample will be  collected, 
whenever feasible, from cases and controls. Laryngeal tumour samples will be collected, 
whenever feasible, from cases.  The analysis of genetic polymorphism to GST M  and 
NAT2 enzymes will be performed on DNA extracted from lymphocytes. Tumour samples 
of a subgroup of cases  selected  according to relevant exposures (e.g.,  exposed  and 
unexposed to occupational carcinogens) will be analysed for mutations in the p53 and 
ras genes using denaturing gradient gel electrophoresis. 
The target audience of the Conference are  researchers  in the field of occupation and 
environmental  health  and  professionals involved in  occupational  he.alth.  Among the 
topics to be  covered  are:  state  of the art in  occupational  and  environmental cancer 
research; industrialization and health; burden of occupational and environmental cancer 
in developing countries; transfer of hazardous technology and patterns of exposure to 
occupational and environmental carcinogens in developing countries. The Conference 
will be held in Rio de Janeiro on 30 July- 1 August 1998. 
Expected outcome 
The  study  will  assess  the  contribution  of occupational  exposure  to  an  important 
neoplasm in the study areas.  It will contribute original information on the interaction 
between  genetic  factors,  known  risk  factors,  such  as  tobacco  and  alcohol,  and 
occupational exposures in laryngeal cancer formation. 
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These data will be  useful in the prevention of cancers of the larynx and other organs 
sharing some of the risk factors, such as the lung, oral cavity, oesophagus and bladder. 
The conference will provide first systematic review of current knowledge and research 
needs in occupational and environmental cancer in developing countries. It will offer a 
major  opportunity  for  establishing  collaboration  between  researchers  and  health 
professionals  from  developing  and  developed  countries.  Its  proceedings  will  be 
published in the medical literature. 
Partners 
Int. Agency for Research on Cancer 
Unit of Environmental Cancer Epid. 
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Brazil 
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Av. Leopolda Bulhoes 1480/827 
20230-130 Rio de Janeiro 
Brazil 
Universidade Federal de Pelotas 
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Av. Dugue de Caxias 250 
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Institute de Oncologia II Angel H. Raffo" 
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1417 Buenos Aires 
Argentina 
Registro Nacional de Cancer del Uruguay 
Av. Brasil 3080, ap. 402 
Montevideo 11300 
Uruguay 
lnstitut Municipal d'lnvestigacio Medica 
Dept. Epidemiology and Public Health 
c/Doctor Aiguader 80 
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Spain 
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ENVIRONMENTAL  EPIDEMIOLOGY  - HEALTH  EFFECTS  OF  CADMIUM  POLLUTION 
FROM SMELTING IN CHINA 
Period: 
Co-ordinator: 
Objectives 
October 1, 1997- September 30, 2000 
UMEA UNIVERSITY, DEPT. OF OCCUP. & ENVIRON. MEDICINE 
Umea, Sweden (G. NORDBERG) 
To obtain increased knowledge in humans about: 
•  Dose-response relationship between cadmium exposure and kidney dysfunction 
•  Bone effects of cadmium (Cd) and its relationship to kidney dysfunction 
•  Adverse effects of Cd on male reproduction 
•  Preventive measures against the adverse human health effects of cadmium 
Activities 
Population groups with high and medium Cd  exposure via rice will be compared with 
controls  concerning:  measured  Cd  concentration  in  urine  (indicator  of cumulative 
exposure),  indices of kidney dysfunction  (urinary beta-2-microglobulin, albumin and 
other protein). Bone density will be measured in selected population groups by external 
measurements and biomarker of bone effects will be analysed in blood samples from the 
same groups. Male persons will be  invited to join a sex function test (assessment of 
semen  quality  and  sexual  hormones  in  serum).  The  same  measurements  will  be 
performed also on a group of persons from the selected areas, who have or have had 
occupational Cd exposure at the smelter. 
Expected outcome 
The  studies  will  generate  new and  important knowledge  about the  dose-response 
relationships for kidney dysfunction using both well es.tablished and newly developed 
bioindicators.  It will demonstrate effects of Cd  exposure on  bone density in  an  area 
outside of Japan. Such information will be of crucial importance in risk assessments for 
cadmium since the occurrence of bone effects outside of the original Japanese areas 
where  itai-itai  diseases  occurred  is  much  debated.  Since  effects  of  Cd  on  male 
reproductive function has been extensively documented in animals , it will be of great 
value to obtain information in  humans concerning the absence or occurrence of such 
effects in a Cd  exposed group of male persons. Data obtained can be directly used for 
preventive action by Chinese Health Authorities participating in studies. 
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! PARTNERSHIP BETWEEN EUROPE AND DEVELOPING  COUNTRIES
IN HEALTH RESEARCH1
The European Commission has been supporting joint research activities relevant
to development,  including health related research, since 1983, and has recently
issued the second call for scientific proposals within the programme  of
International Cooperation with Developing Countries (INCO-DC) which has
become a broader programme than its predecessor. Health research remains a
priority area, together with research on agriculture and the sustainable use of
natural resources. The Commission's  International Scientific Cooperation
Programme is an integral part of the European Union's Fourth Framework
Programme on Research. lt serves Europe's research policy but it does even more.
It is also an instrument to support other European policies, such as development
cooperation, external relations or economic cooperation with third countries.
A guiding principle of the European Union is a desire to contribute to worldwide
sustainable development. A desire which stems from a sense of co-responsibility
for the problems faced by third countries. This responsibility must be shared by
every citizen but a special role, undervalued in the past, must be reserved for the
scientists who have chosen to address problems of developing countries.
The most important commodity for sustainable development is knowledge  and
knowledge will be the number one production factor in the 21st century. lts
importance willfar outweigh that of capital and labour in the present century, and
if one wishes to safeguard the future and to increase knowledge, more needs to
be invested in research now. Research is increasingly perceived as a basis for
welfare within the EU. Research must therefore be just as important for the
welfare of third countries. This assumption has received too little attention.
Knowledge is an invaluable commodity and to acquire knowledge one has to
help develop a culture of questioning.
Responsibility  and Mandates
The development of a culture of science and research is the responsibility  of
everyone. Scientists within the individual member states of the European Union
are already involved at personal, institutional, regional, or national level in a
variety of programmes with a variety of goals related to Health in tropical areas
or developing countries. A wealth of research activities are, or can also be,
performed or developed on a bilateral basis by each of the European Member
States. The Commission strongly encourages all these efforts.
' Reprinted with permission from : Tropical Medicine and lnternational  Health 1996 5 553-557
195Moreover, the Commission has a mandate to keep informed of  any such initiatives 
and whenever possible to be in synergy with them, but the Commission's strength 
lies in its ability to harness expertise at a supra-national level within Europe, in the 
context  of its  relations  with  third  countries.  Adding  a  European  dimension, 
complementing the existing bilateral regional and national interactions. 
The European Commission will not replace any of the inputs from others. The 
more support scientists in Europe or Developing Countries receive or acquire 
from  national  or  other  sources,  the  more  European  programmes  will  be 
meaningful  and  give  room  for  substantial  cost  efficient  added  value.  The 
Commission functions on the basis of subsidiarity, a concept which has been a 
matter of debate in the EU. At the European level, the Commission does what can 
be done only at this level, and most importantly, done better at this level. The 
Commission  builds  on  the  valuable  contributions  to  health  research  of the 
individual  Member  States  of the  European  Union.  Many  agencies  like  the 
Institutions of the United Nations, such  as  WHO,  have an  alternative agenda 
focused  on  different roles  and  responsibilities,  although  often  in  support of 
common goals. 
It is critical that each has their own clearly defined goals and modes of operation. 
It is also important that all operations are transparent so that what is being done, 
and  where,  can  be  precisely  established,  thus  avoiding  wasted  efforts  and 
unnecessary duplication. What it boils down to, is the need to establish equita~le 
partnerships which  will facilitate the sharing  of knowledge.  Clearly with the 
financial  and  human  resources  which  can  be  harnessed  from  within  the 
European  Union  the  opportunity  can  be  provided  for  partnerships  to  be 
established within Europe and with third countries. These resources are not an 
objective  or a  solution  in  themselves.  They  simply  provide the  appropriate 
environment and the means to progress. 
For too long it was considered that ideas and practices in health research were 
llfor"  Developing Countries, and that they could  be  exported from Europe to 
Developing  Countries  for  direct  application.  While  that  attitude  was  not 
exceptional  in  times gone  by,  it is  now certainly  no  longer acceptable.  The 
European Union encourages health research 
11With" Developing Countries. 
In  establishing partnerships in health research  with Developing Countries, the 
criteria considered to be most important can be divided in three parts. The first is 
the scientific aspect. It is essential that the process of science is of a high quality, 
indeed of international status, and respected on its own merits and rules. There 
is  only one science,  whether it is  classified  as  basic,  fundamental,  strategic, 
operational or action research. What matters is that science flourishes in a variety 
of socio-economic and cultural environments. 
196 The second, but equally important consideration is the mechanism to implement 
the EU  policy of scientific cooperation in health research. It would be  naive to 
consider that any scientific interaction can take place in a vacuum, insulated from 
other aspects of life. There must be consideration of the societal aspects of the 
science. In other words there must be an expectation that the scientific work will, 
at one time, bring tangible benefits for society as a whole. Therefore, the work 
supported by the Commission is aimed at addressing the major health problems 
faced  by developing countries.  New practices and  technologies  have to take 
account of the context in which they may be applied and the health benefits of 
their application  have to be  clearly established.  Public  health  concepts are  a 
common platform for all health research. 
The third important point to consider is that health research partnerships cannot 
be established unless there are partners to establish them with. Partners within 
Europe  are  easier  to find,  but  research  capacity  in  Developing  Countries  is 
relatively scarce  and  cannot be  created  overnight. Although the  inputs from 
national or international research programmes can help, they are not  the solution 
in themselves. 
What is needed is a prolonged intensive investment and other support to ensure 
capacity and  capability strengthening. This will only be  achieved through the 
political will and the economic commitment of  the countries themselves together 
with support from other national and international sources. Fortunately the need 
for  this  support  has  been  recognised  by  the  European  Union  through  its 
economic and development cooperation policy which is mainly the responsibility 
of DGIB and DGVIII within the Commission. 
Science should not suffer from any unproductive rivalry, as was the case in the 
early years of this century, when scientists argued over whether resistance to 
disease was dependent upon cells or serum. Scientists allied themselves on one 
side or the other on the  basis  of their nationality.  In  the  initial stages of the 
European  Union's  Research  Programmes  even  the  prospect  of ·uniting  two 
European  research  institutions or laboratories from  different member states 
seemed  daunting to  less  receptive  scientists,  and  brought some  opposition. 
Scientists assumed, falsely, that their efficiency or competitiveness would be 
diminished by having to participate in  what was considered by some to be  a 
cumbersome interaction. But the imposition of this requirement of joint research 
for eligibility for European Union support has stood the test of  time and is helping 
to  change  the  paradigm  for  international  cooperation  to  one  of  equitable 
partnerships. 
197 The  benefits this  brings are  many.  Now, there  is  an  unprecedented  level  of 
European cooperation with many examples of the EU  programme providing the 
initial  contacts  between  labs  which  have  blossomed  and  been  extended  to 
address many problems outside the current programme. Competition between 
laboratories  remains  a  driving force for advances,  but this  has  ensured that 
scientists tended to become better specialists in their own particular area. There 
is now an appreciation that the complexity of the problems and challenges being 
faced, can be solved only through cooperation among scientists with expertise in 
complementary disciplines. 
If establishing  links  between  scientists  in  Europe  needed  some  persuasion, 
European  scientists  found  establishing  links  with  developing  countries  even 
more  difficult to  accept.  The  EC  is  not  interested  in  providing  strictly  pre-
conceived II European" solutions to problems of development. There is an acute 
awareness that the complex  problems of development cannot  be  contained 
within national or regional boundaries, they affect all societies. The aim is to find 
a common path to achieving improvements in development, bringing together 
scientists from North and South who will address the problems as an integrated 
unit, each bringing their own expertise and experience to bear on the problem at 
hand. If  this is done in the right way, the goal of learning to learn will be achieved. 
A culture of learning, in which scientific methodology becomes an  intrinsic part 
of society  will  be  established.  Hypotheses  will  be  tested  and  development 
programmes modified in the light of the results, things will not be left to chance. 
The interactions of the scientists in the Commission's programme leads to the 
establishment of a culture of learning across the globe. 
The Commission continues to encourage interactions among scientists.  Links 
between European laboratories are stronger now than they have ever been. The 
same can  be said for links between European scientists and their colleagues in 
Developing countries. 
But there  is  an  additional  benefit from the  requirements of the  programme, 
South-South  cooperation,  and  the  sharing  of  knowledge  among  the  third 
countries  anxious  to  involve  their  regional  neighbours  in  their  quest  for 
knowledge of common problems which are  best addressed in  partnership. Of 
course this is not a unique achievement but it is clear that the Programme has 
done much to facilitate additional steps in this direction. 
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FOR RESEARCH AND TECHNOLOGICAL  DEVELOPMENT (RTDI
Collaborative  research with developing countries is carried out against the
background of the Commission's Fourth Framework Programme for Research
(FP4). The basic aim of FP4 is: To support inter-Member State scientific
collaboration, networking and concertation on issues of common concern.  To
reach this goal FP4 supports multi-centre research projects, concerted actions
and accompanying  measures which help to improve quality of life and increase
European competitiveness, in a global context. More than this, FP4 serves to
support other EU policies, such as economic and development  cooperation.
The total budget of FP4 (1994-1998) is 12.31 billion ECU and is divided over four
main activities:
l. Research, Technological  Development  and Demonstration within the EU
Member States
(10686 Million ECU (MECU)),
ll. Cooperation with Third Countries and International Organisations (540 MECU),
lll. Dissemination and optimization of results (330 MECU) and
fV. Training and Mobility of researchers within the EU U4O MECU).
Activity ll, Cooperation with Third Countries and lnternational Organisations has a
pivotal role, linking EU policies in science, economic cooperation and development
through coherent collaborative research activities with third countries.
Health-related research can take place in activity land in activity ll programmes.
The BIOMED and the BIOTECH programmes of Activity I have a budget of 552
MECU and 336 MECU respectively. Many aspects of health research which are
trans-disease,  can be covered by these programmes and might also be of great
importance for collaboration with Developing Countries for example, malaria
vaccine development. Within the activity ll INCO programme  (540 MECU) there is
also a health component. In the specific Programme for developing countries a
total budget of 63 MECU will be available for health between 1994-1998 and in
the component geared towards Eastern and central Europe, health-related
research is also covered (INCO-Copernicus).
1 In 1996, budgets of specific programmes are to be increased to the new total of 13.1MECU.
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Although they may differ in detail the Commission's research programmes in FP4 
have the following modes of implementation: 
I  Multilateral joint research projects, 
II  Concerted Actions, covering the actual costs of concertation, such as the 
search for partners, meetings, common publications 
Ill  Accompanying Measures, such  as  contract holders meetings, networks, 
studies, targeted research training and mobility and the dissemination of 
results and 
IV  Concertation through consultation with the Member states and in the case 
of the I  NCO-DC programme consultation with developing countries. 
These  are  set  out  in  the  detailed  Work  Programme together with  the  main 
objectives of the programme. For INCO-DC these are, to promote the role of 
relevant high quality RTD in development in economic cooperation, to encourage 
scientific  collaboration  between  Europe  and  DCs,  between  DCs  and  within 
Europe, to help reinforce and maintain RTD capacities, including human capital, 
in DCs, to contribute to maintaining a competence in Europe in scientific sectors 
of mutual interest and in those pertinent to problems of DCs, to capitalise on the 
experience gained during the implementation of previous Commission S&T co-
operation activities and to take into consideration the political obligations of the 
Union and the recommendations of international fora such as the Rio conference 
concerning research in DCs. 
The Work Programme is  implemented through Calls for Proposals which are 
updated from year to year. Details of research themes which are to be supported 
are provided in these Calls for Proposals. 
The Call for Proposals 
The  Call  for Proposals  (Anon  1996)  contains detailed  information  on  criteria 
which have to be fulfilled by applicants, for example partnerships, and also on 
tt)e specific topic areas for which research  proposals are  invited. The Call  for 
Proposals is  updated for each  call  and  permits the Commission to direct the 
research programme on the basis of  the consultation processes with the Member 
States,  developing  countries  and  on  the  Commission's  existing  research 
portfolio. In general the Call for Proposals is issued six months in advance of the 
deadline for submission of proposals. On  arrival at the Commission, proposals 
undergo a stringent review procedure. 
200 The Evaluation Process 
In addition to scientific quality each proposal is evaluated on a variety of aspects, 
which include: 
Is the health problem relevant to developing countries? 
Is the problem of national, regional or global relevance? 
Is the problem of known, documented magnitude? 
Is the problem vulnerable (are there opportunities for cost-effective impact)? 
Is there political will to overcome the problem? 
Will the research be induce changes in approach or political awareness? 
Does the research build on existing and matching capacities? 
Does the research partnership have a comparative advantage (including DC) 
Is there a demonstration value (spin-off in financial or scientific terms)? 
Is there a likelihood of leverage for complementary funding in European Member 
States and/or DCs? 
Is there likelihood of sustainability of the proposed approaches? 
What is the research capability strengthening aspect of the proposal? 
What is the training and mobility aspect of the proposal? 
How is the integration of the DC partner(s) in the national setting? 
How does the project fit in the international funding picture? 
The evaluation of proposals is effectively done in four tranches: 
I.  Decision on eligibility by the Commission's Services based on partnership 
and documentation of the innovation and relevance of the project. 
II.  Scientific evaluation by selected experts. 
Ill.  Evaluation  of the  highly-rated  proposals from the second  tranche  by a 
regional panel from developing countries 
IV.  Prioritisation  of  the  highly-rated  proposals  based  on  coherence  and 
complementarity  with  the  Commission's  existing  research  portfolio, 
partnership value, research capacity strengthening and training value and 
regional versus national relevance. 
Following  these  procedures  the  Programme  Committee  consisting  of  the 
representatives of the Member States and associated countries, give an opinion 
on the proposals.  Finally the Commission  decides to implement the selected 
projects and activities. 
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Regulation  of sexual  development  in  malarial  parasites  and  the  design  of  logical 
intervention strategies. 
TS3*CT940272 
Studies on humoral and cellular immune responses in  humans to previously defined 
malaria vaccine candidates. 
TS3*CT940317 
Identification of malaria vaccine candidates by passive transfer in infected individuals of 
antibodies with defined specificities. 
TS3*CT940345 
Assessment of immune responses induced in  primates immunized with lipopeptides 
derived from P.  falciparum MPES antigens. 
TS3*CT940346 (see also 920053) 
Malaria pre-erythrocytic stages (MPES)  European network antigens target of immune 
responses capable of inhibiting P.  falciparum pre-erythrocytic development. 
IC18*CT950015 
The African Malaria Vaccine Testing Network. 
IC18*CT9500 19 
Evaluation  and  delivery  of  Thrombospondin  Related  Anonymous  Protein  (TRAP) 
immunogens for the development of malaria vaccine. 
IC18*CT950020 
A concerted European approach towards the development of malaria vaccines. 
IC 18*CT950021 
Pre-clinical  study  of the  immunogenicity of MSP3  and  GLURP  TWO  P.  falciparum 
antigens targeted by protective antibodies. 
228 IC18*CT950022 
The application of transfection technology to malaria vaccine development. 
IC18*CT960125 
Concerted action  in support of high quality Non-Human Primate (NHP)  breeding and 
biomedical research in NHP source countries. 
IC18CT970238 
Immunity  to  genetically  characterised  malaria  infections.  A  comparison  between 
longitudinal  studies  in  a  West  and  an  East  African  village  experiencing  different 
intensities of transmission. 
IC18CT970242 
Mathematical models of the immunological and clinical epidemiology of Plasmodium 
falciparum malaria. 
Transmission 
TS3*CT920045 
Plasmodium vivax malaria in man: anti-disease and transmission blocking immunity. 
TS3*CT920063 
The biological and epidemiological significance of transmission blocking immunity and 
transmission  reducing  factors  in  endemic  falciparum  malaria.  Human  factors  that 
influence infection of mosquitoes. 
IC18*CT9500  18 
The development and potential of midgut antigens as vaccine agents for novel mosquito 
and malaria control. 
Drugs 
TS3*CT920084 
The  development of a pharmacological model for anti-malarials which interfere with 
phospholipid metabolism. 
TS3*CT920145 
Identification  of  Plasmodium  falciparum  proteases  and  their  implications  for  the 
membrane organization the infected red cell. Design of high affinity receptors. 
TS3*CT930224 
Epidemiology of drug resistance in Plasmodium falciparum. 
TS3*CT940297 
DNA polymerases of malaria  parasites:  targets of choice,  both for treatment of the 
disease and for control of the infection. 
IC18*CT960056 
Phospholipid metabolism, a novel target for antimalarial drugs : development of the 
pharmacological model. 
IC18*CT960074 
Development of novel drugs against malaria. 
229 IC18CT970223 
Development of inhibitors of malarial  and  trypanosoma!  dihydrofolate reductase  as 
antiparasitic agents through combinatorial chemistry. 
IC18CT970227 
Detection of Plasmodium falciparum resistant to antifolate and sulphonamide drugs, 
and assessment of the efficacy of drug treatment using molecular methods. 
Intervention 
TS3*CT920070 
Community based malaria control under the guidance of health services: intervention 
study in Ecuador and Colombia. 
TS3*CT920083 
The consequences of malarial infection in pregnant women and their infants. 
TS3*CT930225 
Epidemiology and control of malaria in the province of Ratchaburi, Thailand. 
TS3*CT930251 
Three  years  controlled  trial  of  lambda-cyhalothrin  impregnated  bed  nets  and 
maloprim/placebo  chemosuppression  in  control  of  malaria  in  children  living  in  a 
holoendemic area of Sierra Leone. 
IC18CT970210 
Delayed  child  mortality and  insecticide-impregnated  materials : theoretic fantasy or 
harsh reality? 
2. Schistosomiasis 
Development of candidate vaccine antigens 
TS3*CT91  0030 
Development of a vaccine strategy against human and bovine schistosomiasis. 
TS3*CT920050 
Evaluation of defined antigen vaccines against Schistosoma bovis and s. japonicum in 
bovines. 
TS3*CT920118 
Cell mediated immunity to schistosomes. Evaluation of mechanisms operating against 
lung stage parasites, which might be exploited in a vaccine. 
TS3*CT940296 
Genetic and immunological factors in human resistance to Schistosoma mansoni. 
TS3*CT940303 
Cell mediated immunity to schistosomes: evaluation of mechanisms operating against 
lung stage parasites, which might be exploited in a vaccine. 
230 IC18CT970212 
Evaluation of the radiation-attenuated schistosome vaccine in primates as a model for 
human vaccine development. 
IC18CT970240 
Efficacy of RSH28GST as  an  antifecundity vaccine against Schistosoma haematobium 
infection (II)  : immune mechanisms in experimental models and in man. 
IC18CT970243 
Development of a vaccine for schistosomiasis japonica. 
Development of improved immunodiagnostic tools 
TS3*CT91  0040 
Quantitative  diagnosis  of  Schistosoma  infections  by  measurement  of  circulating 
antigens in serum and urine. 
IC18CT970241 
Field applicable antigen assays for human schistosomiasis : a multicentre development 
and implementation study. 
Epidemiology, Immunology and Morbidity of schistosome infection 
TS3*CT910041 
Epidemiology,  serology and  chemotherapy of Schistosoma  mansoni infections  in  a 
recently exposed community near Richard Toll, Senegal. 
TS3*CT920066 
Immunity and morbidity in human Schistosoma mansoni. 
TS3*CT920 117 
Epidemiology  and  transmission  dynamics  of  Schistosoma  infections  of  the  S. 
haematobium group in Mali, Senegal and Zambia. 
TS3*CT930237 
Markers of morbidity in Schistosoma haematobium infection. 
TS3*CT930248 
The epidemiology, immunology and morbidity of Schistosoma haematobium infections 
in diverse communities in Zimbabwe. 
TS3*CT940330 
Modeling  for  the  control  of  schistosomiasis  and  other  extensions  of  CEC/STD 
schistosomiasis research network activities. 
IC18*CT960041 
The development of a control strategy for Schistosoma haematobium in the Senegal 
river basin. 
IC18*CT960112 
lmmuno-epidemiology, chemotherapy and control of Schistosoma mansoni in recently 
established foci in northern Senegal. 
231 IC1BCT970228 
Patterns  of  praziquantel  usage  and  monitoring  of  possible  resistance  in  Africa. 
IC18CT970237 
Multidisciplinary studies of human schistosomiasis mansoni in Kenya and Uganda : new 
perspectives on immunity and morbidity. 
3. Trypanosomiasis 
TS3*CT91  0029 
A survey of Chagas cycles in Uruguay by use of genetic markers with special emphasis 
on reinfestation hazards of domestic structures by sylvatic cycles. 
TS3*CT920075 
Studies of the vaccine potential of recombinant invariant surface membrane proteins of 
the African trypanosomes. 
TS3*CT920092 
Biosystematics and adaptive trends in the genus rhodnius. 
TS3*CT920 155 
Experimental study of the impact of population clonal structure on relevant medical and 
biological properties of Trypanosoma cruzi. 
TS3*CT920 130 
Risk  of reinfestation from wild foci of Triatoma  infestans in  Bolivia, a country of the 
southern cone programme. 
TS3*CT930226 
Role of insect host defenses in trypanosome development in Chagas' disease vectors 
with emphasis on the activity of immune depression agents. 
TS3*CT930240 
Trypanocidal drugs: laboratory and field evaluation of novel controlled release systems. 
TS3*CT930246 
Characterization  of a  new therapeutic target on  African  trypanosomes:  the  glucose 
transporter and development of a vaccination strategy. 
TS3*CT940266 
Characterization  of the  immune  response  against  Trypanosoma  cruzi antigens  (GP 
50/55  and  urinary antigen)  involved  in  immunopathology and  their potential  use  in 
diagnostics. 
4. Leishmaniasis 
TS3*CT920052 
Synthetic peptide antigens as a tool for species-specific serodiagnosis of leishmaniasis 
with field applications in Brazil and Colombia. 
232 TS3*CT920113 
Visceral leishmaniasis: epidemiology and disease control. 
TS3*CT920123 
Recombinant antigens as serological tools for specific and sensitive tergumentary and 
visceral leishmaniasis diagnosis. 
TS3*CT920129 
Clonal variability of the parasite as a predictive tool for different clinical manifestations 
in tegumentary leishmaniasis of Peru and Bolivia. 
TS3*CT930245 
Visceral leishmaniasis in the Sudan: an epidemiological and entomological study. 
TS3*CT930247 
Molecular techniques for vector and  parasite  identification  applied to a  pilot vector 
control study of leishmaniasis. 
TS3*CT930253 
Comparative evaluation of classical and molecular tools for the diagnosis and for eco-
epidemiological investigations of leishmaniasis. 
TS3*CT940263 
Analysis of phosphofructokinase and pyruvate kinase of leishmania, potential targets for 
new drugs. 
TS3*CT940319 
Dissection of the mechanisms leading to the selective triggering of protective and non 
protective murine T-cell responses following infection with Leishmania: relevance for the 
induction and detection of human protective immunity. 
IC1BCT960079 
Characterisation of phosphofructokinase and pyruvate kinase of Leishmania. Potential 
targets for new drugs. 
IC1BCT960084 
Antileishmanial and antitrypanosomal activities of alkyl-lysophospholipids. 
IC1BCT960123 
Clinical  variability  of  American  tegumentary  leishmaniasis  in  Peru  and  Bolivia: 
relationship  with  polymorphism  of the  parasite  within  the  Leishmania  braziliensis 
complex of species (syn. subgenus viannia). 
ICIBCT970213 
Host-parasite  relationship  in  canine  visceral  leishmaniasis  (L.  infantum/L.  chagasl) 
development and validation of the dog model. 
IC18CT970220 
New trypanocidal compounds based on inhibitors of glycolysis and the specific import 
of these inhibitors into the parasite. 
233 JC18CT970225 
Production and characterisation of synthetic inhibitors of parasite of proteases as drug 
candidates for the predominant protozoal diseases South America and other developing 
regions. 
JC18CT970252 
Molecular genetics, cellular immunology and peptide-chemistry for the development on 
control tools against leishmaniosis. 
IC18CT970256 
Investigations on polymorphic genomic markers in relation to applied field research on 
the  biology  of leishmania  parasites  in  various  eco-epidemiological  settings  in  the 
Mediterranean basin. 
5. Filariases 
Lymphatic Filariasis 
TS3*CT91  0031 
Dynamics of lymphatic filarial infection at the cellular and molecular level. 
TS3*CT920141 
Studies on the development of protective immunity in lymphatic filariasis caused  by 
Brugia malayi in an age-graded population. 
JC 18CT9500  14 
Immunology of lymphatic filariasis T-cell responsiveness and protective antigens. 
JC18CT950026 
Vaccination against filarial infections/use of Loa loa a murine model for identification of 
protective mechanisms and antigens. 
JC18CT970245 
Immunology of lymphatic filariasis. 
/C18CT970257 
Brancroftian filariasis: the interrelationship between transmission, infection, host response 
and clinical manifestations in endemic communities before and after intervention. 
Onchocerciasis 
TS3*CT91  0037 
Characterization and utilization of two new filarial models for investigation of immunity, 
chemotherapy and pathology. 
TS3*CT920056 
Can  cattle protect man from onchocerciasis?: reduction of similium vectorial capacity 
and crossreacting immunity as factors of zooprophylaxis. 
TS3*CT920058 
Immune responses in onchocerciasis : studies with molecular probes in patients and an 
animal model. 
234 TS3*CT920096 
Protein  components of chemoreceptor organelles  and  of the  cuticle  of nematodes: 
identification and cloning of  the genes, production as recombinant proteins and analysis 
of the immune response elicited. 
TS3*CT930235 
Genetic variation in Onchocerca volvulus from Cameroon, Tanzania and Sierra Leone. 
TS3*CT940271 
Anti-oxidant enzymes in filarial nematodes: their role in defense and persistence. 
Chemotherapy 
TS3*CT920057 
lvermectin -facilitated immunity in onchocerciasis. 
TS3*CT920082 
Exploitation of targets for chemotherapy in polyamine metabolism of filarial worms. 
6. Other Parasites 
TS3*CT910038 
Identification of candidate protective molecules of E.  granulosus and development of 
combined Salmonella vaccines. 
TS3*CT91 0039 
Molecular approach to Echinococcus development. 
TS3*CT940270 
Human cystic and alveolar echinococcosis in Northwest China: community screening, 
case follow-up and transmission studies. 
TS3*CT940277 
Control  of  Taenia  solium  cysticercosis  through  specific  diagnosis,  systematic 
epidemiology and development of a recombinant vaccine. 
TS3*CT930219 
Field  evaluation  and  further  characterization  of  an  invasive-specific  monoclonal 
antibody against Entamoeba histolytica. 
TS3*CT930227 
Immunological  correlates  of resistance  and  susceptibility to  infections with  gastro-
intestinal nematodes in North East Brazil. 
TS3*CT940294 
Integrated  multidisciplinary  study  of  human  fascioliasis  in  the  Bolivian  northern 
Altiplano. 
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